"ChEMBL ID";"Assay Type";"Description";"Organism";"Compounds";"Activities";"BAO Format ID";"BAO Format";"Confidence Score";"Confidence Label";"Strain";"Source";"Tax ID";"Tissue ChEMBL ID";"Tissue Name";"Cell Type";"Subcellular Fraction";"Document ChEMBL ID";"PubMed ID";"DOI";"Year";"Journal";"Volume";"First Page";"Last Page";"Assay Parameters";"Assay Classification L1";"Assay Classification L2";"Assay Classification L3";"Variant Sequence Accession";"Variant Sequence Mutation"
"CHEMBL1614410";"F";"PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)]";"Homo sapiens";"17175";"17193";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL763715";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line PC3";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1614045";"F";"PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]";"Plasmodium falciparum";"390";"392";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614331";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a. (Class of assay: confirmatory) ";"Homo sapiens";"6328";"6343";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613914";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ";"Homo sapiens";"39332";"39754";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794311";"F";"PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855]";"";"20124";"20420";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613900";"F";"PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]";"";"627";"629";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL699350";"F";"In vitro inhibitory activity against MCF-7 mammary cell line";"Homo sapiens";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1126952";"8340911";"10.1021/jm00067a005";"1993";"J Med Chem";"36";"2084";"2090";"";"";"";"";"";""
"CHEMBL966979";"F";"Cytotoxicity against human HeLa cells expressing telomerase after 96 hrs by MTT assay";"Homo sapiens";"44";"44";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1140074";"18754611";"10.1021/jm800160v";"2008";"J Med Chem";"51";"5566";"5574";"";"";"";"";"";""
"CHEMBL748128";"F";"Antitumor activity against human ovarian OVCAR-3 cell lines.";"Homo sapiens";"26";"26";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL1613997";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response. (Class of assay: confirmatory) ";"Rattus norvegicus";"673";"695";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10116";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL663630";"F";"Compound was evaluated for the increase in melting temperature (delta Tm) for calf Thymus DNA on interaction with Ligand at DNAp to ligand ratio 10:1";"Bos taurus";"14";"14";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL1794352";"F";"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]";"";"59860";"60142";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL665844";"B";"CT-DNA binding required to produce a 50% drop in fluorescence of DNA-bound ethidium.";"Bos taurus";"19";"19";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1135709";"11806721";"10.1021/jm011004x";"2002";"J Med Chem";"45";"696";"702";"";"";"";"";"";""
"CHEMBL1794536";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638]";"";"7413";"7660";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855046";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM verapamil by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1738186";"B";"PUBCHEM_BIOASSAY: C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431]";"Salmonidae";"130";"130";"BAO_0000217";"biochemical format";"3";"3 - Target assigned is molecular non-protein target";"";"PubChem BioAssays";"8015";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL687286";"F";"Relative cytotoxicity against Human promyelocytic Leukemia(HL-60) cells; Value is in range, activity expressed as IC90";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1132240";"10377219";"10.1021/jm980324m";"1999";"J Med Chem";"42";"2136";"2144";"";"";"";"";"";""
"CHEMBL692884";"F";"Effect of compound as percent survival at dose of 100n g/mL on HT-29 cell line after 72 hours";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1964065";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ";"";"34103";"34374";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SR";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614114";"F";"PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ";"";"742";"745";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL872736";"F";"Anti-tumor activity against human OVCAR-3 ovarian cancer cell lines by using MTT assay";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL652119";"F";"Concentration required to inhibit CH1-cell growth by 50%";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CH1";"";"CHEMBL1131065";"9703471";"10.1021/jm9801105";"1998";"J Med Chem";"41";"3253";"3260";"";"";"";"";"";""
"CHEMBL1286018";"F";"Resistance index, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1275381";"20961767";"10.1016/j.bmc.2010.08.025";"2010";"Bioorg Med Chem";"18";"8119";"8133";"";"";"";"";"";""
"CHEMBL1614142";"F";"PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]";"";"602";"606";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1908289";"A";"Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL939283";"B";"Inhibition of human BCRP mediated mitoxantrone accumulation in mitoxantrone resistant MCF7 cells at 5 uM by flow cytometry";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1143908";"17964170";"10.1016/j.bmc.2007.10.006";"2008";"Bioorg Med Chem";"16";"171";"180";"";"";"";"";"";""
"CHEMBL965578";"B";"Inhibition of mouse brain MAOA";"Mus musculus";"385";"391";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1152129";"18834112";"10.1021/jm800656v";"2008";"J Med Chem";"51";"6740";"6751";"";"";"";"";"";""
"CHEMBL1908083";"A";"Specific activity of expressed human recombinant UGT1A6";"Homo sapiens";"122";"166";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1907987";"10836148";"10.1146/annurev.pharmtox.40.1.581";"2000";"Annu Rev Pharmacol Toxicol";"40";"581";"616";"";"";"";"";"";""
"CHEMBL660976";"B";"In vitro calf thymus DNA binding affinity by ethidium bromide displacement";"Bos taurus";"12";"12";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1135121";"12031316";"10.1016/s0960-894x(02)00218-4";"2002";"Bioorg Med Chem Lett";"12";"1443";"1446";"";"";"";"";"";""
"CHEMBL1955303";"F";"Cytotoxicity against human H1299 cells assessed as cell growth at 1 uM after 48 hrs by MTT assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL1949585";"22357112";"10.1016/j.ejmech.2012.01.044";"2012";"Eur J Med Chem";"50";"102";"112";"";"";"";"";"";""
"CHEMBL1820601";"F";"Ratio of IC50 for homoharringtonine300-resistant human K562 cells to IC50 for human K562 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL1697722";"A";"Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset";"";"530";"544";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1697692";"20553011";"10.1021/tx1000865";"2010";"Chem Res Toxicol";"23";"1215";"1222";"";"";"";"";"";""
"CHEMBL1794467";"F";"PUBCHEM_BIOASSAY: Inhibitors of USP1/UAF1: Pilot qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504878]";"";"1930";"2027";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL708947";"F";"Antitumor activity against sensitive L1210 murine leukemia cell lines.";"Mus musculus";"26";"26";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL1955305";"F";"Cytotoxicity against human H1299 cells assessed as cell growth at 100 uM after 48 hrs by MTT assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL1949585";"22357112";"10.1016/j.ejmech.2012.01.044";"2012";"Eur J Med Chem";"50";"102";"112";"";"";"";"";"";""
"CHEMBL1764596";"F";"Cytotoxicity against human HL60/MX2 cells";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL1759981";"21439821";"10.1016/j.bmcl.2011.02.106";"2011";"Bioorg Med Chem Lett";"21";"2259";"2263";"";"";"";"";"";""
"CHEMBL1794584";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]";"";"63980";"64461";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL967539";"F";"Growth inhibition of etoposide-resistant human K/VP.5 cells after 72 hrs by MTS method";"Homo sapiens";"10";"10";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1157147";"18258442";"10.1016/j.bmc.2008.01.033";"2008";"Bioorg Med Chem";"16";"3959";"3968";"";"";"";"";"";""
"CHEMBL816202";"F";"Activity against human colon carcinoma multi drug resistant (MDR)-WiDr cell line.";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL712920";"F";"Antitumor activity against human mammary carcinoma sensitive MXF7 breast cell line.";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL845915";"F";"Resistance index measured as the ratio of IC50 of LoVo/Dx cell line to that of LoVo cell line.";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1131450";"9876113";"10.1021/jm9804432";"1998";"J Med Chem";"41";"5429";"5444";"";"";"";"";"";""
"CHEMBL1909184";"B";"DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613928";"F";"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]";"Homo sapiens";"336";"339";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855617";"F";"Antiproliferative activity against P388 cells by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1909097";"B";"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)";"Sus scrofa";"871";"1742";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"9823";"CHEMBL3638187";"Heart";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL927383";"F";"Cytotoxicity against human K562 cells after 5 days by XTT assay";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1141448";"18076140";"10.1021/np070332i";"2007";"J Nat Prod";"70";"1884";"1888";"";"";"";"";"";""
"CHEMBL1613941";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells. (Class of assay: confirmatory) ";"Homo sapiens";"308";"309";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL929842";"F";"Cytotoxicity against human HL60 cells after 48 hrs by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL1794499";"F";"PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856]";"";"13678";"13785";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613805";"F";"PUBCHEM_BIOASSAY: Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells. (Class of assay: confirmatory) ";"Homo sapiens";"270";"271";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"MEF";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697779";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents";"Rodentia";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9989";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL708503";"F";"In vitro cytotoxicity was tested against human colon adenocarcinoma LoVo/Dx resistant cell line";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1132293";"10411474";"10.1021/jm9805586";"1999";"J Med Chem";"42";"2535";"2541";"";"";"";"";"";""
"CHEMBL1614670";"A";"Volume of distribution at steady state in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1909130";"B";"DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909155";"B";"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"5";"5 - Multiple direct protein targets may be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638246";"Spinal cord";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909156";"B";"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909148";"B";"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909206";"B";"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909111";"B";"DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909089";"B";"DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909143";"B";"DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909214";"B";"DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL707961";"F";"Inhibitory concentration of compound against proliferation of murine leukemia L1210 cell line";"Mus musculus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1135121";"12031316";"10.1016/s0960-894x(02)00218-4";"2002";"Bioorg Med Chem Lett";"12";"1443";"1446";"";"";"";"";"";""
"CHEMBL1909139";"B";"DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909162";"B";"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909168";"B";"DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909188";"B";"DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909192";"B";"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909137";"B";"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909112";"B";"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909211";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909191";"B";"DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)";"Bos taurus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9913";"CHEMBL3638197";"Uterus";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909095";"B";"DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638191";"Lens of camera-type eye";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614079";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ";"Homo sapiens";"22998";"23070";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909215";"B";"DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909129";"B";"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"1321-N1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909177";"B";"DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"IMR-32";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909181";"B";"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909131";"B";"DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf21";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909132";"B";"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909153";"B";"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909166";"B";"DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614531";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ";"Homo sapiens";"9451";"9571";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613995";"F";"PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ]";"Homo sapiens";"6267";"6303";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL929839";"F";"Cytotoxicity against human NCI-H460 cells at 4 ug/ml after 48 hrs by SRB assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL848847";"F";"Resistance index was determined by ratio of cytotoxicities of human colon adenocarcinoma (LoVo) cells to human colon adenocarcinoma resistant to doxorubicin (LoVo Dx) cells.";"";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1133386";"10698460";"10.1016/s0960-894x(99)00689-7";"2000";"Bioorg Med Chem Lett";"10";"305";"308";"";"";"";"";"";""
"CHEMBL1654783";"F";"Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay";"Mycobacterium smegmatis";"24";"48";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1772";"";"";"";"";"CHEMBL1649296";"19786608";"10.1128/aac.00803-09";"2009";"Antimicrob Agents Chemother";"53";"5279";"5283";"";"";"";"";"";""
"CHEMBL1772488";"F";"Cytotoxicity against human HCT116 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1770094";"21444205";"10.1016/j.bmcl.2011.03.021";"2011";"Bioorg Med Chem Lett";"21";"3110";"3112";"";"";"";"";"";""
"CHEMBL1614537";"F";"PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]";"";"476";"478";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL873001";"F";"Cytotoxicity against human SCLC cells resistant to cisplatin (SCLC/CDDP)";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SCLC";"";"CHEMBL1127036";"8258835";"10.1021/jm00077a016";"1993";"J Med Chem";"36";"4108";"4112";"";"";"";"";"";""
"CHEMBL704611";"F";"In vitro cytotoxicity on human colon adenocarcinoma (LoVo ) tumor cell line.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1131450";"9876113";"10.1021/jm9804432";"1998";"J Med Chem";"41";"5429";"5444";"";"";"";"";"";""
"CHEMBL746226";"F";"Percentage ratio of treated animals to cured animals against P388 leukemia (day 30 surv)";"Mus musculus";"42";"42";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124226";"3397990";"10.1021/jm00403a009";"1988";"J Med Chem";"31";"1527";"1539";"";"";"";"";"";""
"CHEMBL1041307";"B";"Inhibition of Enterobacter cloacae AmpC using nitrocefin as substrate at 25 uM after 15 mins by microtiter plate assay";"Enterobacter cloacae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"550";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL818943";"F";"Antitumor activity against human melanoma UACC375 cell line.";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"UACC-375";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL708502";"F";"In vitro cytotoxicity on human colon adenocarcinoma resistant to doxorubicin (LoVo/Dx ) tumor cell line.";"Homo sapiens";"38";"38";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1131450";"9876113";"10.1021/jm9804432";"1998";"J Med Chem";"41";"5429";"5444";"";"";"";"";"";""
"CHEMBL1614310";"F";"PUBCHEM_BIOASSAY: Validation of Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ";"Homo sapiens";"280";"280";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737902";"F";"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355]";"";"75513";"75614";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1820602";"F";"Ratio of IC50 for vinblastine100-resistant human CCRF-CEM cells to IC50 for human CCRF-CEM cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL1964062";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"13726";"13816";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DMS-273";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909185";"B";"DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)";"";"871";"1742";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909203";"B";"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909183";"B";"DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)";"Mus musculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"ICR";"DrugMatrix";"10090";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909124";"B";"DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909136";"B";"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909121";"B";"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909098";"B";"DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638251";"Adrenal gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL706332";"F";"Tested in vitro against murine L1210 leukemia.";"Mus musculus";"78";"78";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123657";"3806589";"10.1021/jm00384a021";"1987";"J Med Chem";"30";"121";"131";"";"";"";"";"";""
"CHEMBL1909199";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909109";"B";"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909127";"B";"DRUGMATRIX: Chemokine CXCR1 (IL-8A)";"";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909135";"B";"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909141";"B";"DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909171";"B";"DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909208";"B";"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"New Zealand albino";"DrugMatrix";"9986";"CHEMBL3638205";"Urinary bladder";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909209";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909101";"B";"DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"T47D";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614521";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]";"Homo sapiens";"6501";"6540";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL802473";"F";"Bacterial mutagenicity was measured against Salmonella Typhimurium TA97a at dose range of 0-400 ug/plate";"Salmonella enterica subsp. enterica serovar Typhimurium";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"90371";"";"";"";"";"CHEMBL1131105";"9733500";"10.1021/jm980167r";"1998";"J Med Chem";"41";"3748";"3752";"";"";"";"";"";""
"CHEMBL1794580";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"130891";"131175";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737980";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493163, AID504444, AID504648]";"Homo sapiens";"338";"338";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613922";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) ";"Homo sapiens";"83";"83";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL918569";"F";"Antiproliferative activity against human MDA-MB-231 cells by WST-1 method after 72 hrs";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1142974";"17335189";"10.1021/jm061410m";"2007";"J Med Chem";"50";"1716";"1719";"";"";"";"";"";""
"CHEMBL705267";"F";"Dose level for 50% inhibition of L1210 cell growth was measured after 48 hr.";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"";"";"";"";""
"CHEMBL696140";"F";"Percent inhibition at G2/M phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29 cell line";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1963991";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"36454";"36745";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HOP-92";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1014323";"B";"Binding affinity to poly(dA).poly(dT) DNA assessed as change in melting temperature";"";"3";"3";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1152837";"18403056";"10.1016/j.ejmech.2008.02.011";"2008";"Eur J Med Chem";"43";"2307";"2315";"";"";"";"";"";""
"CHEMBL907426";"F";"Antiproliferative activity against HT29 cells by MTT assay after 72 hrs";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1149365";"16824751";"10.1016/j.bmcl.2006.06.074";"2006";"Bioorg Med Chem Lett";"16";"4822";"4825";"";"";"";"";"";""
"CHEMBL1267246";"F";"Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay";"Plasmodium falciparum 7G8";"572";"601";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"57266";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1963915";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay. (Class of assay: confirmatory) ";"";"463";"469";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613933";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]";"Homo sapiens";"7185";"7272";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL666638";"F";"Increase in Melting temperature (delta Tm) for Clostridium perfringens DNA on interaction against ligand (mole ratio of 10:1)";"Clostridium perfringens";"7";"7";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"1502";"";"";"";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL2076208";"F";"TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells";"";"28";"28";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK-II";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1614086";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 918 ]";"Homo sapiens";"411";"417";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614275";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]";"Giardia intestinalis";"14724";"14961";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"5741";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL995341";"B";"Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM";"Homo sapiens";"26";"26";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1136967";"19463000";"10.1021/jm9003297";"2009";"J Med Chem";"52";"3784";"3793";"";"";"";"";"";""
"CHEMBL1963990";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ";"";"40970";"41313";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"UO-31";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614257";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ";"Homo sapiens";"37649";"37911";"BAO_0000019";"assay format";"5";"5 - Multiple direct protein targets may be assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1786568";"F";"Cytotoxicity against human HL60 cells after 24 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1781940";"21507644";"10.1016/j.bmcl.2011.03.089";"2011";"Bioorg Med Chem Lett";"21";"2845";"2849";"";"";"";"";"";""
"CHEMBL1741322";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1772159";"F";"Antiproliferative activity against human RKOp27 cells after 48 hrs by XTT assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RKOp27";"";"CHEMBL1770061";"21458262";"10.1016/j.bmcl.2011.03.013";"2011";"Bioorg Med Chem Lett";"21";"3117";"3121";"";"";"";"";"";""
"CHEMBL2346395";"F";"Antiproliferative activity against human RKOp27 cells after 48 hrs";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RKOp27";"";"CHEMBL2331492";"23395656";"10.1016/j.bmcl.2013.01.022";"2013";"Bioorg Med Chem Lett";"23";"1846";"1852";"";"";"";"";"";""
"CHEMBL663631";"F";"Compound was evaluated for the increase in melting temperature (delta Tm) for calf Thymus DNA on interaction with Ligand at DNAp to ligand ratio 20:1";"Bos taurus";"14";"14";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL1614280";"F";"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)]";"Homo sapiens";"13811";"13828";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1654781";"F";"Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay";"Mycobacterium smegmatis";"24";"48";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1772";"";"";"";"";"CHEMBL1649296";"19786608";"10.1128/aac.00803-09";"2009";"Antimicrob Agents Chemother";"53";"5279";"5283";"";"";"";"";"";""
"CHEMBL1955300";"F";"Inhibition of human TERT expression in H1299 cells at 1 uM after 24 hrs by secreted alkaline phosphatase reporter gene assay relative to control";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL1949585";"22357112";"10.1016/j.ejmech.2012.01.044";"2012";"Eur J Med Chem";"50";"102";"112";"";"";"";"";"";""
"CHEMBL1963961";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ";"";"39679";"40011";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"CCRF-CEM";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1267249";"F";"Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"567";"596";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"GB4";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1267247";"F";"Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay";"Plasmodium falciparum D10";"426";"451";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"478861";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1267248";"F";"Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"340";"365";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Dd2";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1908080";"A";"Specific activity of expressed human recombinant UGT1A1";"Homo sapiens";"166";"221";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1907987";"10836148";"10.1146/annurev.pharmtox.40.1.581";"2000";"Annu Rev Pharmacol Toxicol";"40";"581";"616";"";"";"";"";"";""
"CHEMBL619302";"F";"In vitro inhibition of tumor cell growth in the human myeloma 8226 system.";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RPMI-8226";"";"CHEMBL1125355";"1447730";"10.1021/jm00101a001";"1992";"J Med Chem";"35";"4259";"4263";"";"";"";"";"";""
"CHEMBL759438";"F";"Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 1.5 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:1.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL967537";"B";"Binding affinity to calf thymus DNA assessed as change in thermal stability at 2 uM in tris-HCl buffer at pH 7.5 by thermal denaturation assay";"Bos taurus";"10";"10";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1157147";"18258442";"10.1016/j.bmc.2008.01.033";"2008";"Bioorg Med Chem";"16";"3959";"3968";"";"";"";"";"";""
"CHEMBL929844";"F";"Ratio of GI50 for human HL60/MX2 cells to GI50 for human HL60 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL850358";"F";"The quotient of the IC50 in the myocytes divided by the mean IC50 in the three cell lines";"";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL880739";"F";"Compound was tested for tumor cell growth inhibition against HL 60 cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1150507";"None";"10.1016/S0960-894X(00)80385-6";"1992";"Bioorg Med Chem Lett";"2";"659";"662";"";"";"";"";"";""
"CHEMBL753743";"F";"In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.5 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123842";"3625713";"10.1021/jm00392a028";"1987";"J Med Chem";"30";"1682";"1686";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL879451";"F";"Percent increase in life span when given at a dose in P388 leukemia cells of mice";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1925790";"F";"Cytotoxicity against human LoVo cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1921783";"22011244";"10.1021/jm200984x";"2011";"J Med Chem";"54";"8224";"8227";"";"";"";"";"";""
"CHEMBL806790";"F";"Number of mice dead with toxic dose was measured on S180 tumor cell at 0.75 mg/kg (cumulative dose 16 mg/kg) introduced (in vivo) ip";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL715479";"F";"Tested for inhibitory activity against human tumor cell line UA375 of melanoma using sulforhodamine B assay.";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"UACC-375";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL1041315";"F";"Bactericidal activity against imipenem-non resistant Escherichia coli BL21(DE3) at 2.1 ug/mL after 24 hrs by broth microdilution method";"Escherichia coli BL21(DE3)";"1";"1";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL621429";"F";"Tested against A549 lung carcinoma in the sulforhodamine B assay.";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL664588";"F";"Apparent equilibrium constant for binding to calf thymus DNA by competitive displacement fluorometric assay";"Bos taurus";"8";"8";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1134414";"11563932";"10.1021/jm010917o";"2001";"J Med Chem";"44";"3329";"3333";"";"";"";"";"";""
"CHEMBL824871";"F";"Cytotoxicity against human H460M cancer cell line was determined after 144 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL874880";"A";"Cytotoxicity against human H460M cancer cell line was determined after 1 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL701570";"F";"Compound was tested in vitro for cytotoxicity against MDR cell line K562R (72 hr exposure to compound)";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL696139";"F";"Percent inhibition at G1 phase of cell cycle at a dose of 25 ng/mL after 72 hours of induction in HT-29 cell line";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL679274";"F";"EBV-positive nasopharyngeal colony count obtained from the examination of uniform plate surface areas after a dose of 0.1 ug/mL";"epstein barr virus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10376";"";"";"EBV-positive nasopharyngeal cell line";"";"CHEMBL1122406";"6685770";"10.1021/jm00366a004";"1983";"J Med Chem";"26";"1679";"1686";"";"";"";"";"";""
"CHEMBL700736";"F";"Effect of dosing on L1210 leukemia in vivo measured as mean at 0.75 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"standard_type:DOSE standard_relation:= standard_value:0.75 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL802474";"F";"Bacterial mutagenicity was measured against Salmonella Typhimurium TA98 at dose range of 0-10 ug/plate";"Salmonella enterica subsp. enterica serovar Typhimurium";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"90371";"";"";"";"";"CHEMBL1131105";"9733500";"10.1021/jm980167r";"1998";"J Med Chem";"41";"3748";"3752";"";"";"";"";"";""
"CHEMBL757078";"F";"In vivo antitumor activity against P388 leukemia cells at a dose of 1.5 mg/kg as a single injection and 3 mg/kg as a total";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122737";"6699870";"10.1021/jm00369a002";"1984";"J Med Chem";"27";"253";"255";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL636873";"F";"Inhibitory activity against AUC375 cell line";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"UACC-375";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL1055754";"F";"Cytotoxicity against human HL60 cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL732191";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.8 mg/kg, expressed as body weight change";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.8 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL707837";"F";"Tested in vitro for inhibitory activity against L1210 murine leukemia";"Mus musculus";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL1963945";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ";"";"26355";"26576";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"Hs-578T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963895";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) ";"";"39421";"39735";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-OV-3";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL662306";"F";"Tested for the cytotoxicity against the repair deficient xrs-6 chinese hamster ovary cell line";"Cricetulus griseus";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10029";"";"";"ovary";"";"CHEMBL1127394";"7525959";"10.1021/jm00048a017";"1994";"J Med Chem";"37";"3819";"3827";"";"";"";"";"";""
"CHEMBL757012";"F";"Compound was tested against P388 leukemia at % increase in life span (ILS) in mice at 1.6 mg/kg dosage.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"standard_type:DOSE standard_relation:= standard_value:1.6 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1963913";"F";"PUBCHEM_BIOASSAY: Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"1511";"1512";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855056";"F";"Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant P388 cells";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1103695";"B";"Binding affinity to calf thymus DNA assessed as temperature required to cause 50% of DNA denatured at 10 uM by thermal denaturation assay";"Bos taurus";"13";"13";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1157022";"20064676";"10.1016/j.ejmech.2009.12.047";"2010";"Eur J Med Chem";"45";"1430";"1437";"";"";"";"";"";""
"CHEMBL1103696";"B";"Displacement of ethidium bromide from calf thymus DNA assessed as decrease of fluorescence of bound ethidium bromide by fluorometric assay";"Bos taurus";"13";"13";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1157022";"20064676";"10.1016/j.ejmech.2009.12.047";"2010";"Eur J Med Chem";"45";"1430";"1437";"";"";"";"";"";""
"CHEMBL852135";"F";"Resistance index is the ratio of IC50 of resistant cell line/IC50 of sensitive cell line";"";"20";"20";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL745102";"A";"The compound was tested for antitumor activity against P388 murine leukemia at 4 (mg/kg/day) dose; 43/48 -no. of toxic deaths/no. of mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL740565";"F";"In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.4 mg/kg, expressed as long time survivors tested in 12 animals";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.4 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL3997702";"F";"Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 2 mg/kg, iv administered twice weekly for 2 weeks";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1.2";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL742839";"F";"Tested for antitumor activity against P388 murine leukemia";"Mus musculus";"11";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL2114811";"F";"PubChem BioAssay. Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Hit Validation. (Class of assay: confirmatory) ";"Homo sapiens";"484";"484";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964099";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) ";"";"25166";"25375";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"BT-549";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964009";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) ";"";"36915";"37215";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"RXF 393";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL846843";"F";"Dose modifying factor expressed as the ratio of IC50 for the chemotherapy drug to IC50 for drug + GG918; Range = 1.2-1850";"";"1";"1";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1146678";"15012986";"10.1016/j.bmcl.2003.12.015";"2004";"Bioorg Med Chem Lett";"14";"881";"885";"";"";"";"";"";""
"CHEMBL1613970";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Induce Erasure of Genomic Imprints. (Class of assay: confirmatory) ";"";"5084";"5184";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1285395";"F";"Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay";"Saccharomyces cerevisiae";"66";"66";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"AD1-8u";"Scientific Literature";"4932";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL4322536";"B";"Inhibition of BCRP in human HEK293/R2 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL1772156";"F";"Antiproliferative activity against human SKOV3 cells after 48 hrs by XTT assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL1770061";"21458262";"10.1016/j.bmcl.2011.03.013";"2011";"Bioorg Med Chem Lett";"21";"3117";"3121";"";"";"";"";"";""
"CHEMBL708810";"F";"Effective concentration required to inhibit by 50% the growth of L1210 cells";"Mus musculus";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1123978";"3172129";"10.1021/jm00118a015";"1988";"J Med Chem";"31";"1956";"1959";"";"";"";"";"";""
"CHEMBL1285393";"F";"Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay";"Saccharomyces cerevisiae";"66";"66";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"AD1-8u";"Scientific Literature";"4932";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL1738498";"F";"PUBCHEM_BIOASSAY: Discovery of Small Molecule Probes for H1N1 Influenza NS1A. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504399]";"Influenza A virus (A/California/07/2009(H1N1))";"1012";"1013";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"641809";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794345";"F";"PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]";"Plasmodium falciparum";"170142";"170462";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964037";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ";"";"40395";"40740";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-3";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL665014";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line DU145";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"DU-145";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL848215";"F";"It is the ratio of IC50 for LOVO tumor cell line to that of LOVO/DOXO cell line.";"";"4";"4";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"LOVO/DOXO";"";"CHEMBL1125604";"1875336";"10.1021/jm00112a009";"1991";"J Med Chem";"34";"2373";"2380";"";"";"";"";"";""
"CHEMBL692407";"F";"In vitro cytotoxicity was tested against human colon adenocarcinoma HT-29 cell line";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132293";"10411474";"10.1021/jm9805586";"1999";"J Med Chem";"42";"2535";"2541";"";"";"";"";"";""
"CHEMBL1737868";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493143, AID504466]";"Homo sapiens";"244";"245";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL693253";"F";"Compound was tested for tumor cell growth inhibition against HeLa cell line";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1150507";"None";"10.1016/S0960-894X(00)80385-6";"1992";"Bioorg Med Chem Lett";"2";"659";"662";"";"";"";"";"";""
"CHEMBL1697798";"A";"FDA HLAED, alkaline phosphatase increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1909122";"B";"DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909138";"B";"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909170";"B";"DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909142";"B";"DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614110";"A";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ]";"Homo sapiens";"3370";"3649";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909119";"B";"DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HT-29";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909120";"B";"DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909105";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL679417";"F";"Cytotoxic potency required to inhibit G-361 cell growth by 50%";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"G-361";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL1955302";"F";"Inhibition of human TERT expression in H1299 cells at 100 uM after 24 hrs by secreted alkaline phosphatase reporter gene assay relative to control";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL1949585";"22357112";"10.1016/j.ejmech.2012.01.044";"2012";"Eur J Med Chem";"50";"102";"112";"";"";"";"";"";""
"CHEMBL1772157";"F";"Antiproliferative activity against human SF268 cells after 48 hrs by XTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1770061";"21458262";"10.1016/j.bmcl.2011.03.013";"2011";"Bioorg Med Chem Lett";"21";"3117";"3121";"";"";"";"";"";""
"CHEMBL845602";"F";"Concentration required to reduce ethidium bromide fluorescence to 50% of control in presence of calf thymus DNA; ND is Not Determined.";"";"2";"2";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1127394";"7525959";"10.1021/jm00048a017";"1994";"J Med Chem";"37";"3819";"3827";"";"";"";"";"";""
"CHEMBL4196661";"F";"Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL4196011";"29407981";"10.1016/j.ejmech.2018.01.074";"2018";"Eur J Med Chem";"146";"564";"576";"";"";"";"";"";""
"CHEMBL1925791";"F";"Cytotoxicity against human LoVo cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1921783";"22011244";"10.1021/jm200984x";"2011";"J Med Chem";"54";"8224";"8227";"";"";"";"";"";""
"CHEMBL4196664";"F";"Antiproliferative activity against human K562 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4196011";"29407981";"10.1016/j.ejmech.2018.01.074";"2018";"Eur J Med Chem";"146";"564";"576";"";"";"";"";"";""
"CHEMBL4196665";"F";"Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4196011";"29407981";"10.1016/j.ejmech.2018.01.074";"2018";"Eur J Med Chem";"146";"564";"576";"";"";"";"";"";""
"CHEMBL886127";"F";"Growth inhibition of topoisomerase 2 mutated mitoxantrone-resistant MX2 cells by Alamar blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MX2";"";"CHEMBL1139925";"17418582";"10.1016/j.bmc.2007.03.067";"2007";"Bioorg Med Chem";"15";"4237";"4246";"";"";"";"";"";""
"CHEMBL1794486";"F";"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813]";"";"10834";"10946";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1041302";"B";"Inhibition of IMP1 using nitrocefin as substrate at 56 uM after 15 mins by microtiter plate assay";"";"3";"3";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL801011";"T";"Cardiotoxicity was measured by using Neonatal rat heart myocyte assay";"Rattus norvegicus";"25";"25";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10116";"CHEMBL3638187";"Heart";"";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL3137738";"T";"Comments (NB not yet translated). [column 'COMMENTAIRES' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137736";"T";"Animal toxicity known. [column 'TOXIC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL967541";"B";"Inhibition of human topoisomerase 2alpha decantation activity";"Homo sapiens";"10";"10";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1157147";"18258442";"10.1016/j.bmc.2008.01.033";"2008";"Bioorg Med Chem";"16";"3959";"3968";"";"";"";"";"";""
"CHEMBL1041295";"B";"Inhibition of VIM2 using CCF2 as substrate after 15 mins by FRET assay";"";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1614240";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ";"Homo sapiens";"5299";"5346";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL660973";"B";"In vitro inhibition of calf thymus DNA/ethidium bromide complex formation.";"";"19";"19";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1135469";"12036369";"10.1021/jm011117g";"2002";"J Med Chem";"45";"2599";"2609";"";"";"";"";"";""
"CHEMBL1738606";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398]";"Homo sapiens";"13828";"13960";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL708949";"F";"Antitumor activity against murine leukemia L1210 cell line.";"Mus musculus";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL1697778";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans";"Homo sapiens";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL929832";"F";"Cytotoxicity against human SF268 cells after 48 hrs by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL3240728";"A";"Cytotoxicity against HEK293 cells overexpressing ABCG2 after 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL3232774";"24611893";"10.1021/jm401879z";"2014";"J Med Chem";"57";"2930";"2941";"";"";"";"";"";""
"CHEMBL1741323";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3253049";"F";"Ratio of adriamycin to compound for inhibition of DNA synthesis in mouse L5178Y cells";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"";"";"";"";""
"CHEMBL3997703";"F";"Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1.2";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2078493";"F";"TP_TRANSPORTER: drug resistance in BCRP-expressing MEF3.8 cells";"";"7";"7";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MEF3.8";"";"CHEMBL2074346";"12649196";"None";"2003";"Cancer Res";"63";"1339";"1344";"";"";"";"";"";""
"CHEMBL1285394";"B";"Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u";"Candida albicans";"66";"66";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"5476";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL1614211";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ";"";"36499";"36798";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL707142";"F";"Compound was tested in vitro for cytotoxicity against L1210 murine cell line (48 hr exposure to compound)";"Mus musculus";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL3137729";"T";"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3749672";"B";"Binding affinity to calf thymus double stranded DNA by spectrophotometric titration method";"Bos taurus";"3";"3";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL3745659";"26633734";"10.1021/acs.jmedchem.5b00859";"2015";"J Med Chem";"58";"9522";"9534";"";"";"";"";"";""
"CHEMBL4354738";"A";"Cytotoxicity against human NCI-H460 cells assessed as inhibition of cell viability incubated for 2 hrs by MTT assay";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL4351028";"31302589";"10.1016/j.ejmech.2019.06.066";"2019";"Eur J Med Chem";"179";"849";"862";"";"";"";"";"";""
"CHEMBL3137727";"T";"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1614456";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ]";"Homo sapiens";"2288";"2372";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256959";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 1 mg/kg qd for 9 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL979643";"F";"Cytotoxicity against human HL60 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1154573";"10843567";"10.1021/np9903705";"2000";"J Nat Prod";"63";"599";"601";"";"";"";"";"";""
"CHEMBL663635";"F";"Increase in Melting temperature (delta Tm) for Calf thymus DNA on interaction against ligand (mole ratio of 10:1)";"Bos taurus";"7";"7";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL3734568";"F";"Effect on Tet-induced Flag-tagged mouse TRPM7 expression in HEK293 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HEK293";"";"CHEMBL3727350";"None";"None";"2014";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561978";"F";"PubChem BioAssay. nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"";"97";"98";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"C2C12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3137731";"T";"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3562146";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) ";"";"1812";"1824";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738442";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404]";"Homo sapiens";"90360";"91293";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613897";"F";"PUBCHEM_BIOASSAY: Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]";"";"311";"316";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738610";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962]";"Homo sapiens";"593";"594";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3123711";"B";"Inhibition of human tert transcriptional activity assessed as SEAP activity at 100 uM after 24 hrs by SEAP reporter assay";"Homo sapiens";"37";"37";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3120102";"24051300";"10.1016/j.ejmech.2013.06.058";"2013";"Eur J Med Chem";"69";"278";"293";"";"";"";"";"";""
"CHEMBL1909176";"B";"DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"KAN-TS";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909161";"B";"DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"NIH3T3";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909151";"B";"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613823";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 895 ]";"Homo sapiens";"518";"532";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909108";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909092";"B";"DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL823493";"B";"Binding affinity towards [poly(dA-dT)]2";"";"17";"17";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1132293";"10411474";"10.1021/jm9805586";"1999";"J Med Chem";"42";"2535";"2541";"";"";"";"";"";""
"CHEMBL845133";"F";"Ratio of antilog(mean log IC50 in bone marrow sample) and antolog(mean log IC50) in HL-60)";"";"6";"6";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3638253";"Bone marrow";"";"";"CHEMBL1132240";"10377219";"10.1021/jm980324m";"1999";"J Med Chem";"42";"2136";"2144";"";"";"";"";"";""
"CHEMBL619150";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780/DX(RI)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1909172";"B";"DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909179";"B";"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL840341";"A";"Fraction absorbed in human intestine after oral administration compound was measured; NA=Not available";"Homo sapiens";"1";"1";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3638176";"Intestine";"";"";"CHEMBL1145178";"15658873";"10.1021/jm049711o";"2005";"J Med Chem";"48";"604";"613";"";"";"";"";"";""
"CHEMBL1909198";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909102";"B";"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909154";"B";"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697802";"A";"FDA HLAED, gamma-glutamyl transferase (GGT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1909194";"B";"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909117";"B";"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"U-937";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909096";"B";"DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909099";"B";"DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)";"Bacillus cereus";"871";"1742";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"1396";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562078";"F";"PubChem BioAssay. A TR-FRET Counter Screen assay to evaluate Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G.   (Class of assay: confirmatory) ";"";"103";"103";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909213";"B";"DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL907427";"F";"Antiproliferative activity against MES-SA cells by MTT assay after 72 hrs";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1149365";"16824751";"10.1016/j.bmcl.2006.06.074";"2006";"Bioorg Med Chem Lett";"16";"4822";"4825";"";"";"";"";"";""
"CHEMBL1963918";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line. (Class of assay: confirmatory) ";"";"1001";"1008";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"P388/ADR";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL712584";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line LoVo";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL3090301";"B";"Antagonist activity at human recombinant dopamine D2 long receptor expressed in CHOK1 cells coexpressing mitochondrial apoaequorin assessed as inhibition of agonist-induced effect at 50 uM after 15 mins by luminometric analysis relative to haloperidol";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"CHO-K1";"";"CHEMBL3085742";"24088053";"10.1021/jm400813y";"2013";"J Med Chem";"56";"8377";"8388";"";"";"";"";"";""
"CHEMBL3088736";"F";"Agonist activity at human recombinant dopamine D1 receptor expressed in CHOK1 cells assessed as stimulation of cAMP accumulation at 100 uM after 30 mins by HTRF assay relative to SKF81297";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"CHO-K1";"";"CHEMBL3085742";"24088053";"10.1021/jm400813y";"2013";"J Med Chem";"56";"8377";"8388";"";"";"";"";"";""
"CHEMBL3562038";"F";"PubChem BioAssay. SNU-C1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"229";"230";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"SNU-C1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614466";"F";"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1705 (qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) ), 2324 (Probe Development Summary of Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1707 (Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay), 2517 (qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1)), 1708 (Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV)]";"Homo sapiens";"573";"575";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354285";"F";"PubChem BioAssay. FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"635";"636";"BAO_0000217";"biochemical format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114847";"F";"PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP. (Class of assay: confirmatory) ";"";"197";"197";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614421";"B";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]";"Homo sapiens";"49165";"49809";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2075712";"F";"TP_TRANSPORTER: Northern blot in vivo Wistar rat";"Rattus norvegicus";"1";"1";"BAO_0000218";"organism-based format";"9";"9 - Direct single protein target assigned";"Wistar";"TP-search Transporter Database";"10116";"";"";"";"";"CHEMBL2074079";"8937457";"10.1016/s0006-2952(96)00512-6";"1996";"Biochem Pharmacol";"52";"1453";"1460";"";"";"";"";"";""
"CHEMBL3562152";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) ";"";"1822";"1837";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL816437";"B";"Inhibition of Taq polymerase at 10 uM (Slight inhibition)";"Thermus aquaticus";"3";"3";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"271";"";"";"";"";"CHEMBL1131065";"9703471";"10.1021/jm9801105";"1998";"J Med Chem";"41";"3253";"3260";"";"";"";"";"";""
"CHEMBL2169430";"A";"Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting";"Homo sapiens";"223";"223";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL1614502";"F";"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]";"";"23781";"24086";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1101455";"F";"Growth inhibition of human HL60 cells by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1155373";"20153184";"10.1016/j.bmcl.2010.01.096";"2010";"Bioorg Med Chem Lett";"20";"1528";"1531";"";"";"";"";"";""
"CHEMBL1908292";"B";"Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay";"Canis lupus familiaris";"60";"60";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL2091135";"F";"Resistance index, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL1614458";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]";"Homo sapiens";"75376";"75927";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963976";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ";"";"27593";"27827";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MDA-N";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL626616";"A";"Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.";"";"9";"9";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1129744";"None";"10.1016/0960-894X(96)00130-8";"1996";"Bioorg Med Chem Lett";"6";"865";"870";"";"";"";"";"";""
"CHEMBL1101457";"F";"Growth inhibition of human A549 cells by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1155373";"20153184";"10.1016/j.bmcl.2010.01.096";"2010";"Bioorg Med Chem Lett";"20";"1528";"1531";"";"";"";"";"";""
"CHEMBL1964017";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ";"";"28020";"28262";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DU-145";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2150100";"F";"Cytotoxicity against human HL60 cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"54";"54";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150101";"F";"Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150102";"F";"Cytotoxicity against human CCRF-CEM cells assessed as cell viability after 48 hrs by celltiter-blue assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150105";"F";"Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150109";"F";"Ratio of IC50 for human CCRF-CEM/C2 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL834298";"F";"In vitro cytotoxicity against mouse leukemia L1210 cell lines";"Mus musculus";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1137037";"15341949";"10.1016/j.bmcl.2004.07.036";"2004";"Bioorg Med Chem Lett";"14";"4907";"4909";"";"";"";"";"";""
"CHEMBL848174";"F";"Differential cytotoxicity was determined from the ratio between BR1(IC50) and xrs-6 (IC50)";"";"9";"9";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1127394";"7525959";"10.1021/jm00048a017";"1994";"J Med Chem";"37";"3819";"3827";"";"";"";"";"";""
"CHEMBL813448";"F";"Effect of dose dependent inhibition of TOPO II-catalyzed kDNA decatenation in vitro";"Crithidia fasciculata";"9";"9";"BAO_0000019";"assay format";"4";"4 - Multiple homologous protein targets may be assigned";"";"Scientific Literature";"5656";"";"";"";"";"CHEMBL1127394";"7525959";"10.1021/jm00048a017";"1994";"J Med Chem";"37";"3819";"3827";"";"";"";"";"";""
"CHEMBL1772489";"F";"Cytotoxicity against human MES-SA cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1770094";"21444205";"10.1016/j.bmcl.2011.03.021";"2011";"Bioorg Med Chem Lett";"21";"3110";"3112";"";"";"";"";"";""
"CHEMBL855605";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL3562137";"F";"PubChem BioAssay. High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction.   (Class of assay: confirmatory) ";"";"1498";"1501";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964066";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ";"";"40373";"40696";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"TK-10";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3881621";"F";"Antiproliferative activity against human mitoxantrone-resistant HL60/MX2 cells";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HL-60";"";"CHEMBL3881525";"None";"None";"2007";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3881620";"F";"Antiproliferative activity against human mitoxantrone-sensitive HL60 cells";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HL-60";"";"CHEMBL3881525";"None";"None";"2007";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3734567";"B";"Inhibition of Tet-induced Flag-tagged mouse TRPM7 expressed in HEK293 cells assessed as inhibition of channel-mediated cell death in presence of Mg2+ incubated for 24 to 48 hrs by propidium iodide uptake assay";"Mus musculus";"359";"359";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Patent Bioactivity Data";"10090";"";"";"HEK293";"";"CHEMBL3727350";"None";"None";"2014";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL979645";"F";"Cytotoxicity against human MKN28 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MKN-28";"";"CHEMBL1154573";"10843567";"10.1021/np9903705";"2000";"J Nat Prod";"63";"599";"601";"";"";"";"";"";""
"CHEMBL855610";"F";"Antiproliferative activity against adriamycin resistant P388 cells by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL855055";"F";"Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM verapamil by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1738433";"F";"PUBCHEM_BIOASSAY: Cytotoxicity screening for potential Inhibitors of Bacterial Capsule Biogenesis. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488970]";"";"29";"29";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4029349";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1613803";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 914 ]";"Homo sapiens";"2288";"2372";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855045";"F";"Antiproliferative activity against multidrug resistant MDA435/LCC6 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL713503";"F";"In vivo antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose at 3 mg/kg/day";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MX1";"";"CHEMBL1131450";"9876113";"10.1021/jm9804432";"1998";"J Med Chem";"41";"5429";"5444";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Carcinoma Oncology Models | Neoplasm Oncology Models";"Carcinoma | Neoplasms";"";""
"CHEMBL707497";"F";"Number of tumor free survivors of mice was measured (in vivo) at a 0.75 mg/kg dose (cumulative dose 225 mg/kg)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1041308";"F";"Antibacterial activity against imipenem-non resistant Escherichia coli BL21(DE3) after 18 hrs by twofold serial broth dilution method";"Escherichia coli BL21(DE3)";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1963953";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ";"";"40772";"41108";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"786-0";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4006909";"F";"Selectivity index, ratio of IC50 for mouse NIH/3T3 cells to IC50 for mouse L1210 cells";"Mus musculus";"29";"29";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4004858";"28222315";"10.1016/j.ejmech.2017.02.013";"2017";"Eur J Med Chem";"129";"151";"158";"";"";"";"";"";""
"CHEMBL1614522";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]";"Homo sapiens";"777";"781";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1955304";"F";"Cytotoxicity against human H1299 cells assessed as cell growth at 10 uM after 48 hrs by MTT assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL1949585";"22357112";"10.1016/j.ejmech.2012.01.044";"2012";"Eur J Med Chem";"50";"102";"112";"";"";"";"";"";""
"CHEMBL704122";"F";"Inhibitory activity against sensitive L1210 cell lines";"Mus musculus";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL1794461";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262]";"";"21849";"21853";"BAO_0000019";"assay format";"6";"6 - Homologous protein complex subunits assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL697469";"F";"In vitro cytotoxic activity against human colon adenocarcinoma (HT-29).";"Homo sapiens";"26";"26";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1144932";"12825949";"10.1021/jm030820x";"2003";"J Med Chem";"46";"3109";"3115";"";"";"";"";"";""
"CHEMBL800729";"F";"Compound was evaluated for cytotoxicity against SCOV-3 cell lines.";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL1129744";"None";"10.1016/0960-894X(96)00130-8";"1996";"Bioorg Med Chem Lett";"6";"865";"870";"";"";"";"";"";""
"CHEMBL880161";"F";"Effect of compound as percent survival at dose of 25 ng/mL on HT-29 cell line after 72 hours";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL3256958";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 2 mg/kg qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL826020";"F";"Toxicity ratio determined by the quotient of IC50 values in the myocytes divided by the average value in the three tumor lines.";"";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL1697801";"A";"FDA HLAED, lactate dehydrogenase (LDH) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1613791";"F";"PUBCHEM_BIOASSAY: A counter screen for small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 2252, 1985 ]";"";"1121";"1126";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL701043";"F";"Antitumor activity against murine L1210 resistant cell line by using MTT assay";"Mus musculus";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL1614166";"B";"PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ";"";"34209";"34246";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL695200";"F";"Effect of compound as percent survival at dose of 250 ng/mL on HT-29/Mx cell line after 72 hours";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL742708";"A";"Net log value for P388 leukemia cell kill in mice was determined";"Mus musculus";"35";"35";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124226";"3397990";"10.1021/jm00403a009";"1988";"J Med Chem";"31";"1527";"1539";"";"";"";"";"";""
"CHEMBL1794423";"F";"PUBCHEM_BIOASSAY: Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504849]";"";"31";"31";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL967538";"F";"Growth inhibition of human K562 cells after 72 hrs by MTS method";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1157147";"18258442";"10.1016/j.bmc.2008.01.033";"2008";"Bioorg Med Chem";"16";"3959";"3968";"";"";"";"";"";""
"CHEMBL967540";"F";"Resistance factor, ratio of IC50 for etoposide-resistant human K/VP.5 cells to IC50 for human K562 cells";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1157147";"18258442";"10.1016/j.bmc.2008.01.033";"2008";"Bioorg Med Chem";"16";"3959";"3968";"";"";"";"";"";""
"CHEMBL3592577";"F";"Antiproliferative activity against human FM3 cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"FM3";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL635339";"B";"DNA binding dissociation constant as KD; No data";"";"51";"51";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1122633";"6708048";"10.1021/jm00370a007";"1984";"J Med Chem";"27";"450";"465";"";"";"";"";"";""
"CHEMBL880194";"F";"In vitro inhibition of tumor cell growth in the human mammary tumor MCF-7 system";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1125355";"1447730";"10.1021/jm00101a001";"1992";"J Med Chem";"35";"4259";"4263";"";"";"";"";"";""
"CHEMBL845134";"F";"Ratio of antilog(mean log IC50 in bone marrow sample) and antolog(mean log IC90) in HL-60)";"";"6";"6";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3638253";"Bone marrow";"";"";"CHEMBL1132240";"10377219";"10.1021/jm980324m";"1999";"J Med Chem";"42";"2136";"2144";"";"";"";"";"";""
"CHEMBL822591";"F";"Inhibition of cellular growth was evaluated in vitro against human colon carcinoma subline resistant to DOXO (LOVO/DOXO).";"Homo sapiens";"4";"4";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1125604";"1875336";"10.1021/jm00112a009";"1991";"J Med Chem";"34";"2373";"2380";"";"";"";"";"";""
"CHEMBL1963893";"F";"PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) ";"";"3181";"3225";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614364";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ";"Homo sapiens";"11958";"12273";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL619118";"F";"Compound was evaluated for cytotoxicity against A2780 cell lines.";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1129744";"None";"10.1016/0960-894X(96)00130-8";"1996";"Bioorg Med Chem Lett";"6";"865";"870";"";"";"";"";"";""
"CHEMBL1909307";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909315";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1292792";"B";"Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to absorbance of compound at 100 uM after 24 hrs by UV spectrophotometer analysis";"Bos taurus";"14";"14";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1287653";"20846761";"10.1016/j.ejmech.2010.08.061";"2010";"Eur J Med Chem";"45";"5362";"5369";"";"";"";"";"";""
"CHEMBL857734";"A";"Apparent equilibrium constant for DNA binding (C-T)";"";"27";"27";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1144932";"12825949";"10.1021/jm030820x";"2003";"J Med Chem";"46";"3109";"3115";"";"";"";"";"";""
"CHEMBL929834";"F";"Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL874883";"A";"Cytotoxicity against human HCT116 cancer cell line was determined after 1 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL626617";"A";"Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.";"";"9";"9";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1129744";"None";"10.1016/0960-894X(96)00130-8";"1996";"Bioorg Med Chem Lett";"6";"865";"870";"";"";"";"";"";""
"CHEMBL1925788";"B";"Displacement of ethidium bromide from DNA by fluorometric analysis";"";"2";"2";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1921783";"22011244";"10.1021/jm200984x";"2011";"J Med Chem";"54";"8224";"8227";"";"";"";"";"";""
"CHEMBL756321";"F";"In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.06 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123842";"3625713";"10.1021/jm00392a028";"1987";"J Med Chem";"30";"1682";"1686";"standard_type:DOSE standard_relation:= standard_value:0.06 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL1738675";"F";"PUBCHEM_BIOASSAY: Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493125, AID504467]";"Homo sapiens";"366";"366";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL966980";"A";"Cytotoxicity against human 293T cells expressing telomerase after 96 hrs by MTT assay";"Homo sapiens";"44";"44";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"HEK-293T";"";"CHEMBL1140074";"18754611";"10.1021/jm800160v";"2008";"J Med Chem";"51";"5566";"5574";"";"";"";"";"";""
"CHEMBL1786566";"F";"Cytotoxicity against human A549 cells after 24 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1781940";"21507644";"10.1016/j.bmcl.2011.03.089";"2011";"Bioorg Med Chem Lett";"21";"2845";"2849";"";"";"";"";"";""
"CHEMBL996148";"F";"Antitumor activity against human NCI60 cells after 48 hrs by SRB assay";"Homo sapiens";"15";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI60";"";"CHEMBL1140056";"18715786";"10.1016/j.bmc.2008.07.069";"2008";"Bioorg Med Chem";"16";"8003";"8010";"";"";"";"";"";""
"CHEMBL1925793";"F";"Cytotoxicity against doxorubicin-sensitive human MCF7 cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1921783";"22011244";"10.1021/jm200984x";"2011";"J Med Chem";"54";"8224";"8227";"";"";"";"";"";""
"CHEMBL3252590";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3253040";"T";"Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL988383";"F";"Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP";"Rattus norvegicus";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL987566";"B";"Inhibition of tubulin polymerization in rat C6 cells at 50 ug/mL to 2.5 mg/mL after 4 hrs";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL4196662";"F";"Antiproliferative activity against human HT-29 cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL4196011";"29407981";"10.1016/j.ejmech.2018.01.074";"2018";"Eur J Med Chem";"146";"564";"576";"";"";"";"";"";""
"CHEMBL1613886";"A";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ]";"Homo sapiens";"6513";"6846";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1769827";"F";"Cytotoxicity against human HL60 cells by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1765038";"21458279";"10.1016/j.bmc.2011.03.009";"2011";"Bioorg Med Chem";"19";"2625";"2632";"";"";"";"";"";""
"CHEMBL929843";"F";"Cytotoxicity against DNA topoisomerase-2 deficient human HL60/MX2 cells by MTT assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL663879";"B";"Binding affinity towards calf thymus DNA";"Bos taurus";"18";"18";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1132293";"10411474";"10.1021/jm9805586";"1999";"J Med Chem";"42";"2535";"2541";"";"";"";"";"";""
"CHEMBL1614019";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators. (Class of assay: confirmatory) ";"Drosophila";"2097";"2166";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"7215";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1654780";"F";"Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry";"Mycobacterium smegmatis";"24";"48";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1772";"";"";"";"";"CHEMBL1649296";"19786608";"10.1128/aac.00803-09";"2009";"Antimicrob Agents Chemother";"53";"5279";"5283";"";"";"";"";"";""
"CHEMBL773034";"T";"Cardiotoxicity by a neonatal rat heart myocyte assay";"Rattus norvegicus";"33";"33";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"CHEMBL3638187";"Heart";"";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL805683";"F";"Cytotoxicity against human small-cell lung cancer (SCLC)";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"N592";"";"CHEMBL1127036";"8258835";"10.1021/jm00077a016";"1993";"J Med Chem";"36";"4108";"4112";"";"";"";"";"";""
"CHEMBL843990";"F";"An average for IC50 values in the two solid tumor cell lines and sensitive L1210 leukemia cell line.";"";"33";"33";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"L1210";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL1964047";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41644";"41993";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"U-251";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1041326";"B";"Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 4.2 ug/mL after 18 hrs by checkerboard microdilution method";"Escherichia coli BL21(DE3)";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1614250";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]";"Homo sapiens";"20446";"20646";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1056843";"B";"Displacement of fluorescent pyrene-neomycin conjugate from tau stem-loop RNA";"";"16";"16";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154635";"19839622";"10.1021/jm9013407";"2009";"J Med Chem";"52";"6523";"6526";"";"";"";"";"";""
"CHEMBL1041292";"B";"Inhibition of VIM2 using nitrocefin as substrate after 15 mins by microtiter plate assay";"";"8";"8";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1964059";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41127";"41477";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SNB-19";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738588";"F";"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]";"Homo sapiens";"94040";"94083";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738402";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) ";"Homo sapiens";"582";"656";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2091131";"F";"Antiproliferative activity against human MESSA/DX5 cells after 72 hrs by SRB assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL2076217";"F";"TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing MDCKII cells";"";"25";"25";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK-II";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1820600";"F";"Ratio of IC50 for daunorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1817624";"21780800";"10.1021/jm200764t";"2011";"J Med Chem";"54";"5937";"5948";"";"";"";"";"";""
"CHEMBL1964055";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ";"";"251";"251";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1741325";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL823133";"F";"Tested for inhibitory activity against human tumor cell line A549 (a non small, drug resistant cell line that does not produce P-glycoprotein) of lung carcinoma using sulforhodamine B assay.";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL1614108";"A";"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ]";"Homo sapiens";"6513";"6846";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963860";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ";"";"37184";"37494";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HCC 2998";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614034";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 917 ]";"Homo sapiens";"411";"417";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614067";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";"Homo sapiens";"2514";"2577";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL758597";"F";"Optimal dose per injection in mg/kg required to inhibit growth of P388 leukemia cells in mice";"Mus musculus";"91";"91";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123657";"3806589";"10.1021/jm00384a021";"1987";"J Med Chem";"30";"121";"131";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1909134";"B";"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909086";"B";"DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909118";"B";"DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HUVEC";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963865";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen. (Class of assay: confirmatory) ";"";"821";"835";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614673";"A";"Mean residence time in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1614674";"A";"Half life in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1909190";"B";"DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL701720";"B";"Tested for inhibition of HIV-1 integrase, under 1 uM for the strand transfer";"Human immunodeficiency virus 1";"21";"22";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL1133723";"10841789";"10.1021/jm990322h";"2000";"J Med Chem";"43";"2100";"2114";"";"";"";"";"";""
"CHEMBL1909158";"B";"DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909114";"B";"DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909174";"B";"DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909196";"B";"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"Rheumatoid synovial fibroblasts";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909090";"B";"DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963885";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ";"";"28139";"28384";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"PC-3";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613923";"F";"PUBCHEM_BIOASSAY: A cytotoxicity screen of small molecule inhibitors of the PhoP region in Salmonella typhi identified in the primary screen. (Class of assay: confirmatory) [Related pubchem assays: 1850, 1864, 1985 ]";"";"1504";"1509";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909128";"B";"DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114788";"F";"PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ";"Homo sapiens";"103470";"103901";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737978";"F";"PUBCHEM_BIOASSAY: 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431]";"Homo sapiens";"165";"165";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738441";"U";"PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: VIM-2 Ki Assay";"";"1";"1";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1035434";"A";"Renal clearance in human";"Homo sapiens";"390";"390";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3638241";"Kidney";"";"";"CHEMBL1151930";"19445515";"10.1021/jm900403j";"2009";"J Med Chem";"52";"4844";"4852";"";"";"";"";"";""
"CHEMBL2114916";"F";"PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ";"Trypanosoma brucei";"6592";"6616";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"5691";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1041311";"B";"Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 50 uM after 18 hrs by twofold serial broth dilution method";"Escherichia coli BL21(DE3)";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1738317";"F";"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]";"Homo sapiens";"24903";"24918";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2078364";"F";"TP_TRANSPORTER: Northern blot in vivo Wistar rat";"Rattus norvegicus";"1";"1";"BAO_0000218";"organism-based format";"9";"9 - Direct single protein target assigned";"Wistar";"TP-search Transporter Database";"10116";"";"";"";"";"CHEMBL2074079";"8937457";"10.1016/s0006-2952(96)00512-6";"1996";"Biochem Pharmacol";"52";"1453";"1460";"";"";"";"";"";""
"CHEMBL687687";"F";"In vitro cytotoxic potency against HT-29 (human colon adenocarcinoma) cell line.";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1135709";"11806721";"10.1021/jm011004x";"2002";"J Med Chem";"45";"696";"702";"";"";"";"";"";""
"CHEMBL1963934";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay. (Class of assay: confirmatory) ";"";"713";"726";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964087";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40248";"40590";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H322M";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738439";"U";"PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: Nitrocefin-based VIM2 Inhibition Assay";"";"1";"1";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL696143";"F";"Percent inhibition at S phase of cell cycle at a dose of 25 ng/mL after 72 hours of induction in HT-29 cell line";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL2114914";"F";"PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Texas Red FP. (Class of assay: confirmatory) ";"";"172";"172";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL872805";"F";"Tested for inhibitory activity against human tumor cell line OVCAR-3, a resistant ovarian carcinoma using sulforhodamine B assay.";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL1964007";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ";"";"40987";"41343";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-MEL-28";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL753744";"F";"In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 1 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123842";"3625713";"10.1021/jm00392a028";"1987";"J Med Chem";"30";"1682";"1686";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL733219";"F";"The compound was evaluated in vivo for the optimal dose for activity against murine B-16 melanoma";"Mus musculus";"8";"8";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124226";"3397990";"10.1021/jm00403a009";"1988";"J Med Chem";"31";"1527";"1539";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Melanoma Oncology Models | Melanoma Oncology Models";"Experimental Melanoma | General Melanoma";"";""
"CHEMBL1964015";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line. (Class of assay: confirmatory) ";"";"1040";"1047";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SN12K1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1267250";"F";"Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay";"Plasmodium falciparum HB3";"496";"521";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"137071";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1964006";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ";"";"41564";"41913";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HT-29";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL659370";"F";"Thermal denaturation of calf-thymus DNA was evaluated";"Bos taurus";"3";"3";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1126952";"8340911";"10.1021/jm00067a005";"1993";"J Med Chem";"36";"2084";"2090";"";"";"";"";"";""
"CHEMBL737936";"F";"The compound was tested for antitumor activity against P388 murine leukemia by measuring median survival time of treated mice/median survival time of control x 100";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL708991";"F";"Cytotoxic potency required to inhibit L1210 cell growth by 50% after cell drug contact for 48 hrs";"Mus musculus";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL690460";"F";"Cytotoxic potency required to inhibit HT-29 cell growth by 50% after cell drug contact for 144 hrs";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL2354205";"F";"PubChem BioAssay. RAD52: DNA binders Measured in Biochemical System Using Plate Reader - 7018-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"85";"85";"BAO_0000217";"biochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL695201";"F";"Effect of compound as percent survival at dose of 3000 ng/mL on HT-29/Mx cell line after 72 hours";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL620360";"F";"In vitro inhibition of tumor cell growth in the human myeloma 8226/ADR system.";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"RPMI-8226";"";"CHEMBL1125355";"1447730";"10.1021/jm00101a001";"1992";"J Med Chem";"35";"4259";"4263";"";"";"";"";"";""
"CHEMBL707243";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line LoVo/Dx(RI)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1614362";"F";"PUBCHEM_BIOASSAY: Validation screen for inhibitors of Lassa infection. (Class of assay: confirmatory) ";"";"263";"264";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL801182";"F";"Cytotoxic potency required to inhibit SKOV-3 cell growth 50%";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL1964049";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ";"";"40562";"40898";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-5";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL766194";"F";"Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 3 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:3.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL656364";"F";"Survivors of CDF1 mice on day 4 after 1st injection of compound at 6 mg/kg in six mice; 6/6";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:6.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL1964021";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ";"";"40703";"41045";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-MEL-5";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL709038";"F";"Inhibitory activity against human colon adenocarcinoma cell line LoVo.";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1128703";"7853345";"10.1021/jm00003a015";"1995";"J Med Chem";"38";"526";"536";"";"";"";"";"";""
"CHEMBL836336";"F";"Cytotoxicity against human HCT116 cancer cell line was determined after 144 hr";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL874973";"F";"Cytotoxicity is determined as the concentration required to inhibit the growth of human colon adenocarcinoma (HT-29) cell line";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL877298";"A";"Cytotoxicity against human PC3 cancer cell line was determined after 1 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL737405";"A";"The compound was tested for antitumor activity against P388 murine leukemia by measuring maximum tolerated dose";"Mus musculus";"13";"15";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL802472";"F";"Bacterial mutagenicity was measured against Salmonella Typhimurium TA1538 at dose range of 0-5 ug/plate";"Salmonella enterica subsp. enterica serovar Typhimurium";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"90371";"";"";"";"";"CHEMBL1131105";"9733500";"10.1021/jm980167r";"1998";"J Med Chem";"41";"3748";"3752";"";"";"";"";"";""
"CHEMBL755367";"F";"In vivo antitumor activity was measured on systemic P388 murine leukemia cells. Optimal dose at 3 mg/kg/day";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1131450";"9876113";"10.1021/jm9804432";"1998";"J Med Chem";"41";"5429";"5444";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1041325";"B";"Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 8.4 ug/mL after 18 hrs by checkerboard microdilution method";"Escherichia coli BL21(DE3)";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL647084";"F";"Compound was tested against sc B16 melanoma at % tumor growth inhibition(TGI) in mice at 3.2 mg/kg dosage.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"standard_type:DOSE standard_relation:= standard_value:3.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Melanoma Oncology Models | Melanoma Oncology Models | Neoplasm Oncology Models";"Experimental Melanoma | General Melanoma | Neoplasms";"";""
"CHEMBL663968";"B";"Concentration required to give 50% fluorescence quenching of bound ethidium for [ethidium]: [poly(dA-dT)]2 DNA in ratio of 0.1:1 at pH 5";"";"19";"19";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL656072";"F";"Cytotoxicity in human leukemic CCRF-CEM cells.";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL1144914";"14667232";"10.1021/jm030253d";"2003";"J Med Chem";"46";"5790";"5802";"";"";"";"";"";""
"CHEMBL1061624";"F";"Cytotoxicity against human SKOV3 cells by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL1153479";"19615900";"10.1016/j.bmcl.2009.06.097";"2009";"Bioorg Med Chem Lett";"19";"4584";"4588";"";"";"";"";"";""
"CHEMBL1061623";"F";"Cytotoxicity against human MCF7 cells by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1153479";"19615900";"10.1016/j.bmcl.2009.06.097";"2009";"Bioorg Med Chem Lett";"19";"4584";"4588";"";"";"";"";"";""
"CHEMBL819653";"F";"Activity against sensitive cell line of WiDr human colon tumor";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL1613838";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ";"Homo sapiens";"21944";"21990";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL753742";"F";"In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.25 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123842";"3625713";"10.1021/jm00392a028";"1987";"J Med Chem";"30";"1682";"1686";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL1963929";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ";"";"41263";"41617";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"IGROV-1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114931";"F";"PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) ";"Homo sapiens";"3540";"3541";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL688361";"F";"Tested for the cytotoxicity to inhibit replication assay against the human colon tumor cell line HCT116; ND is Not Determined";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1127394";"7525959";"10.1021/jm00048a017";"1994";"J Med Chem";"37";"3819";"3827";"";"";"";"";"";""
"CHEMBL822590";"F";"Inhibition of cellular growth was evaluated in vitro against human colon carcinoma LOVO.";"Homo sapiens";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1125604";"1875336";"10.1021/jm00112a009";"1991";"J Med Chem";"34";"2373";"2380";"";"";"";"";"";""
"CHEMBL844332";"F";"Ratio of antilog(mean log IC90 in bone marrow sample) and antolog(mean log IC90) in HL-60)";"";"6";"6";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3638253";"Bone marrow";"";"";"CHEMBL1132240";"10377219";"10.1021/jm980324m";"1999";"J Med Chem";"42";"2136";"2144";"";"";"";"";"";""
"CHEMBL1963901";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40342";"40685";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H460";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL746227";"F";"Percentage ratio of treated animals to cured animals against murine B-16 melanoma (day 60 surv)";"Mus musculus";"9";"9";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124226";"3397990";"10.1021/jm00403a009";"1988";"J Med Chem";"31";"1527";"1539";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Melanoma Oncology Models | Melanoma Oncology Models";"Experimental Melanoma | General Melanoma";"";""
"CHEMBL2114744";"F";"PubChem BioAssay. HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF. (Class of assay: confirmatory) ";"Homo sapiens";"143";"144";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963911";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ";"";"38809";"39125";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"CAKI-1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614441";"F";"PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ";"Mus musculus";"36283";"36493";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10090";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614433";"F";"PUBCHEM_BIOASSAY: Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV. (Class of assay: confirmatory) [Related pubchem assays: 1705, 1707 ]";"Escherichia coli";"423";"425";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"562";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2346391";"B";"Binding affinity to calf thymus DNA up to 5 mM";"Bos taurus";"10";"10";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL2331492";"23395656";"10.1016/j.bmcl.2013.01.022";"2013";"Bioorg Med Chem Lett";"23";"1846";"1852";"";"";"";"";"";""
"CHEMBL1286016";"F";"Cytotoxicity against human HL60 cells after 72 hrs";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1275381";"20961767";"10.1016/j.bmc.2010.08.025";"2010";"Bioorg Med Chem";"18";"8119";"8133";"";"";"";"";"";""
"CHEMBL1286017";"F";"Cytotoxicity against human HL60/MX2 cells after 72 hrs";"Homo sapiens";"36";"36";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1275381";"20961767";"10.1016/j.bmc.2010.08.025";"2010";"Bioorg Med Chem";"18";"8119";"8133";"";"";"";"";"";""
"CHEMBL745101";"A";"The compound was tested for antitumor activity against P388 murine leukemia at 3 (mg/kg/day) dose; 12/132 -no. of toxic deaths/no. of mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL654328";"B";"Inhibitory concentration against ethidium:Calf thymus DNA (1.26:1) binding at pH 7";"Bos taurus";"15";"15";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL717381";"F";"Compound was evaluated in vivo for the antitumor activity at a dose of 1.25 mg/kg & 3.75 mg/kg against mammary adenocarcinoma 16C to assess tumor growth delay (T-C).";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122737";"6699870";"10.1021/jm00369a002";"1984";"J Med Chem";"27";"253";"255";"";"";"";"";"";""
"CHEMBL804675";"F";"Mean percentage reduction in tumor weight on S180 tumor cell at 0.75 mg/kg (cumulative dose 16 mg/Kg) introduced ip (in vivo)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL802953";"F";"Mean percentage reduction in tumor weight at 0.75 mg/kg (cumulative dose 525 mg/Kg) introduced (in vivo) ip; Significant";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL705030";"F";"Number of tumor free survivors of mice was measured in L1210 leukemia cells (in vivo) at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1963954";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"13960";"14049";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SNB-78";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2150110";"F";"Ratio of IC50 for human CCRF-CEM/VM-1-5 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL1035433";"A";"Total body clearance in human";"Homo sapiens";"390";"390";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1151930";"19445515";"10.1021/jm900403j";"2009";"J Med Chem";"52";"4844";"4852";"";"";"";"";"";""
"CHEMBL1738184";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]";"Homo sapiens";"77876";"78260";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697797";"A";"FDA HLAED, liver enzyme composite activity";"Homo sapiens";"486";"1470";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL648693";"F";"Optimal dose per injection in mg/kg required to inhibit growth of murine B-16 melanoma in vivo";"Mus musculus";"12";"12";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1123657";"3806589";"10.1021/jm00384a021";"1987";"J Med Chem";"30";"121";"131";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Melanoma Oncology Models | Melanoma Oncology Models";"Experimental Melanoma | General Melanoma";"";""
"CHEMBL1697780";"A";"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents";"";"944";"951";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697731";"20014752";"10.1021/tx900326k";"2010";"Chem Res Toxicol";"23";"171";"183";"";"";"";"";"";""
"CHEMBL816201";"F";"Activity against human colon carcinoma sensitive WiDr cell line.";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL739485";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.2 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.2 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL964487";"F";"Cytotoxicity against mitoxantrone-resistant human HL60/MX2 cells after 72 hrs";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL1150431";"18507368";"10.1021/jm800017u";"2008";"J Med Chem";"51";"3617";"3629";"";"";"";"";"";""
"CHEMBL965236";"F";"Resistant index, ratio of IC50 for mitoxantrone-resistant human HL60/MX2 cells to IC50 for mitoxantrone-sensitive human HL60 cells";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1150431";"18507368";"10.1021/jm800017u";"2008";"J Med Chem";"51";"3617";"3629";"";"";"";"";"";""
"CHEMBL1654779";"F";"Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry";"Mycobacterium smegmatis";"24";"48";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1772";"";"";"";"";"CHEMBL1649296";"19786608";"10.1128/aac.00803-09";"2009";"Antimicrob Agents Chemother";"53";"5279";"5283";"";"";"";"";"";""
"CHEMBL760474";"F";"Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 0.75 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:0.75 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL711139";"F";"In vitro cytotoxicity was tested against human colon adenocarcinoma LoVo cell line";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1132293";"10411474";"10.1021/jm9805586";"1999";"J Med Chem";"42";"2535";"2541";"";"";"";"";"";""
"CHEMBL3256954";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 2 mg/kg qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL929840";"F";"Cytotoxicity against human SF268 cells at 4 ug/ml after 48 hrs by SRB assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL1737991";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402]";"Homo sapiens";"51377";"51656";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL886126";"F";"Growth inhibition of human HL60 cells by Almar blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1139925";"17418582";"10.1016/j.bmc.2007.03.067";"2007";"Bioorg Med Chem";"15";"4237";"4246";"";"";"";"";"";""
"CHEMBL1786567";"F";"Cytotoxicity against human HCT116 cells after 24 hrs by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1781940";"21507644";"10.1016/j.bmcl.2011.03.089";"2011";"Bioorg Med Chem Lett";"21";"2845";"2849";"";"";"";"";"";""
"CHEMBL1743160";"A";"Substrates of transporters of clinical importance in the absorption and disposition of drugs, MRP2";"Homo sapiens";"6";"6";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1743141";"20190787";"10.1038/nrd3028";"2010";"Nat Rev Drug Discov";"9";"215";"236";"";"";"";"";"";""
"CHEMBL2114784";"F";"PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ";"Homo sapiens";"53812";"54032";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909087";"B";"DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909160";"B";"DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559723";"Liver";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909180";"B";"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909100";"B";"DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909106";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909200";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909104";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909197";"B";"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909201";"B";"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614671";"A";"Clearance in human after iv administration";"Homo sapiens";"667";"669";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL929833";"F";"Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL1909210";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1654782";"F";"Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay";"Mycobacterium smegmatis";"24";"48";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1772";"";"";"";"";"CHEMBL1649296";"19786608";"10.1128/aac.00803-09";"2009";"Antimicrob Agents Chemother";"53";"5279";"5283";"";"";"";"";"";""
"CHEMBL1909202";"B";"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909150";"B";"DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HeLa S3";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909152";"B";"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2078443";"F";"TP_TRANSPORTER: ATP- and GSH-dependent transport in MCF7/MRP1-10 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF7/MRP1-10";"";"CHEMBL2074176";"16434618";"10.1124/mol.105.017988";"2006";"Mol Pharmacol";"69";"1499";"1505";"";"";"";"";"";""
"CHEMBL2078378";"F";"TP_TRANSPORTER: efflux in MCF7/VP and MCF cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF";"";"CHEMBL2074577";"11454692";"None";"2001";"Cancer Res";"61";"5461";"5467";"";"";"";"";"";""
"CHEMBL3214965";"B";"PubChem BioAssay. C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"124";"124";"BAO_0000217";"biochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL623386";"F";"Activity against A549 cancer cell line.";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL979642";"F";"Cytotoxicity against human K562 cells after 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1154573";"10843567";"10.1021/np9903705";"2000";"J Nat Prod";"63";"599";"601";"";"";"";"";"";""
"CHEMBL4617048";"B";"Stabilization of [32P]-labelled dsDNA (unknown origin) assessed as drug-DNA adduct formation at 5 uM in presence of formaldehyde incubated for 12 hrs by phosphorimaging analysis relative to control";"Not specified";"8";"8";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL4616593";"31870833";"10.1016/j.bmc.2019.115260";"2020";"Bioorg Med Chem";"28";"115260";"115260";"";"";"";"";"";""
"CHEMBL1614177";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle Pyruvate Kinase. (Class of assay: confirmatory) ";"Homo sapiens";"107";"107";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214913";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus.   (Class of assay: confirmatory) ";"";"4591";"5133";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614265";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase. (Class of assay: confirmatory) ";"Homo sapiens";"107";"107";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562085";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4185153";"B";"Inhibition of human APE1 preincubated for 15 mins followed by substrate addition by HTS assay";"Homo sapiens";"8";"8";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4184129";"28161249";"10.1016/j.bmc.2017.01.028";"2017";"Bioorg Med Chem";"25";"2531";"2544";"";"";"";"";"";""
"CHEMBL2330102";"B";"Inhibition of PIM1-mediated BAD phosphorylation in human MV411 cells after 12 hrs by Western blotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL1738552";"F";"PUBCHEM_BIOASSAY: Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465]";"";"693";"694";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL712919";"F";"Antitumor activity against human mammary carcinoma doxorubicin-resistant MXF7 breast cell line.";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL1613800";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]";"Homo sapiens";"6916";"7035";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738369";"F";"PUBCHEM_BIOASSAY: Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID465]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"Jurkat";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL690299";"F";"Concentration required to inhibit cell growth by 50% in vitro against Human colon adenocarcinoma cell line";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1134414";"11563932";"10.1021/jm010917o";"2001";"J Med Chem";"44";"3329";"3333";"";"";"";"";"";""
"CHEMBL804455";"F";"Percentage of tumor free survivors of mice at 0.75 mg/kg (cumulative dose 525 mg/Kg) introduced (in vivo) ip; value given as 0/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"CCRF S-180";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2150104";"F";"Ratio of IC50 for human HL60/ADR cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL1909314";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL814424";"B";"Inhibition of Taq polymerase at 50 uM (Total inhibition)";"Thermus aquaticus";"14";"14";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"271";"";"";"";"";"CHEMBL1131065";"9703471";"10.1021/jm9801105";"1998";"J Med Chem";"41";"3253";"3260";"";"";"";"";"";""
"CHEMBL757077";"F";"In vivo antitumor activity against P388 leukemia cells at a dose of 0.75 mg/kg as a single injection and 1.5 mg/kg as a total";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1122737";"6699870";"10.1021/jm00369a002";"1984";"J Med Chem";"27";"253";"255";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3214944";"B";"PubChem BioAssay. Development of Small Molecule Probes of the Histone Methyltransferase, NSD2 Measured in Biochemical System Using Plate Reader - 7053-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"578";"579";"BAO_0000217";"biochemical format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215034";"B";"PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: Thiazole Orange DNA Binding Counterscreen.   (Class of assay: confirmatory) ";"";"257";"257";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614198";"F";"PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ";"";"717";"719";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2150106";"F";"Ratio of IC50 for doxorubicin-resistant human HL60 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL699261";"F";"Effective concentration required to inhibit by 50% the growth of HeLa S3 cells";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL1123978";"3172129";"10.1021/jm00118a015";"1988";"J Med Chem";"31";"1956";"1959";"";"";"";"";"";""
"CHEMBL1964030";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ";"";"40735";"41067";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"K562";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3592576";"F";"Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL3592578";"F";"Antiproliferative activity against human Ishikawa cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Ishikawa";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL3592580";"F";"Antiproliferative activity against human MES-SA cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL732267";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.1 mg/kg, expressed as body weight change";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.1 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL717382";"F";"Compound was evaluated in vivo for the antitumor activity at a dose of 2.5 mg/kg & 7.5 mg/kg against mammary adenocarcinoma 16C to assess tumor growth delay (T-C)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122737";"6699870";"10.1021/jm00369a002";"1984";"J Med Chem";"27";"253";"255";"";"";"";"";"";""
"CHEMBL1963960";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ";"";"41287";"41632";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"UACC-257";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2169431";"A";"Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting";"Homo sapiens";"223";"223";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL827154";"A";"Inhibitory concentration against cytochrome P450 2D6";"";"35";"37";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1137221";"15481972";"10.1021/jm049934e";"2004";"J Med Chem";"47";"5340";"5346";"";"";"";"";"";""
"CHEMBL2114863";"F";"PubChem BioAssay. Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in WT MEF Cells: Hit Validation. (Class of assay: confirmatory) ";"Homo sapiens";"512";"512";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114736";"F";"PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme. (Class of assay: confirmatory) ";"";"1364";"1364";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1772155";"F";"Antiproliferative activity against human KB/HeLa cells after 48 hrs by XTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL1770061";"21458262";"10.1016/j.bmcl.2011.03.013";"2011";"Bioorg Med Chem Lett";"21";"3117";"3121";"";"";"";"";"";""
"CHEMBL1772158";"F";"Antiproliferative activity against human NCI-H460 cells after 48 hrs by XTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL1770061";"21458262";"10.1016/j.bmcl.2011.03.013";"2011";"Bioorg Med Chem Lett";"21";"3117";"3121";"";"";"";"";"";""
"CHEMBL1772160";"F";"Antiproliferative activity against human RKOp27IND cells after 48 hrs by XTT assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1770061";"21458262";"10.1016/j.bmcl.2011.03.013";"2011";"Bioorg Med Chem Lett";"21";"3117";"3121";"";"";"";"";"";""
"CHEMBL3257130";"F";"Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase in survival time at 0.5 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL1763107";"F";"Cytotoxicity against human A549 cells after 72 hrs";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1759843";"21354791";"10.1016/j.bmcl.2011.01.072";"2011";"Bioorg Med Chem Lett";"21";"2155";"2159";"";"";"";"";"";""
"CHEMBL1909204";"B";"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909147";"B";"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3638188";"Brain";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909144";"B";"DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252380";"F";"Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse assessed as survival at 0.69 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Colon 26";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.69 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL1772490";"F";"Cytotoxicity against human MES-SA/Dx5 cells assessed as inhibition of cell proliferation after 72 hrs by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL1770094";"21444205";"10.1016/j.bmcl.2011.03.021";"2011";"Bioorg Med Chem Lett";"21";"3110";"3112";"";"";"";"";"";""
"CHEMBL1772491";"F";"Resistant factor, ratio of IC50 for doxorubicin-resistant human MES-SA/Dx5 cells to IC50 for doxorubicin-sensitive human MES-SA cells";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1770094";"21444205";"10.1016/j.bmcl.2011.03.021";"2011";"Bioorg Med Chem Lett";"21";"3110";"3112";"";"";"";"";"";""
"CHEMBL1614221";"F";"PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]";"Plasmodium falciparum";"475";"477";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"5833";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963985";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"41631";"41977";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H23";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794380";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588378, AID588380]";"Homo sapiens";"326";"327";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"SH-SY5Y";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL633166";"P";"Estimated pKa value of the compound";"";"14";"14";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL1041305";"B";"Inhibition of TEM-1 using nitrocefin as substrate at 25 uM after 15 mins by microtiter plate assay";"";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1041294";"B";"Inhibition of IMP1 using nitrocefin as substrate after 15 mins by microtiter plate assay";"";"4";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1041314";"F";"Bactericidal activity against imipenem-resistant Escherichia coli BL21(DE3) expressing VIM2 gene at 2.1 ug/mL after 24 hrs by broth microdilution method";"Escherichia coli BL21(DE3)";"1";"1";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL872954";"F";"Inhibitory activity against human tumor cell line HT1080.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-1080";"";"CHEMBL1128703";"7853345";"10.1021/jm00003a015";"1995";"J Med Chem";"38";"526";"536";"";"";"";"";"";""
"CHEMBL1794401";"F";"PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962]";"";"91505";"91819";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614279";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]";"Trypanosoma brucei";"648";"649";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"185431";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614234";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ]";"Rattus norvegicus";"11394";"11448";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10116";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614249";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]";"Equus caballus";"42059";"42303";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9796";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL695188";"F";"Percent inhibition at G1 phase of cell cycle at a dose of 250 ng/mL after 72 hours of induction in HT-29/Mx cell line";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL732268";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.4 mg/kg, expressed as body weight change";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.4 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL740563";"F";"In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.1 mg/kg, expressed as long time survivors tested in 12 animals";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.1 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1908285";"A";"Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL715095";"F";"Tested for inhibitory activity against human tumor cell line MCF7, a strain sensitive to doxorubicin of breast carcinoma using sulforhodamine B assay.";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL3256957";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 2 mg/kg qd for 9 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1613856";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase. (Class of assay: confirmatory) ";"Leishmania mexicana mexicana";"86";"86";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"44270";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL709042";"F";"Tested in vitro for cytotoxic activity against Human colon Adenocarcinoma sensitive cell line (LoVo)";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL837599";"F";"Cytotoxicity against human LoVo cancer cell line was determined after 144 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL709285";"F";"Tested for inhibitory activity against murine cell line L12110, a strain resistant to doxorubicin using MTT assay.";"Mus musculus";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL1614274";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway. (Class of assay: confirmatory) ";"Homo sapiens";"518";"532";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738509";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504632]";"Trypanosoma brucei TREU927";"54";"54";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"185431";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL715093";"F";"Tested for inhibitory activity against human tumor cell line D40, a strain resistant to doxorubicin of breast carcinoma using sulforhodamine B assay.";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL1738312";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391]";"Homo sapiens";"55525";"55724";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL695195";"F";"Percent inhibition at S phase of cell cycle at a dose of 250 ng/mL after 72 hours of induction in HT-29/Mx cell line";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL806577";"F";"The IC50 value was measured on human breast cancer cell line SK-BR-3.";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-BR-3";"";"CHEMBL1128261";"7699696";"10.1021/jm00006a024";"1995";"J Med Chem";"38";"1039";"1043";"";"";"";"";"";""
"CHEMBL1056844";"B";"Binding affinity to tau stem-loop RNA assessed as inhibition of RNA stem-loop unfolding";"";"16";"16";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154635";"19839622";"10.1021/jm9013407";"2009";"J Med Chem";"52";"6523";"6526";"";"";"";"";"";""
"CHEMBL3562077";"F";"PubChem BioAssay. High Throughput Screening for Foot and Mouth Disease Virus Antivirals.   (Class of assay: confirmatory) ";"";"69295";"69674";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL817163";"F";"Tested for inhibitory activity against a sensitive strain of human colon carcinoma WiDr using sulforhodamine B assay (it is MRP positive but non-P-glycoprotein).";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL707198";"F";"In vitro cytotoxic activity against human breast MDA-MB-231 cell line ( standard deviation in parenthesis)";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1135469";"12036369";"10.1021/jm011117g";"2002";"J Med Chem";"45";"2599";"2609";"";"";"";"";"";""
"CHEMBL3592575";"F";"Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL3592581";"F";"Antiproliferative activity against human MES-SA/Dx5 cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL2091134";"F";"Antiproliferative activity against human HL60/MX2 cells after 72 hrs by SRB assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL2075594";"F";"TP_TRANSPORTER: intracellular accumulation in MCF-7 and MCF-7 AdVp3000 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF-7; MCF-7 AdVp3000";"";"CHEMBL2073744";"10806112";"10.1242/jcs.113.11.2011";"2000";"J Cell Sci";"113";"2011";"2021";"";"";"";"";"";""
"CHEMBL2114881";"F";"PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens. (Class of assay: confirmatory) ";"Homo sapiens";"2057";"2057";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2330107";"B";"Inhibition of BTK (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL695196";"F";"Effect of compound as percent survival at dose of 1000 ng/mL on HT-29/Mx cell line after 72 hours";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1963844";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ";"";"38877";"39199";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SK-MEL-2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964091";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ";"";"39577";"39897";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-4";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964095";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line. (Class of assay: confirmatory) ";"";"1024";"1031";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"P388";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964048";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ";"";"41865";"42213";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"OVCAR-8";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964043";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40357";"40693";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HOP-62";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL709966";"F";"Tested against MXF7 breast carcinoma (doxorubicin resistant) cell line in the sulforhodamine B assay.";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL4345279";"B";"Inhibition of MTH1 in human U2OS cells assessed as activation of p53 at 2.25 uM incubated for 4 and 24 hrs by Peggy sue Western blot assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"U2OS";"";"CHEMBL4342490";"32184970";"10.1021/acsmedchemlett.9b00420";"2020";"ACS Med Chem Lett";"11";"358";"364";"";"";"";"";"";""
"CHEMBL1613829";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]";"Homo sapiens";"4515";"4620";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4384571";"F";"Antiproliferative activity against human SGC7901 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SGC-7901";"";"CHEMBL4382251";"30485090";"10.1021/acs.jnatprod.8b00482";"2018";"J Nat Prod";"81";"2667";"2672";"";"";"";"";"";""
"CHEMBL1963887";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"14897";"14993";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DMS-114";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963882";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ";"";"28394";"28635";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MCF7";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963868";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ";"";"41234";"41579";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HCT-15";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613913";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase. (Class of assay: confirmatory) ";"Leishmania mexicana mexicana";"86";"86";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"44270";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1057283";"F";"Cytotoxicity against human HT-29 cells by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1153479";"19615900";"10.1016/j.bmcl.2009.06.097";"2009";"Bioorg Med Chem Lett";"19";"4584";"4588";"";"";"";"";"";""
"CHEMBL704057";"F";"Percentage increase in lifespan of mice was measured (in vivo) at 0.75 mg/kg dose";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"standard_type:DOSE standard_relation:= standard_value:0.75 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL874570";"B";"Concentration required to displace ethidium from CT-DNA was determined from fluorescence binding studies";"Bos taurus";"35";"35";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL874878";"A";"Cytotoxicity against human LoVo cancer cell line was determined after 1 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL874881";"A";"Cytotoxicity against human MKN45 cancer cell line was determined after 1 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Cancer cell lines";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL1908291";"B";"Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM";"Spodoptera frugiperda";"60";"60";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"7108";"";"";"Sf9";"Membrane";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1964072";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ";"";"41891";"42241";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SW-620";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1101458";"F";"Growth inhibition of human HT-29 cells by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1155373";"20153184";"10.1016/j.bmcl.2010.01.096";"2010";"Bioorg Med Chem Lett";"20";"1528";"1531";"";"";"";"";"";""
"CHEMBL1963994";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ";"";"37749";"38068";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HL-60";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL705717";"F";"Inhibitory activity against resistant murine leukemia L1210 cell lines.";"Mus musculus";"33";"33";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL1741324";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964081";"F";"PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ";"";"1025";"1028";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"Schwann";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963876";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41148";"41498";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SF-268";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963866";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"38557";"38887";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SNB-75";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963880";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"40605";"40938";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"EKVX ";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1293121";"F";"Cytotoxicity against human HL60 cells by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1287676";"20951582";"10.1016/j.bmcl.2010.09.074";"2010";"Bioorg Med Chem Lett";"20";"7110";"7115";"";"";"";"";"";""
"CHEMBL1006005";"B";"Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control";"Homo sapiens";"189";"189";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"Sf9";"";"CHEMBL1150338";"18457386";"10.1021/jm7015683";"2008";"J Med Chem";"51";"3275";"3287";"";"";"";"";"";""
"CHEMBL1614493";"F";"PUBCHEM_BIOASSAY: Counterscreen for Luciferase (Kinase-Glo TM) Inhibition. (Class of assay: confirmatory) ";"Photuris pennsylvanica";"1549";"1554";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"41716";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794308";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249]";"Homo sapiens";"61908";"62243";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HEK293";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4617059";"B";"Stabilization of dsBE12 oligonucleotide (unknown origin) assessed as drug-DNA adduct formation at 5 to 50 uM incubated for 4 hrs in presence of formaldehyde using [gamma-32P]ATP by phosphorimaging analysis relative to control";"Not specified";"6";"6";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL4616593";"31870833";"10.1016/j.bmc.2019.115260";"2020";"Bioorg Med Chem";"28";"115260";"115260";"";"";"";"";"";""
"CHEMBL1613767";"F";"PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]";"";"881";"885";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1061625";"F";"Cytotoxicity against human U937 cells by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U-937";"";"CHEMBL1153479";"19615900";"10.1016/j.bmcl.2009.06.097";"2009";"Bioorg Med Chem Lett";"19";"4584";"4588";"";"";"";"";"";""
"CHEMBL1057282";"F";"Cytotoxicity against human HL60 cells by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1153479";"19615900";"10.1016/j.bmcl.2009.06.097";"2009";"Bioorg Med Chem Lett";"19";"4584";"4588";"";"";"";"";"";""
"CHEMBL964486";"F";"Cytotoxicity against human mitoxantrone-sensitive HL60 cells after 72 hrs";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1150431";"18507368";"10.1021/jm800017u";"2008";"J Med Chem";"51";"3617";"3629";"";"";"";"";"";""
"CHEMBL1964075";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"37652";"37966";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H522";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3529281";"A";"Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL1041306";"B";"Inhibition of Enterobacter cloacae AmpC using nitrocefin as substrate after 15 mins by microtiter plate assay";"Enterobacter cloacae";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"550";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL2346399";"F";"Antiproliferative activity against human NCI-H460 cells after 48 hrs";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL2331492";"23395656";"10.1016/j.bmcl.2013.01.022";"2013";"Bioorg Med Chem Lett";"23";"1846";"1852";"";"";"";"";"";""
"CHEMBL1764595";"F";"Cytotoxicity against human HL60 cells";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1759981";"21439821";"10.1016/j.bmcl.2011.02.106";"2011";"Bioorg Med Chem Lett";"21";"2259";"2263";"";"";"";"";"";""
"CHEMBL1769828";"F";"Cytotoxicity against human A549 cells by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1765038";"21458279";"10.1016/j.bmc.2011.03.009";"2011";"Bioorg Med Chem";"19";"2625";"2632";"";"";"";"";"";""
"CHEMBL1769830";"F";"Cytotoxicity against human MCF7 cells by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1765038";"21458279";"10.1016/j.bmc.2011.03.009";"2011";"Bioorg Med Chem";"19";"2625";"2632";"";"";"";"";"";""
"CHEMBL1614236";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ";"Influenza A virus (A/WSN/1933(H1N1))";"32268";"32314";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"382835";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL873381";"F";"Anti-tumor activity against human UACC375 melanoma cell lines by using MTT assay";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"UACC-375";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL1614544";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ";"Homo sapiens";"36150";"36356";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909116";"B";"DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909140";"B";"DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614213";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) ";"Rattus norvegicus";"4704";"4707";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10116";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL709969";"F";"Antitumor activity against human mammary carcinoma mitoxantrone-resistant MXF7 breast cell line.";"Homo sapiens";"28";"28";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL884328";"F";"In vitro cytotoxicity against colorectal adenocarcinoma HT-29 cells";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1143647";"16169719";"10.1016/j.bmcl.2005.07.079";"2005";"Bioorg Med Chem Lett";"15";"5057";"5060";"";"";"";"";"";""
"CHEMBL1909207";"B";"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909189";"B";"DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)";"";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"DrugMatrix";"32644";"";"";"HIT-T15";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL759554";"F";"Inhibition of P388 leukemia cells in mice, measured as percent treated to the control values with the number of 30 day survivors";"Mus musculus";"89";"89";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123657";"3806589";"10.1021/jm00384a021";"1987";"J Med Chem";"30";"121";"131";"";"";"";"";"";""
"CHEMBL772067";"F";"Cardiotoxicity measured by the ATP/protein ratio compared with untreated controls using neonatal rat heart myocyte assay.";"Rattus norvegicus";"26";"26";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"CHEMBL3638187";"Heart";"";"";"CHEMBL1129597";"8960558";"10.1021/jm960623g";"1996";"J Med Chem";"39";"4978";"4987";"";"";"";"";"";""
"CHEMBL679826";"F";"Percent colony reduction in cell growth in EBV-positive nasopharyngeal cell lines after administration of 0.1 ug/mL dose";"epstein barr virus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10376";"";"";"EBV-positive nasopharyngeal cell line";"";"CHEMBL1122406";"6685770";"10.1021/jm00366a004";"1983";"J Med Chem";"26";"1679";"1686";"";"";"";"";"";""
"CHEMBL3252764";"T";"Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.5 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"BDF1";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL740564";"F";"In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.2 mg/kg, expressed as long time survivors tested in 6 animals";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.2 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL712023";"F";"In vitro inhibition of tumor cell growth in the human mammary carcinoma MCF-7/ADR system.";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1125355";"1447730";"10.1021/jm00101a001";"1992";"J Med Chem";"35";"4259";"4263";"";"";"";"";"";""
"CHEMBL3252746";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.12 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.12 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL823494";"B";"Binding affinity towards [poly(dG-dC)]2";"";"17";"17";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1132293";"10411474";"10.1021/jm9805586";"1999";"J Med Chem";"42";"2535";"2541";"";"";"";"";"";""
"CHEMBL705265";"F";"Dose level for 50% inhibition of L1210 cell growth was measured after 24 h.";"Mus musculus";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"";"";"";"";""
"CHEMBL733217";"F";"In vivo for the optimal dose for activity against P388 leukemia per injection";"Mus musculus";"42";"42";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124226";"3397990";"10.1021/jm00403a009";"1988";"J Med Chem";"31";"1527";"1539";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL2433629";"F";"Growth inhibition of human HepG2 cells at 10 uM after 48 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL2429715";"None";"10.1007/s00044-013-0805-z";"2013";"Med Chem Res";"None";"1";"7";"";"";"";"";"";""
"CHEMBL1955301";"F";"Inhibition of human TERT expression in H1299 cells at 10 uM after 24 hrs by secreted alkaline phosphatase reporter gene assay relative to control";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL1949585";"22357112";"10.1016/j.ejmech.2012.01.044";"2012";"Eur J Med Chem";"50";"102";"112";"";"";"";"";"";""
"CHEMBL2091086";"F";"Antiproliferative activity against human MESSA cells after 72 hrs by SRB assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL2439156";"F";"Antitrypanosomal activity against bloodstream form of Trypanosoma brucei brucei 427 after 3 days by Alamar Blue assay";"Trypanosoma brucei brucei";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"427";"Scientific Literature";"5702";"";"";"";"";"CHEMBL2434842";"23927763";"10.1021/jm4004279";"2013";"J Med Chem";"56";"7727";"7740";"";"";"";"";"";""
"CHEMBL3123713";"B";"Inhibition of human tert transcriptional activity assessed as SEAP activity at 1 uM after 24 hrs by SEAP reporter assay";"Homo sapiens";"37";"37";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3120102";"24051300";"10.1016/j.ejmech.2013.06.058";"2013";"Eur J Med Chem";"69";"278";"293";"";"";"";"";"";""
"CHEMBL691909";"F";"Inhibitory concentration of compound against proliferation of colon carcinoma HT-29 cell line";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1135121";"12031316";"10.1016/s0960-894x(02)00218-4";"2002";"Bioorg Med Chem Lett";"12";"1443";"1446";"";"";"";"";"";""
"CHEMBL1697730";"A";"Human drug-induced liver injury (DILI) modelling dataset from Ekins et al";"Homo sapiens";"529";"532";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL1697723";"20843939";"10.1124/dmd.110.035113";"2010";"Drug Metab Dispos";"38";"2302";"2308";"";"";"";"";"";""
"CHEMBL929838";"F";"Cytotoxicity against human MCF7 cells at 4 ug/ml after 48 hrs by SRB assay";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL1909091";"B";"DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1697799";"A";"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1654778";"F";"Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry";"Mycobacterium smegmatis";"24";"48";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"1772";"";"";"";"";"CHEMBL1649296";"19786608";"10.1128/aac.00803-09";"2009";"Antimicrob Agents Chemother";"53";"5279";"5283";"";"";"";"";"";""
"CHEMBL1909187";"B";"DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909103";"B";"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909123";"B";"DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Erythrocyte";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909157";"B";"DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909167";"B";"DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909175";"B";"DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"SK-N-MC";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL710180";"F";"In vitro extracellular concentration required to reduce cell population to 50% against L1210 leukemia cells";"Mus musculus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL1764597";"F";"Resistance index, ratio IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1759981";"21439821";"10.1016/j.bmcl.2011.02.106";"2011";"Bioorg Med Chem Lett";"21";"2259";"2263";"";"";"";"";"";""
"CHEMBL701571";"F";"Compound was tested in vitro for cytotoxicity against MDR cell line K562R (RI) (72 hr exposure to compound)";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1908086";"A";"Specific activity of expressed human recombinant UGT1A9";"Homo sapiens";"122";"141";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1907987";"10836148";"10.1146/annurev.pharmtox.40.1.581";"2000";"Annu Rev Pharmacol Toxicol";"40";"581";"616";"";"";"";"";"";""
"CHEMBL1614342";"F";"PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ";"Homo sapiens";"18552";"18602";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2076219";"F";"TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells";"";"22";"22";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"Sf9";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL709286";"F";"Tested for inhibitory activity against murine cell line L12110, a strain sensitive to doxorubicin using MTT assay.";"Mus musculus";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL2114913";"F";"PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ";"Homo sapiens";"29268";"29277";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1293122";"F";"Cytotoxicity against human HCT116 cells by MTT assay";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1287676";"20951582";"10.1016/j.bmcl.2010.09.074";"2010";"Bioorg Med Chem Lett";"20";"7110";"7115";"";"";"";"";"";""
"CHEMBL755674";"F";"Relative cytotoxicity against Human bone marrow samples; Value is in range, activity expressed as IC90";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3638253";"Bone marrow";"P388";"";"CHEMBL1132240";"10377219";"10.1021/jm980324m";"1999";"J Med Chem";"42";"2136";"2144";"";"";"";"";"";""
"CHEMBL855609";"F";"Antiproliferative activity against MDA435/LCC6 cells by ELISA";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL709053";"F";"In vitro cytotoxic activity against human colon adenocarcinoma (LoVo) cells";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1133386";"10698460";"10.1016/s0960-894x(99)00689-7";"2000";"Bioorg Med Chem Lett";"10";"305";"308";"";"";"";"";"";""
"CHEMBL624584";"F";"Inhibitory activity against human tumor cell line A0375 melanoma.";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A-375";"";"CHEMBL1128703";"7853345";"10.1021/jm00003a015";"1995";"J Med Chem";"38";"526";"536";"";"";"";"";"";""
"CHEMBL647080";"F";"Tested for activity against murine B-16 melanoma in mice and percent treated to the control values with the number of 60 day survivors";"Mus musculus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL1123657";"3806589";"10.1021/jm00384a021";"1987";"J Med Chem";"30";"121";"131";"";"";"";"";"";""
"CHEMBL1794557";"B";"PUBCHEM_BIOASSAY: MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442]";"Homo sapiens";"854";"854";"BAO_0000217";"biochemical format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL805529";"F";"Concentration required to inhibit SKOV-3-cell growth by 50%";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL1131065";"9703471";"10.1021/jm9801105";"1998";"J Med Chem";"41";"3253";"3260";"";"";"";"";"";""
"CHEMBL1738023";"F";"PUBCHEM_BIOASSAY: Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488970]";"";"56";"56";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL689461";"F";"Relative cytotoxicity against Human promyelocytic Leukemia(HL-60) cells; Value is in range, activity expressed as IC50";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1132240";"10377219";"10.1021/jm980324m";"1999";"J Med Chem";"42";"2136";"2144";"";"";"";"";"";""
"CHEMBL737126";"F";"In vitro for its inhibitory activity against murine L1210 leukemia";"Mus musculus";"35";"35";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124226";"3397990";"10.1021/jm00403a009";"1988";"J Med Chem";"31";"1527";"1539";"";"";"";"";"";""
"CHEMBL4029350";"T";"Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status";"Homo sapiens";"929";"929";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028802";"26948801";"10.1016/j.drudis.2016.02.015";"2016";"Drug Discov Today";"21";"648";"653";"";"";"";"";"";""
"CHEMBL1613808";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ";"Homo sapiens";"7224";"7260";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909310";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909316";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909320";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909311";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909313";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL3252301";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.25 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL872507";"F";"Anti-tumor activity against murine L1210 sensitive cell line by using MTT assay";"Mus musculus";"25";"25";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL619465";"F";"Concentration required to inhibit A2780-cell growth by 50%";"Homo sapiens";"27";"27";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1131065";"9703471";"10.1021/jm9801105";"1998";"J Med Chem";"41";"3253";"3260";"";"";"";"";"";""
"CHEMBL879742";"F";"Tested against MXF7 breast carcinoma (sensitive) cell line in the sulforhodamine B assay.";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL1909319";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL3214970";"F";"PubChem BioAssay. qHTS Assay for Identifying Gametocytocidal Compounds.   (Class of assay: confirmatory) ";"";"1095";"1204";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614328";"F";"PUBCHEM_BIOASSAY: Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay. (Class of assay: confirmatory) [Related pubchem assays: 2528 (qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2585 (qHTS Confirmation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]";"";"311";"316";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1920323";"B";"Inhibition of ATP-dependent ABCG2 pump assessed as ratio of compound IC50 for HEK/ABCG2-482-R2 cells to IC50 for HEK293/pcDNA3.1 cells after 72 hrs by MTT assay";"";"1";"1";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1914443";"21920748";"10.1016/j.bmcl.2011.08.070";"2011";"Bioorg Med Chem Lett";"21";"6495";"6499";"";"";"";"";"";""
"CHEMBL1108963";"P";"Octanol-water partition coefficient, log P of the compound";"";"55";"55";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1157036";"20106561";"10.1016/j.ejmech.2009.12.043";"2010";"Eur J Med Chem";"45";"1639";"1647";"";"";"";"";"";""
"CHEMBL2320298";"B";"Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MDCK-II";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL817042";"F";"Activity against resistant cell line of WiDr human colon tumor";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL1964086";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"12281";"12354";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"XF498";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964077";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ";"";"41347";"41698";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"KM12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1041309";"F";"Antibacterial activity against imipenem-resistant Escherichia coli BL21(DE3) expressing VIM2 gene after 18 hrs by twofold serial broth dilution method";"Escherichia coli BL21(DE3)";"5";"5";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1614100";"F";"PUBCHEM_BIOASSAY: A small molecule screen for inhibitors of the PhoP region in Salmonella typhi. (Class of assay: confirmatory) [Related pubchem assays: 1864, 2252, 1985 ]";"";"1016";"1021";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL721945";"F";"The percent increase in life span of compound was measured against P388 Leukemia cells in mice at at a dose of 1.6 mg/kg on days 1,5 and 9";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"standard_type:DOSE standard_relation:= standard_value:1.6 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1964092";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ";"";"38953";"39286";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"LOX IMVI ";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL696138";"F";"Percent inhibition at G1 phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29 cell line";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1614087";"F";"PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ";"Mus musculus";"51951";"52238";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10090";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL669721";"B";"In vitro inhibition of partially purified human ovarian carcinoma topoisomerase II of kDNA decatenation";"";"8";"8";"BAO_0000224";"protein format";"4";"4 - Multiple homologous protein targets may be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1128184";"7473578";"10.1021/jm00022a016";"1995";"J Med Chem";"38";"4503";"4507";"";"";"";"";"";""
"CHEMBL701719";"B";"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing";"Human immunodeficiency virus 1";"25";"26";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"11676";"";"";"";"";"CHEMBL1133723";"10841789";"10.1021/jm990322h";"2000";"J Med Chem";"43";"2100";"2114";"";"";"";"";"";""
"CHEMBL1963848";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line. (Class of assay: confirmatory) ";"";"14290";"14389";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"KM-20L2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2320306";"B";"Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay";"Homo sapiens";"62";"62";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL851907";"A";"Permeability Coefficient in 2/4/A1 cell model";"Homo sapiens";"30";"30";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"2/4/A1";"";"CHEMBL1145178";"15658873";"10.1021/jm049711o";"2005";"J Med Chem";"48";"604";"613";"";"";"";"";"";""
"CHEMBL851908";"A";"Permeability Coefficient in Caco-2 cell culture model";"Homo sapiens";"29";"29";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL1145178";"15658873";"10.1021/jm049711o";"2005";"J Med Chem";"48";"604";"613";"";"";"";"";"";""
"CHEMBL696142";"F";"Percent inhibition at S phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29 cell line";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL2076475";"F";"TP_TRANSPORTER: drug resistance in BCRP-expressing LLC-PK1 cells";"";"3";"3";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"LLC-PK1";"";"CHEMBL2074466";"12920197";"10.1124/mol.64.3.610";"2003";"Mol Pharmacol";"64";"610";"618";"";"";"";"";"";""
"CHEMBL651390";"B";"Inhibitory concentration against ethidium:Calf thymus DNA(0.1:1) binding at pH 5";"Bos taurus";"19";"19";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL1925792";"F";"Cytotoxicity against doxorubicin-sensitive human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1921783";"22011244";"10.1021/jm200984x";"2011";"J Med Chem";"54";"8224";"8227";"";"";"";"";"";""
"CHEMBL3881636";"F";"Cytotoxicity against human Jurkat cells assessed as cell death";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"Jurkat";"";"CHEMBL3881525";"None";"None";"2007";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3881634";"F";"Induction of apoptosis in human Jurkat cells assessed as caspase3 activation";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"Jurkat";"";"CHEMBL3881525";"None";"None";"2007";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562088";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562112";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL716675";"F";"Number of mice(with Colon 38 tumors) cured after treatment of 3.9 mg/kg/day dose given as 3 times in a day for 4 days out of 5 mice";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3638202";"Colon";"";"";"CHEMBL1136718";"12620081";"10.1021/jm020420u";"2003";"J Med Chem";"46";"1049";"1054";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3562133";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) ";"";"570";"570";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3529276";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3253042";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL1908286";"A";"Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells";"Canis lupus familiaris";"60";"63";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"(null)";"Scientific Literature";"9615";"";"";"MDR1-MDCKII";"";"CHEMBL1908284";"11602674";"None";"2001";"J Pharmacol Exp Ther";"299";"620";"628";"";"";"";"";"";""
"CHEMBL1614263";"F";"PUBCHEM_BIOASSAY: Quantitative High-Throughput Screen for Regulators of Epigenetic Control. (Class of assay: confirmatory) [Related pubchem assays: 1041, 1039, 890, 1036, 1653, 1035, 1043, 1038, 990, 597, 1042, 1037 ]";"";"5529";"5572";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1041304";"B";"Inhibition of TEM-1 using nitrocefin as substrate after 15 mins by microtiter plate assay";"";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL3529272";"A";"Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL1041322";"F";"Bacteriostatic activity against imipenem-resistant Escherichia coli BL21(DE3) expressing VIM2 gene at 2.1 ug/mL after 24 hrs by broth microdilution method";"Escherichia coli BL21(DE3)";"1";"1";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL3562069";"F";"PubChem BioAssay. Colo320 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"234";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL885013";"F";"In vitro cytotoxicity variant MES-SA/Dx5 multidrug resistant cells";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1143647";"16169719";"10.1016/j.bmcl.2005.07.079";"2005";"Bioorg Med Chem Lett";"15";"5057";"5060";"";"";"";"";"";""
"CHEMBL1737994";"F";"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504444]";"";"15530";"15589";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252370";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 2 mg/kg qd for 9 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL1909133";"B";"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614052";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ";"Homo sapiens";"14862";"14887";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909085";"B";"DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3987361";"Submaxillary gland";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL907429";"F";"Resistant factor, IC50 for MES-SA/Dx5/ IC50 for MES-SA cells by MTT assay after 72 hrs";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL1149365";"16824751";"10.1016/j.bmcl.2006.06.074";"2006";"Bioorg Med Chem Lett";"16";"4822";"4825";"";"";"";"";"";""
"CHEMBL3706545";"A";"Percentage of administered dose recovered as unchanged drug in urine within 48 h of drug administration";"Homo sapiens";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Curated Drug Metabolism Pathways";"9606";"CHEMBL3638201";"Urine";"";"";"CHEMBL3706496";"None";"None";"1999";"None";"None";"None";"None";"standard_type:DOSED_COMPOUND_ID standard_relation:= standard_value:2582827.0 standard_units:None comments:None | standard_type:DOSED_COMPOUND_NAME standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL762168";"F";"Activity against P388 leukemia cells in mice, by intraperitoneal dosing and net log tumor cell kill was reported";"Mus musculus";"91";"91";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123657";"3806589";"10.1021/jm00384a021";"1987";"J Med Chem";"30";"121";"131";"";"";"";"";"";""
"CHEMBL1909205";"B";"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Insect cells";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909186";"B";"DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Platelet";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL883178";"F";"Resistant factor as ability to overcome multidrug resistance of MES-SA/Dx5 cells compared to MES-SA cells";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1143647";"16169719";"10.1016/j.bmcl.2005.07.079";"2005";"Bioorg Med Chem Lett";"15";"5057";"5060";"";"";"";"";"";""
"CHEMBL885025";"F";"In vitro cytotoxicity against uterine sarcoma MES-SA cells";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL1143647";"16169719";"10.1016/j.bmcl.2005.07.079";"2005";"Bioorg Med Chem Lett";"15";"5057";"5060";"";"";"";"";"";""
"CHEMBL1041297";"B";"Inhibition of VIM2 using nitrocefin as substrate by rapid dilution method";"";"3";"3";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL1041298";"B";"Inhibition of VIM2 using nitrocefin as substrate at 44 uM after 15 mins by microtiter plate assay";"";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL987562";"F";"Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL after 3 days treated 4 hrs before db-cAMP challenge by MTT assay";"Rattus norvegicus";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL1158219";"8988604";"10.1021/np960144k";"1996";"J Nat Prod";"59";"1179";"1182";"";"";"";"";"";""
"CHEMBL706036";"F";"Compound was tested against L1210 leukemia at % increase in life span (ILS) in mice at 1.6 mg/kg dosage.";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"standard_type:DOSE standard_relation:= standard_value:1.6 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL1909318";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909312";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909317";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909308";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL1909309";"A";"Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis";"";"888";"888";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"CHEMBL3559723";"Liver";"";"";"CHEMBL1909294";"22194678";"10.1371/journal.pcbi.1002310";"2011";"PLoS Comput Biol";"7";"1";"13";"";"";"";"";"";""
"CHEMBL3997694";"A";"Drug uptake in mouse 4T1.2 cell nucleus at 5 uM after 4 hrs by laser scanning confocal microscopic method";"Mus musculus";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"Nucleus";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL851288";"A";"Toxicity ratio of quotient of the IC50 in myocytes divided by the average IC50 for three tumor cell lines";"";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1128275";"7699715";"10.1021/jm00006a018";"1995";"J Med Chem";"38";"983";"993";"";"";"";"";"";""
"CHEMBL664085";"F";"Increase in Melting temperature (delta Tm) for Micrococcus lysodeikticus DNA on interaction against ligand (mole ratio of 10:1)";"Micrococcus luteus";"7";"7";"BAO_0000019";"assay format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"1270";"";"";"";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL884217";"F";"In vitro cytotoxicity against murine leukemia cell line L1210";"Mus musculus";"15";"15";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1143647";"16169719";"10.1016/j.bmcl.2005.07.079";"2005";"Bioorg Med Chem Lett";"15";"5057";"5060";"";"";"";"";"";""
"CHEMBL816180";"F";"Tested against WiDr colon carcinoma (resistant) in the sulforhodamine B assay.";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL709967";"F";"Tested against MXF7 breast carcinoma (mitoxantrone resistant)cell line in the sulforhodamine B assay.";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL819953";"F";"In vitro extracellular concentration required to reduce cell population to 50% against Walker 256 (WS) carcinoma cells";"Rattus norvegicus";"14";"14";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"";"";"CHEMBL1125436";"1573635";"10.1021/jm00086a010";"1992";"J Med Chem";"35";"1418";"1429";"";"";"";"";"";""
"CHEMBL1697800";"A";"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase";"Homo sapiens";"486";"1470";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1697781";"16472241";"10.2174/1570163043334794";"2004";"Curr Drug Discov Technol";"1";"243";"254";"";"";"";"";"";""
"CHEMBL1663502";"A";"Drug absorption in human assessed as human intestinal absorption rate";"Homo sapiens";"159";"159";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3638176";"Intestine";"";"";"CHEMBL1649380";"21112128";"10.1016/j.ejmech.2010.11.005";"2011";"Eur J Med Chem";"46";"218";"228";"";"";"";"";"";""
"CHEMBL2330173";"B";"Inhibition of PIM1 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assayATP";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL1614207";"F";"PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]";"";"562";"564";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738570";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504639]";"Leishmania major strain Friedlin";"46";"46";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"347515";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794553";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860]";"Homo sapiens";"58172";"58459";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"9606";"";"";"HepG2";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614194";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485296]";"Bacillus subtilis";"66";"66";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"1423";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614171";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity. (Class of assay: confirmatory) ";"Homo sapiens";"696";"699";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL755742";"F";"Relative cytotoxicity against Human bone marrow samples; Value is in range, activity expressed as IC50";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"CHEMBL3638253";"Bone marrow";"P388";"";"CHEMBL1132240";"10377219";"10.1021/jm980324m";"1999";"J Med Chem";"42";"2136";"2144";"";"";"";"";"";""
"CHEMBL929841";"F";"Cytotoxicity against human PC3 cells after 48 hrs by SRB assay";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL1738096";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation from the primary screen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2675, AID2700]";"Homo sapiens";"104";"105";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1167965";"B";"Binding affinity to calf thymus DNA assessed as ratio of final absorbance area to the absorbance at 100 uM after 24 hrs by UV spectrophotometer analysis relative to control";"Bos taurus";"7";"7";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1165945";"20471844";"10.1016/j.bmc.2010.04.074";"2010";"Bioorg Med Chem";"18";"4433";"4440";"";"";"";"";"";""
"CHEMBL3252378";"F";"Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse assessed as survival at 1.08 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Colon 26";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.08 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL748137";"F";"Inhibitory activity against OVCAR-3 cell line";"Homo sapiens";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"OVCAR-3";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL2075711";"F";"TP_TRANSPORTER: Northern blot from primary hepatocytes";"Rattus norvegicus";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"TP-search Transporter Database";"10116";"";"";"Hepatocyte";"";"CHEMBL2074079";"8937457";"10.1016/s0006-2952(96)00512-6";"1996";"Biochem Pharmacol";"52";"1453";"1460";"";"";"";"";"";""
"CHEMBL1963854";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"41955";"42298";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"A549";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214817";"B";"PubChem BioAssay. Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"306";"306";"BAO_0000217";"biochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794569";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636]";"";"18965";"19022";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794521";"F";"PUBCHEM_BIOASSAY: Confirmation dose response of additional hit compounds from high-throughput yeast screen for caloric restriction mimetics that inhibit age-related superoxide. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2714]";"";"32";"33";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL907428";"F";"Antiproliferative activity against doxorubicin-resistant MES-SA/Dx5 cells by MTT assay after 72 hrs";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MES-SA/Dx5";"";"CHEMBL1149365";"16824751";"10.1016/j.bmcl.2006.06.074";"2006";"Bioorg Med Chem Lett";"16";"4822";"4825";"";"";"";"";"";""
"CHEMBL3252606";"F";"Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase of median life span at 0.8 mg/kg, ip on day 1 to 9 measured up to 80 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"standard_type:DOSE standard_relation:= standard_value:0.8 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3253047";"F";"Antitumor activity against mouse LLC cells intravenously implanted in mouse";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"";"";"";"";""
"CHEMBL715094";"F";"Tested for inhibitory activity against human tumor cell line MCF7, a strain resistant to mitoxantrone of breast carcinoma using sulforhodamine B assay.";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL4029721";"F";"Cytotoxicity against human HL60/MX2 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL4028815";"28342398";"10.1016/j.ejmech.2017.03.028";"2017";"Eur J Med Chem";"132";"63";"80";"";"";"";"";"";""
"CHEMBL1964025";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ";"";"38812";"39141";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"Malme-3M";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909193";"B";"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)";"Escherichia coli";"871";"1742";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909173";"B";"DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909182";"B";"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909107";"B";"DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"9";"9 - Direct single protein target assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3638255";"Striatum";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909084";"B";"DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)";"Cavia porcellus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Dunkin-Hartley";"DrugMatrix";"10141";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909088";"B";"DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909115";"B";"DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)";"Escherichia coli";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"562";"";"";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909126";"B";"DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909146";"B";"DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909164";"B";"DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO-K1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909110";"B";"DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Jurkat";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909113";"B";"DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"CHO";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909094";"B";"DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"MDCK";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252376";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 0.25 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL1909149";"B";"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1737912";"F";"PUBCHEM_BIOASSAY: Dose response counterscreen of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489026]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614672";"A";"Fraction unbound in human after iv administration";"Homo sapiens";"554";"554";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1614632";"18426954";"10.1124/dmd.108.020479";"2008";"Drug Metab Dispos";"36";"1385";"1405";"";"";"";"";"";""
"CHEMBL1794483";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623]";"";"114923";"115311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964088";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ";"";"38535";"38847";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"RPMI-8226";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738494";"F";"PUBCHEM_BIOASSAY: Dose response cytotoxicity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a HEK-293T cell line using a luminescence assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID435003, AID435012, AID489041]";"";"693";"694";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HEK-293T";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1741321";"F";"PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active";"";"16572";"17143";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL886129";"F";"Ratio of GI50 for mitoxantrone-resistant human MX2 cells to GI50 for human HL60 cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1139925";"17418582";"10.1016/j.bmc.2007.03.067";"2007";"Bioorg Med Chem";"15";"4237";"4246";"";"";"";"";"";""
"CHEMBL1964018";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"38940";"39248";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SF-539";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964063";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ";"";"27642";"27872";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MDA-MB-231";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613991";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response. (Class of assay: confirmatory) ";"Rattus norvegicus";"484";"498";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"10116";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909178";"B";"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)";"Rattus norvegicus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10116";"CHEMBL3638233";"Cerebellum";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613927";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter. (Class of assay: confirmatory) [Related pubchem assays: 2281 (Summary of qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a)]";"Homo sapiens";"42";"42";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909145";"B";"DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Sf9";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909159";"B";"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)";"Rattus norvegicus";"871";"1742";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Wistar";"DrugMatrix";"10116";"CHEMBL3559724";"Cerebral cortex";"";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL826140";"A";"Percentage of mass balance in hexadecane membranes model";"Homo sapiens";"29";"29";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145178";"15658873";"10.1021/jm049711o";"2005";"J Med Chem";"48";"604";"613";"";"";"";"";"";""
"CHEMBL3072283";"F";"Cytotoxicity against Rattus norvegicus (rat) C6 cells after 24 hr by MTT assay";"Rattus norvegicus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL3046656";"None";"10.1007/s00044-012-0325-2";"2013";"Med Chem Res";"22";"3751";"3759";"";"";"";"";"";""
"CHEMBL3215284";"F";"PubChem BioAssay. qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay.   (Class of assay: confirmatory) ";"";"66";"66";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1738440";"U";"PubChem BioAssay. Late stage results from the probe development efforts to identify selective inhibitors of VIM-2 metallo-beta-lactamase: Prior art results. (Class of assay: screening) Panel member name: Nitrocefin-based IMP1 Inhibition Counterscreen";"";"1";"1";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354301";"F";"PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"1637";"1637";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"RMG-I";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214963";"F";"PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"1499";"1502";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL620339";"F";"Inhibitory concentration of compound against proliferation of lung carcinoma A549 cell line";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1135121";"12031316";"10.1016/s0960-894x(02)00218-4";"2002";"Bioorg Med Chem Lett";"12";"1443";"1446";"";"";"";"";"";""
"CHEMBL855054";"F";"Antiproliferative activity against adriamycin resistant P388 cells in presence of 5 uM 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane by ELISA";"Mus musculus";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388/ADR";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL3599765";"F";"Cytotoxicity against human MCF7 cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL3596161";"25811651";"10.1021/jm501180v";"2015";"J Med Chem";"58";"5699";"5727";"";"";"";"";"";""
"CHEMBL1963921";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ";"";"28183";"28420";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MDA-MB-435";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL855052";"F";"Relative fold, IC50 in absence to presence of 1,13-bis[4'-((5,7-dihydroxy)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10,13-pentaoxatridecane in multidrug resistant MDA435/LCC6 cells";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-435";"";"CHEMBL1137344";"17154505";"10.1021/jm060593+";"2006";"J Med Chem";"49";"6742";"6759";"";"";"";"";"";""
"CHEMBL1738622";"B";"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation in AlphaScreen assay for MBNL1-(CUG)12 binding. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2675, AID2700]";"Homo sapiens";"73";"73";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL695183";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line HT-29/Mx";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL937447";"F";"Antiproliferative activity against human MDA-MB-231 cells";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MDA-MB-231";"";"CHEMBL1142405";"18296053";"10.1016/j.bmc.2007.03.003";"2008";"Bioorg Med Chem";"16";"3445";"3455";"";"";"";"";"";""
"CHEMBL1794375";"B";"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]";"";"83389";"88483";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL708504";"F";"Resistance index is IC50 ratio of LoVo/Dx to LoVo";"Homo sapiens";"16";"16";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1132293";"10411474";"10.1021/jm9805586";"1999";"J Med Chem";"42";"2535";"2541";"";"";"";"";"";""
"CHEMBL695863";"F";"In vitro cytotoxic activity against human colon HT-29 cell line ( standard deviation in parenthesis)";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1135469";"12036369";"10.1021/jm011117g";"2002";"J Med Chem";"45";"2599";"2609";"";"";"";"";"";""
"CHEMBL765521";"F";"Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 12 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:12.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL1794367";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of ATXN expression: Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588349, AID588380]";"";"376";"378";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1769829";"F";"Cytotoxicity against human HCT116 cells by MTT assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL1765038";"21458279";"10.1016/j.bmc.2011.03.009";"2011";"Bioorg Med Chem";"19";"2625";"2632";"";"";"";"";"";""
"CHEMBL1071874";"F";"Cytotoxicity against human HL60 cells by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1153134";"19926279";"10.1016/j.bmcl.2009.10.110";"2010";"Bioorg Med Chem Lett";"20";"309";"314";"";"";"";"";"";""
"CHEMBL1929959";"F";"Cytotoxicity against human PC3 cells after 48 hrs by SRB assay";"Homo sapiens";"42";"42";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1926565";"22100139";"10.1016/j.ejmech.2011.10.059";"2012";"Eur J Med Chem";"47";"323";"336";"";"";"";"";"";""
"CHEMBL1614283";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) [Related pubchem assays: 1707, 1708 ]";"Homo sapiens";"145";"145";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL705836";"F";"Antitumor activity against L1210 lymphocytic cells in vitro";"Mus musculus";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1122737";"6699870";"10.1021/jm00369a002";"1984";"J Med Chem";"27";"253";"255";"";"";"";"";"";""
"CHEMBL1614330";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]";"Homo sapiens";"59";"59";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215185";"F";"PubChem BioAssay. qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay.   (Class of assay: confirmatory) ";"";"651";"652";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215105";"F";"PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"2629";"2638";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL737730";"F";"In vitro inhibitory activity against L1210 leukemia cell line";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126952";"8340911";"10.1021/jm00067a005";"1993";"J Med Chem";"36";"2084";"2090";"";"";"";"";"";""
"CHEMBL3214850";"F";"PubChem BioAssay. qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter).   (Class of assay: confirmatory) ";"";"126";"126";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214875";"F";"PubChem BioAssay. qHTS Assay for the Inhibitors of FEN1: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"874";"882";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1925795";"F";"Cytotoxicity against doxorubicin-resistant human MCF7 cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1921783";"22011244";"10.1021/jm200984x";"2011";"J Med Chem";"54";"8224";"8227";"";"";"";"";"";""
"CHEMBL2114715";"F";"PubChem BioAssay. qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: HTRF Assay. (Class of assay: confirmatory) ";"";"154";"154";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114796";"F";"PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ";"Homo sapiens";"8305";"8310";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL740325";"F";"In vitro cytotoxicity against L1210 leukemia cell line";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1126952";"8340911";"10.1021/jm00067a005";"1993";"J Med Chem";"36";"2084";"2090";"";"";"";"";"";""
"CHEMBL687154";"F";"Compound was tested in vitro for cytotoxicity against HL60 human leukemia cell line (72 hr exposure to compound)";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL2077538";"F";"TP_TRANSPORTER: uptake in BCRP-expressing oocyte cells";"Xenopus laevis";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"8355";"";"";"Oocyte";"";"CHEMBL2074207";"14645676";"10.1124/mol.64.6.1452";"2003";"Mol Pharmacol";"64";"1452";"1462";"";"";"";"";"";""
"CHEMBL1963963";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line. (Class of assay: confirmatory) ";"";"14626";"14722";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"DLD-1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1794585";"F";"PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ";"";"35474";"35582";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964012";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ";"";"41240";"41578";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"COLO 205";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114738";"F";"PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ";"Homo sapiens";"15496";"15567";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114775";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ";"";"75093";"75549";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL620128";"F";"In vitro cytotoxic activity against human lung A549 cell line ( standard deviation in parenthesis)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1135469";"12036369";"10.1021/jm011117g";"2002";"J Med Chem";"45";"2599";"2609";"";"";"";"";"";""
"CHEMBL1909165";"B";"DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)";"Oryctolagus cuniculus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9986";"";"";"Reticulocytes";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909212";"B";"DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909125";"B";"DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"Chem-1";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909163";"B";"DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)";"Cavia porcellus";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"10141";"CHEMBL3638235";"Lung";"";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909169";"B";"DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)";"";"871";"1742";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"BTI-TN-5B1-4";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909195";"B";"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)";"Homo sapiens";"871";"1742";"BAO_0000221";"tissue-based format";"9";"9 - Direct single protein target assigned";"";"DrugMatrix";"9606";"";"";"Neutrophil";"";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1613992";"F";"PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ";"Homo sapiens";"10316";"10385";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1909093";"B";"DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)";"";"871";"1742";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"DrugMatrix";"32644";"";"";"HEK293";"Membrane";"CHEMBL1909046";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL708499";"F";"Inhibitory activity against human colon adenocarcinoma cell line LoVo/Dx.";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1128703";"7853345";"10.1021/jm00003a015";"1995";"J Med Chem";"38";"526";"536";"";"";"";"";"";""
"CHEMBL824872";"F";"Cytotoxicity against human MKN45 cancer cell line was determined after 144 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MKN-45";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL619469";"F";"Cytotoxic potency required to inhibit A2780 cell growth by 50% after cell drug contact for 96 hrs";"Homo sapiens";"17";"17";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL817162";"F";"Tested for inhibitory activity against a multi drug resistant (MDR) strain of human colon carcinoma WiDr using sulforhodamine B assay (it is MRP positive but non-P-glycoprotein).";"Homo sapiens";"24";"24";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1133612";"10956214";"10.1021/jm9905817";"2000";"J Med Chem";"43";"3067";"3073";"";"";"";"";"";""
"CHEMBL1963989";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ";"";"41040";"41374";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"ACHN";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL929837";"B";"Binding affinity to calf thymus DNA assessed as thermal denaturation temperature at 10 uM";"Bos taurus";"1";"1";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1143145";"17962028";"10.1016/j.bmc.2007.10.012";"2008";"Bioorg Med Chem";"16";"1006";"1014";"";"";"";"";"";""
"CHEMBL1964034";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line. (Class of assay: confirmatory) ";"";"35810";"36111";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"A498";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964085";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ";"";"40966";"41294";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"M14";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1964040";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ";"";"41083";"41427";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"MOLT-4";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL695184";"F";"Percent inhibition at G1 phase of cell cycle at a dose of 1000 ng/mL after 72 hours of induction in HT-29 cell line";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1964045";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ";"";"28471";"28705";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI/ADR-RES";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963881";"F";"PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Cytotoxicity Assay. (Class of assay: confirmatory) ";"";"435";"440";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1057281";"F";"Cytotoxicity against human A549 cells by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL1153479";"19615900";"10.1016/j.bmcl.2009.06.097";"2009";"Bioorg Med Chem Lett";"19";"4584";"4588";"";"";"";"";"";""
"CHEMBL811893";"B";"Inhibition of commercially obtained pure Drosophila Topoisomerase II in catalytic DNA unwinding.";"";"5";"5";"BAO_0000357";"single protein format";"8";"8 - Homologous single protein target assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1128184";"7473578";"10.1021/jm00022a016";"1995";"J Med Chem";"38";"4503";"4507";"";"";"";"";"";""
"CHEMBL824192";"F";"Cytotoxicity against CHO cell line xrs6";"Cricetulus griseus";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10029";"";"";"XRS6";"";"CHEMBL1128184";"7473578";"10.1021/jm00022a016";"1995";"J Med Chem";"38";"4503";"4507";"";"";"";"";"";""
"CHEMBL815616";"F";"An average for IC50 values in the two solid tumor cell lines.";"";"34";"34";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"";"";"";"Tumor cell line";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL851909";"A";"Permeability Coefficient in hexadecane membranes model";"Homo sapiens";"27";"27";"BAO_0000249";"cell membrane format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1145178";"15658873";"10.1021/jm049711o";"2005";"J Med Chem";"48";"604";"613";"";"";"";"";"";""
"CHEMBL1613918";"F";"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]";"Homo sapiens";"18608";"18631";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL845975";"F";"Resistance index as the ratio of IC50 value against LoVo/Dx to that of LoVo cell lines.";"";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"LoVo";"";"CHEMBL1128703";"7853345";"10.1021/jm00003a015";"1995";"J Med Chem";"38";"526";"536";"";"";"";"";"";""
"CHEMBL961862";"F";"Cytotoxicity against human K562 cells after 48 hrs by MTT assay";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL1148132";"12027731";"10.1021/np0102049";"2002";"J Nat Prod";"65";"633";"637";"";"";"";"";"";""
"CHEMBL1743158";"A";"Substrates of transporters of clinical importance in the absorption and disposition of drugs, BCRP";"Homo sapiens";"5";"5";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1743141";"20190787";"10.1038/nrd3028";"2010";"Nat Rev Drug Discov";"9";"215";"236";"";"";"";"";"";""
"CHEMBL851338";"F";"Ratio of IC50 against V79 cells in the presence of air to that of nitrogen.";"";"8";"8";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"V79";"";"CHEMBL1128261";"7699696";"10.1021/jm00006a024";"1995";"J Med Chem";"38";"1039";"1043";"";"";"";"";"";""
"CHEMBL1055755";"F";"Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL879711";"F";"Percent inhibition at G2/M phase of cell cycle at a dose of 100n g/mL after 72 hours of induction in HT-29/Mx cell line";"Homo sapiens";"2";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL2091083";"F";"Antiproliferative activity against human LoVo cells after 72 hrs by SRB assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL1041313";"B";"Inhibition of VIM2 in imipenem-resistant Escherichia coli BL21(DE3) assessed as potentiation of imipenem-induced bactericidal activity at 2.1 ug/mL after 18 hrs by checkerboard microdilution method";"Escherichia coli BL21(DE3)";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL2078262";"F";"TP_TRANSPORTER: cell accumulation in MEF3.8, M32 and T6400 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MEF3.8;M32;T6400";"";"CHEMBL2074571";"10485464";"None";"1999";"Cancer Res";"59";"4237";"4241";"";"";"";"";"";""
"CHEMBL2114861";"F";"PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) ";"";"26907";"26955";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL660045";"F";"Survivors of CDF1 mice on day 4 after 1st injection of compound 12 at mg/kg in six mice; 6/6";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"";"";"";"";"";""
"CHEMBL1963900";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ";"";"26413";"26627";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"T47D";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL837533";"F";"Cytotoxicity against human PC3 cancer cell line was determined after 144 hr";"Homo sapiens";"6";"6";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"PC-3";"";"CHEMBL1138784";"15456268";"10.1021/jm049706k";"2004";"J Med Chem";"47";"5244";"5250";"";"";"";"";"";""
"CHEMBL656350";"F";"Survivors of CDF1 mice on day 4 after 1st injection of compound at 0.75 mg/kg in six mice; 6/6";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:0.75 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL2354311";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ";"";"31581";"31649";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215013";"F";"PubChem BioAssay. qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen.   (Class of assay: confirmatory) ";"";"502";"515";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3214809";"F";"PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: BLM Helicase Counterscreen for WRN Inhibitors.   (Class of assay: confirmatory) ";"";"505";"505";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252384";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 18 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:18.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2114817";"F";"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ";"";"17358";"17362";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215270";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"22759";"22913";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1267251";"F";"Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"655";"685";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"W2";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL1267245";"F";"Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay";"Plasmodium falciparum";"534";"559";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"3D7";"Scientific Literature";"5833";"";"";"";"";"CHEMBL1255382";"19734910";"10.1038/nchembio.215";"2009";"Nat Chem Biol";"5";"765";"771";"";"";"";"";"";""
"CHEMBL4495582";"F";"SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate";"Severe acute respiratory syndrome coronavirus 2";"7218";"8702";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"SARS-CoV-2 Screening Data 2020-21";"2697049";"";"";"";"";"CHEMBL4495564";"None";"10.6019/CHEMBL4495564";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL711067";"F";"In vitro cytotoxic activity against human colon adenocarcinoma resistant to doxorubicin (LoVo Dx) cells.";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1133386";"10698460";"10.1016/s0960-894x(99)00689-7";"2000";"Bioorg Med Chem Lett";"10";"305";"308";"";"";"";"";"";""
"CHEMBL4006907";"F";"Cytotoxicity against mouse L1210 cells assessed as reduction in cell viability after 24 hrs by MTT assay";"Mus musculus";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL4004858";"28222315";"10.1016/j.ejmech.2017.02.013";"2017";"Eur J Med Chem";"129";"151";"158";"";"";"";"";"";""
"CHEMBL4138792";"B";"Inhibition of ROS1 in human HCC78 cells assessed as reduction in ERK phosphorylation incubated for 48 hrs by Western blot method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3755739";"F";"Cytotoxicity against human A549 cells after 24 hrs by MTT assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3751820";"26599534";"10.1016/j.ejmech.2015.11.002";"2016";"Eur J Med Chem";"107";"288";"294";"";"";"";"";"";""
"CHEMBL1613842";"F";"PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ";"Homo sapiens";"33402";"33647";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9606";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1614291";"F";"PUBCHEM_BIOASSAY: qHTS Validation Assay for Identification of Novel General Anesthetics. (Class of assay: confirmatory) ";"Equus caballus";"346";"347";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"9796";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1101456";"F";"Growth inhibition of human SKOV3 cells by MTT assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL1155373";"20153184";"10.1016/j.bmcl.2010.01.096";"2010";"Bioorg Med Chem Lett";"20";"1528";"1531";"";"";"";"";"";""
"CHEMBL1964074";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line. (Class of assay: confirmatory) ";"";"15163";"15267";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"M19-MEL";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL696141";"F";"Percent inhibition at G2/M phase of cell cycle at a dose of 25 ng/mL after 72 hours of induction in HT-29 cell line";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1285392";"B";"Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u";"Candida albicans";"66";"66";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"5476";"";"";"";"";"CHEMBL1275276";"20739103";"10.1016/j.ejmech.2010.07.050";"2010";"Eur J Med Chem";"45";"4813";"4826";"";"";"";"";"";""
"CHEMBL654326";"B";"Inhibitory concentration against ethidium:calf thymus DNA (1.26:1) binding at pH 5";"Bos taurus";"17";"17";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL717386";"F";"In vivo antitumor activity at a single dose of 6.5 mg/kg & 18.8 mg/kg total against mammary adenocarcinoma 16C";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122737";"6699870";"10.1021/jm00369a002";"1984";"J Med Chem";"27";"253";"255";"";"";"";"";"";""
"CHEMBL3411294";"A";"Inhibition of human OATP1B3-mediated [3H]CCK-8 after 5 mins by Dixon plot method";"Homo sapiens";"6";"12";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3407465";"25618019";"10.1016/j.ejmech.2015.01.011";"2015";"Eur J Med Chem";"92";"723";"731";"";"";"";"";"";""
"CHEMBL3537297";"A";"Drug uptake in Sprague-Dawley rat brain slices at 100 nM after 5 hrs in presence of 20 uM of MK-571";"Rattus norvegicus";"2";"2";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638188";"Brain";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL2075734";"F";"TP_TRANSPORTER: transport in etoposide-selected MCF7 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF7";"";"CHEMBL2074176";"16434618";"10.1124/mol.105.017988";"2006";"Mol Pharmacol";"69";"1499";"1505";"";"";"";"";"";""
"CHEMBL3137739";"T";"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL1266185";"F";"Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay";"Mus musculus";"1252";"1259";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1255231";"17417631";"10.1038/nchembio873";"2007";"Nat Chem Biol";"3";"268";"273";"";"";"";"";"";""
"CHEMBL692393";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line HT-29";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL1964004";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"38197";"38507";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"NCI-H226";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963903";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) ";"";"40754";"41090";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"UACC-62";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL995340";"B";"Displacement of [3H]PSB0413 from human platelet P2Y12 receptor";"Homo sapiens";"49";"49";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL1136967";"19463000";"10.1021/jm9003297";"2009";"J Med Chem";"52";"3784";"3793";"";"";"";"";"";""
"CHEMBL1963981";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ";"";"41327";"41678";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SN12C";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963922";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ";"";"41592";"41947";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"SF-295";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963874";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ";"";"41314";"41656";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HCT-116";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2077081";"F";"TP_TRANSPORTER: ATP hydrolysis in membrane vesicle from BCRP-expressing Sf9 cells";"";"5";"5";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"Sf9";"Membrane vesicle";"CHEMBL2074508";"11437380";"10.1006/bbrc.2001.5130";"2001";"Biochem Biophys Res Commun";"285";"111";"117";"";"";"";"";"";""
"CHEMBL3537288";"A";"Fraction unbound in Sprague-Dawley rat brain homogenates at 5 uM by equilibrium dialysis analysis";"Rattus norvegicus";"56";"56";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638188";"Brain";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL3253048";"F";"Ratio of adriamycin to compound for inhibition of RNA synthesis in mouse L5178Y cells";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L5178Y";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"";"";"";"";""
"CHEMBL3123716";"F";"Cytotoxicity against human H1299 cells assessed as cell viability at 1 uM after 48 hrs by MTT assay";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL3120102";"24051300";"10.1016/j.ejmech.2013.06.058";"2013";"Eur J Med Chem";"69";"278";"293";"";"";"";"";"";""
"CHEMBL2428416";"F";"Cytotoxicity against human SKOV3 cells after 48 hrs by resazurin dye assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL2424651";"23988351";"10.1016/j.bmcl.2013.08.021";"2013";"Bioorg Med Chem Lett";"23";"5264";"5266";"";"";"";"";"";""
"CHEMBL3215096";"B";"PubChem BioAssay. C. difficile toxins: Counterscreen in absence of substrate UDPG Measured in Biochemical System Using Plate Reader - 7074-02_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"330";"331";"BAO_0000217";"biochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3253041";"T";"Toxicity in mouse P388 cells allografted ip dosed mouse assessed as maximum tolerated dose administered as once each 4 days for 3 total injection";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models";"P388 Experimental Leukemia";"";""
"CHEMBL3561981";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, blue channel.   (Class of assay: confirmatory) ";"";"168";"168";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252765";"T";"Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.25 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"BDF1";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL3252767";"T";"Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.06 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"BDF1";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.06 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL3529279";"A";"Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529278";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3529274";"A";"Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3215106";"F";"PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ";"";"46665";"46812";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3881622";"F";"Ratio of IC50 for human mitoxantrone-sensitive HL60 cells to IC50 for human mitoxantrone-resistant HL60/MX2 cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HL-60";"";"CHEMBL3881525";"None";"None";"2007";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2433630";"F";"Growth inhibition of human HCT116 cells at 10 uM after 48 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT-116";"";"CHEMBL2429715";"None";"10.1007/s00044-013-0805-z";"2013";"Med Chem Res";"None";"1";"7";"";"";"";"";"";""
"CHEMBL2320294";"U";"Ratio of Cmax unbound to IC50 for human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells";"";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"MDCK-II";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL2320303";"B";"Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay";"Homo sapiens";"33";"33";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL3755741";"F";"Cytotoxicity against rat 5RP7 cells after 24 hrs by MTT assay";"Rattus norvegicus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"5RP7";"";"CHEMBL3751820";"26599534";"10.1016/j.ejmech.2015.11.002";"2016";"Eur J Med Chem";"107";"288";"294";"";"";"";"";"";""
"CHEMBL3562119";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) ";"";"2170";"2186";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3881635";"F";"Cytotoxicity against human Jurkat cells";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"Jurkat";"";"CHEMBL3881525";"None";"None";"2007";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3537290";"A";"Unbound drug partitioning coefficient, Kp of the compound assessed as ratio of unbound concentration in Sprague-Dawley rat brain to unbound concentration in plasma";"Rattus norvegicus";"56";"56";"BAO_0000366";"cell-free format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3559721";"Plasma";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL3532944";"P";"Dissociation constant, pKa of the acidic compound by capillary electrophoresis-mass spectrometry analysis";"";"42";"42";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL3241169";"A";"Unbound fraction in HEK293 cell homogenate at 0.1 uM by equilibrium dialysis based UPLC-MS/MS analysis";"Homo sapiens";"45";"45";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL3232907";"24601604";"10.1021/jm401963n";"2014";"J Med Chem";"57";"3005";"3010";"";"";"";"";"";""
"CHEMBL4384569";"F";"Antiproliferative activity against human HL60 cells after 72 hrs by CCK8 assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4382251";"30485090";"10.1021/acs.jnatprod.8b00482";"2018";"J Nat Prod";"81";"2667";"2672";"";"";"";"";"";""
"CHEMBL2330101";"B";"Inhibition of PIM1-mediated BAD phosphorylation in human MV411 cells at 100 nM after 12 hrs by Western blotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL3562121";"F";"PubChem BioAssay. alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50.   (Class of assay: confirmatory) ";"";"96";"97";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"C2C12";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1963972";"F";"PUBCHEM_BIOASSAY: Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"1261";"1261";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3411292";"A";"Inhibition of human OATP1B3-mediated [3H]CCK-8 at 100 uM after 5 mins relative to control";"Homo sapiens";"11";"11";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3407465";"25618019";"10.1016/j.ejmech.2015.01.011";"2015";"Eur J Med Chem";"92";"723";"731";"";"";"";"";"";""
"CHEMBL2330109";"B";"Inhibition of CHK2 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL2330174";"B";"Inhibition of CK2alpha2 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL705038";"F";"Number of mice dead with 0.75 mg/kg dose (in vivo)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"standard_type:DOSE standard_relation:= standard_value:0.75 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL4050875";"F";"Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4049418";"28333459";"10.1021/acs.jmedchem.6b01502";"2017";"J Med Chem";"60";"2764";"2779";"";"";"";"";"";""
"CHEMBL3252303";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.06 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.06 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL1763108";"F";"Cytotoxicity against human HL60 cells after 72 hrs";"Homo sapiens";"8";"8";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1759843";"21354791";"10.1016/j.bmcl.2011.01.072";"2011";"Bioorg Med Chem Lett";"21";"2155";"2159";"";"";"";"";"";""
"CHEMBL852519";"F";"Ratio of BR1 IC50 to xrs-6 IC50";"";"10";"10";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1128184";"7473578";"10.1021/jm00022a016";"1995";"J Med Chem";"38";"4503";"4507";"";"";"";"";"";""
"CHEMBL708500";"F";"Tested in vitro for cytotoxic activity against Doxorubicin resistant Human colon Adenocarcinoma sensitive cell line";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL2077937";"F";"TP_TRANSPORTER: Northern blot in vivo NMRI mouse";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"9";"9 - Direct single protein target assigned";"NMRI";"TP-search Transporter Database";"10090";"";"";"";"";"CHEMBL2074079";"8937457";"10.1016/s0006-2952(96)00512-6";"1996";"Biochem Pharmacol";"52";"1453";"1460";"";"";"";"";"";""
"CHEMBL3997699";"T";"Toxicity in Balb/c mouse assessed as body weight loss at 2 mg/kg, iv administered twice weekly for 2 weeks relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Balb/c";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL3562130";"F";"PubChem BioAssay. GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2428415";"F";"Cytotoxicity against human NCI-H460 cells after 48 hrs by resazurin dye assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H460";"";"CHEMBL2424651";"23988351";"10.1016/j.bmcl.2013.08.021";"2013";"Bioorg Med Chem Lett";"23";"5264";"5266";"";"";"";"";"";""
"CHEMBL739486";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.4 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.4 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL722418";"F";"In vivo antitumor activity against subcutaneous Colon 38 tumors in mice determined as delay in growth after 3.9 mg/kg/day dose given as 3 times in a day for 4 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1136718";"12620081";"10.1021/jm020420u";"2003";"J Med Chem";"46";"1049";"1054";"standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL705895";"F";"Inhibitory activity against human tumor cell line MCF-7 breast adenocarcinoma.";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1128703";"7853345";"10.1021/jm00003a015";"1995";"J Med Chem";"38";"526";"536";"";"";"";"";"";""
"CHEMBL2346401";"F";"Antiproliferative activity against human SF268 cells after 48 hrs";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SF-268";"";"CHEMBL2331492";"23395656";"10.1016/j.bmcl.2013.01.022";"2013";"Bioorg Med Chem Lett";"23";"1846";"1852";"";"";"";"";"";""
"CHEMBL700739";"F";"Effect of dosing on L1210 leukemia in vivo measured as mean at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL4143747";"F";"Induction of apoptosis in human Caco2 cells assessed as necrotic cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.12%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL758009";"F";"In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 2 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123842";"3625713";"10.1021/jm00392a028";"1987";"J Med Chem";"30";"1682";"1686";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL753741";"F";"In vivo antineoplastic activity was determined in BDF1 mice implanted with P388 leukemia and activity is expressed as T/C at 0.12 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1123842";"3625713";"10.1021/jm00392a028";"1987";"J Med Chem";"30";"1682";"1686";"standard_type:DOSE standard_relation:= standard_value:0.12 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"General Leukemia | P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL4253055";"F";"Induction of apoptosis in human Jurkat T cells assessed as downregulation of Bcl2 expression at 10 uM after 48 hrs by Western blot analysis";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Jurkat";"";"CHEMBL4251586";"29216561";"10.1016/j.ejmech.2017.11.063";"2018";"Eur J Med Chem";"143";"621";"631";"";"";"";"";"";""
"CHEMBL835259";"B";"Thermal denaturation of calf thymus DNA at 37 degree C";"Bos taurus";"1";"1";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"9913";"";"";"";"";"CHEMBL1137037";"15341949";"10.1016/j.bmcl.2004.07.036";"2004";"Bioorg Med Chem Lett";"14";"4907";"4909";"";"";"";"";"";""
"CHEMBL745099";"A";"The compound was tested for antitumor activity against P388 murine leukemia at 2 (mg/kg/day) dose; 0/82 -no. of toxic deaths/no. of mice";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1127837";"8145234";"10.1021/jm00032a018";"1994";"J Med Chem";"37";"828";"837";"";"";"";"";"";""
"CHEMBL3997705";"F";"Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as mouse survival rate at 2 mg/kg, iv administered twice weekly for 2 weeks measured up to 33 days (rvb = 30%)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1.2";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2075593";"F";"TP_TRANSPORTER: intracellular accumulation in S1 and S1-M1-80 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"S1;S1-M1-80";"";"CHEMBL2073744";"10806112";"10.1242/jcs.113.11.2011";"2000";"J Cell Sci";"113";"2011";"2021";"";"";"";"";"";""
"CHEMBL2320302";"B";"Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL1963999";"F";"PUBCHEM_BIOASSAY: Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ";"";"1367";"1367";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"Shn3RL";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3073188";"F";"Inhibition of nuclear DNA synthesis in Homo sapiens (human) A549 cells assessed as decrease in bromodeoxyuridine incorporation measured during S phase at IC50 after 24 hr by ELISA";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3046656";"None";"10.1007/s00044-012-0325-2";"2013";"Med Chem Res";"22";"3751";"3759";"";"";"";"";"";""
"CHEMBL705031";"F";"Number of tumor free survivors of mice was measured in L1210 leukemia cells (in vivo) at 3 mg/kg (cumulative dose 9 mg/kg) with ip day 1-9 (twice daily); value give as 7/10";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models | Neoplasm Oncology Models";"General Leukemia | L1210 Experimental Leukemia | Neoplasms";"";""
"CHEMBL2320299";"B";"Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL2320301";"B";"Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL3997701";"T";"Toxicity in Balb/c mouse implanted with mouse 4T1.2 cells assessed as body weight loss at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Balb/c";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL5138891";"F";"Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as tumor growth inhibition by measuring T/C ratio at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2428417";"F";"Cytotoxicity against human KB/HeLa cells after 48 hrs by resazurin dye assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2424651";"23988351";"10.1016/j.bmcl.2013.08.021";"2013";"Bioorg Med Chem Lett";"23";"5264";"5266";"";"";"";"";"";""
"CHEMBL3123715";"F";"Cytotoxicity against human H1299 cells assessed as cell viability at 10 uM after 48 hrs by MTT assay";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL3120102";"24051300";"10.1016/j.ejmech.2013.06.058";"2013";"Eur J Med Chem";"69";"278";"293";"";"";"";"";"";""
"CHEMBL939282";"B";"Inhibition of human BCRP mediated mitoxantrone accumulation in wild type MCF7 cells at 5 uM by flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1143908";"17964170";"10.1016/j.bmc.2007.10.006";"2008";"Bioorg Med Chem";"16";"171";"180";"";"";"";"";"";""
"CHEMBL2330100";"F";"Effect on total BAD level in human MV411 cells at 10 to 100 nM after 12 hrs by Western blotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL2078385";"F";"TP_TRANSPORTER: cell accumulation in MCF7/MRP1-M24 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF7/MRP1-M24";"";"CHEMBL2074176";"16434618";"10.1124/mol.105.017988";"2006";"Mol Pharmacol";"69";"1499";"1505";"";"";"";"";"";""
"CHEMBL3381157";"A";"Intrinsic cytotoxicity against HEK293 cells assessed as reduction in cell viability after 72 hrs by MTT assay";"Homo sapiens";"20";"20";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL3352248";"25272055";"10.1021/jm500943z";"2015";"J Med Chem";"58";"265";"277";"";"";"";"";"";""
"CHEMBL3592582";"F";"Ratio of IC50 for human MES-SA/Dx5 cells to IC50 for human MES-SA cells";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"MES-SA ";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL3562026";"F";"PubChem BioAssay. Decreased HeLa cell count-IC50.   (Class of assay: confirmatory) ";"";"180";"181";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562064";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) ";"";"1996";"2013";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354254";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ";"";"153871";"156311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4143733";"B";"Inhibition of NAE in human Caco2 cells assessed as decrease in cyclin D1 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143741";"F";"Induction of apoptosis in human Caco2 cells assessed as early apoptotic cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 1.40%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3256956";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 1 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3215181";"F";"PubChem BioAssay. qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen.   (Class of assay: confirmatory) ";"";"36517";"36531";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4348375";"F";"Cytotoxicity against human Bel7402 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay";"Homo sapiens";"1";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Bel-7402";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL4348377";"F";"Cytotoxicity against human MCF7 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL5138896";"T";"Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as liver lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Balb/c";"Scientific Literature";"10090";"CHEMBL3559723";"Liver";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"";"";"";"";""
"CHEMBL3123712";"B";"Inhibition of human tert transcriptional activity assessed as SEAP activity at 10 uM after 24 hrs by SEAP reporter assay";"Homo sapiens";"37";"37";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3120102";"24051300";"10.1016/j.ejmech.2013.06.058";"2013";"Eur J Med Chem";"69";"278";"293";"";"";"";"";"";""
"CHEMBL3123714";"F";"Cytotoxicity against human H1299 cells assessed as cell viability at 100 uM after 48 hrs by MTT assay";"Homo sapiens";"37";"37";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"NCI-H1299";"";"CHEMBL3120102";"24051300";"10.1016/j.ejmech.2013.06.058";"2013";"Eur J Med Chem";"69";"278";"293";"";"";"";"";"";""
"CHEMBL4348379";"F";"Cytotoxicity against human A375 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A-375";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL3073186";"F";"Inhibition of nuclear DNA synthesis in Rattus norvegicus (rat) C6 cells assessed as decrease in bromodeoxyuridine incorpoRattus norvegicus (rat)ion measured during S phase at IC50 after 24 hr by ELISA";"Rattus norvegicus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL3046656";"None";"10.1007/s00044-012-0325-2";"2013";"Med Chem Res";"22";"3751";"3759";"";"";"";"";"";""
"CHEMBL3137733";"T";"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137728";"T";"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137724";"T";"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3755740";"F";"Cytotoxicity against rat C6 cells after 24 hrs by MTT assay";"Rattus norvegicus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL3751820";"26599534";"10.1016/j.ejmech.2015.11.002";"2016";"Eur J Med Chem";"107";"288";"294";"";"";"";"";"";""
"CHEMBL3137722";"T";"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3592579";"F";"Antiproliferative activity against human Daudi cells after 72 hrs by MTT assay";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Daudi";"";"CHEMBL3588860";"25998504";"10.1016/j.bmcl.2015.04.093";"2015";"Bioorg Med Chem Lett";"25";"2621";"2623";"";"";"";"";"";""
"CHEMBL2150108";"F";"Ratio of IC50 for human K562/HHT300 cells to IC50 for human K562 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL2150111";"F";"Ratio of IC50 for human CCRF-CEM/VLB100 cells IC50 for human CCRF-CEM cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCRF-CEM";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL766198";"F";"Percent ratio of the medium survival time for P388 murine leukemia in CDF1 mice at 6 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:6.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL656359";"F";"Survivors of CDF1 mice on day 4 after 1st injection of compound at 3 mg/kg in six mice; 6/6";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:3.0 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL3215015";"B";"PubChem BioAssay. Alphascreen Interference Assay Measured in Biochemical System Using Plate Reader - 2160-02_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) ";"";"239";"239";"BAO_0000217";"biochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2169429";"A";"Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting";"Homo sapiens";"223";"223";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2163248";"22541068";"10.1021/jm300212s";"2012";"J Med Chem";"55";"4740";"4763";"";"";"";"";"";""
"CHEMBL623407";"F";"In vitro Cytotoxic activity of compound in comparison with reference compounds in human cell line A2780";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A2780";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL3137723";"T";"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137734";"T";"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3562027";"F";"PubChem BioAssay. HCT116 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"232";"232";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562123";"F";"PubChem BioAssay. HT-29 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"228";"229";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4143718";"B";"Inhibition of NAE-mediated Ubcl2-NEDD8 conjugation in human Caco2 cells at 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL2330098";"F";"Effect on total PIM1 level in human MV411 cells at 10 to 100 nM after 12 hrs by Western blotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MV4-11";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL3562033";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, ratio channel.   (Class of assay: confirmatory) ";"";"170";"170";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215234";"B";"PubChem BioAssay. ALPHAscreen artifact counterscreen Measured in Biochemical System Using Plate Reader - 7053-03_Inhibitor_Dose_CherryPick_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ";"";"140";"141";"BAO_0000217";"biochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4143744";"F";"Induction of apoptosis in human Caco2 cells assessed as viable cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 98.4%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3214946";"F";"PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: Confirmatory Assay for Cherry-picked Compounds..   (Class of assay: confirmatory) ";"";"502";"502";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4143722";"B";"Inhibition of UAE1 (unknown origin) assessed as decrease in UAE1-mediated Ubc10-ubiquitin conjugation levels up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143736";"F";"Induction of apoptosis in human Caco2 cells assessed as viable cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 98.4%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143740";"F";"Induction of apoptosis in human Caco2 cells assessed as viable cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 98.4%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3252377";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 0.25 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL4006908";"A";"Cytotoxicity against mouse NIH/3T3 cells assessed as reduction in cell viability after 24 hrs by MTT assay";"Mus musculus";"29";"29";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL4004858";"28222315";"10.1016/j.ejmech.2017.02.013";"2017";"Eur J Med Chem";"129";"151";"158";"";"";"";"";"";""
"CHEMBL3252372";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 1 mg/kg qd for 9 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL4143724";"B";"Inhibition of NAE (unknown origin) assessed as decrease in NAE-mediated Ubc12-NEDD8 conjugation levels at 10 uM treated for 10 mins post ATP and Mg2+ addition measured after 60 mins by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL2433627";"A";"Growth inhibition of human QSG7701 cells at 10 uM after 48 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"QSG7701";"";"CHEMBL2429715";"None";"10.1007/s00044-013-0805-z";"2013";"Med Chem Res";"None";"1";"7";"";"";"";"";"";""
"CHEMBL1041323";"F";"Bacteriostatic activity against imipenem-non resistant Escherichia coli BL21(DE3) at 2.1 ug/mL after 24 hrs by broth microdilution method";"Escherichia coli BL21(DE3)";"1";"1";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"469008";"";"";"";"";"CHEMBL1154107";"19553129";"10.1016/j.bmc.2009.05.070";"2009";"Bioorg Med Chem";"17";"5027";"5037";"";"";"";"";"";""
"CHEMBL3256952";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 4 mg/kg qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3562124";"F";"PubChem BioAssay. DLD-1 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"231";"231";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252375";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 0.5 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3256953";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 2 mg/kg qd for 9 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4143745";"F";"Induction of apoptosis in human Caco2 cells assessed as early apoptotic cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 1.40%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3252385";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 18 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:18.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3252298";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 2 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3252299";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 1 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3252747";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.06 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.06 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL4316822";"F";"Cytotoxicity against human A549 cells after 48 hrs by MTT assay";"Homo sapiens";"42";"42";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4316584";"30684866";"10.1016/j.ejmech.2019.01.028";"2019";"Eur J Med Chem";"166";"1";"10";"";"";"";"";"";""
"CHEMBL3072278";"F";"Inhibition of nuclear DNA synthesis in Rattus norvegicus (rat) C6 cells assessed as decrease in bromodeoxyuridine incorpoRattus norvegicus (rat)ion measured during S phase after 24 hr by ELISA";"Rattus norvegicus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10116";"";"";"C6";"";"CHEMBL3046656";"None";"10.1007/s00044-012-0325-2";"2013";"Med Chem Res";"22";"3751";"3759";"";"";"";"";"";""
"CHEMBL4138767";"A";"Cytotoxicity in human CCD-19Lu cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CCD 19Lu";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3256955";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 1 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2320304";"B";"Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay";"Homo sapiens";"31";"31";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL4143720";"B";"Inhibition of NAE (unknown origin) assessed as decrease in NAE-mediated Ubc12-NEDD8 conjugation levels preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143731";"B";"Inhibition of NAE in human Caco2 cells assessed as increase in c-myc protein levels after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3885882";"F";"In vitro activity on S. mansoni schistosomula at 50 uM";"Schistosoma mansoni";"654";"247666";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Puerto Rican";"DrugMatrix";"6183";"";"";"";"";"CHEMBL3885881";"None";"10.6019/CHEMBL3885881";"None";"None";"None";"None";"None";"standard_type:AGE standard_relation:None standard_value:None standard_units:None comments:None | standard_type:GENDER standard_relation:None standard_value:None standard_units:None comments:None | standard_type:REGIMEN standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL4143729";"B";"Inhibition of NAE in human Caco2 cells harboring p53-luc plasmid assessed as increase in p53 transcriptional activity after 16 hrs by luciferase reporter gene assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3253029";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase of median life span at 6.2 mg/kg, ip on day 1, 5 and 9 measured up to 60 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"standard_type:DOSE standard_relation:= standard_value:6.2 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3253035";"F";"Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase of median life span at 3.1 mg/kg, ip on day 1 to 9 measured up to 80 days relative to control";"Mus musculus";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"standard_type:DOSE standard_relation:= standard_value:3.1 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3256962";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.5 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3252373";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 1 mg/kg qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3537296";"A";"Drug uptake in Sprague-Dawley rat brain slices at 100 nM after 5 hrs in presence of 10 uM of fumitremorgin-C";"Rattus norvegicus";"2";"2";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638188";"Brain";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL4143732";"B";"Inhibition of NAE in human Caco2 cells assessed as increase in p27 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL5138893";"F";"Protection of Balb/c mouse spleen implanted with mouse 4T1 cells at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Balb/c";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL5138898";"T";"Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as lung lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Balb/c";"Scientific Literature";"10090";"CHEMBL3638235";"Lung";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"";"";"";"";""
"CHEMBL5160425";"F";"Antitumor immunity against human U2OS cells assessed as inhibition of RNA synthesis at 3 uM pretreated for 2.5 hrs by bright field microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U2OS";"";"CHEMBL5154772";"35235336";"10.1021/acs.jmedchem.1c01654";"2022";"J Med Chem";"65";"4633";"4648";"";"";"";"";"";""
"CHEMBL4322538";"B";"Inhibition of MDR in human LCC6MDR cells assessed as reduction in cell viability after 5 days by MTS/PMS assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL2076476";"F";"TP_TRANSPORTER: drug resistance in BCRP-expressing K562 cells";"";"3";"3";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"K562";"";"CHEMBL2074130";"12533678";"None";"2003";"Mol Cancer Ther";"2";"105";"112";"";"";"";"";"";""
"CHEMBL5138850";"F";"Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as apoptotic rate of dissected tumor cell at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by flow cytometric analysis (Rvb = 64.83%)";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4138782";"F";"Induction of apoptosis in human HCC78 cells assessed as early apoptotic cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 6.33%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4348395";"F";"Induction of immunogenic cell death in mouse H22 cells assessed as increase in calreticulin level in cell surface at 2 uM incubated for 5 hrs by Hoechst staining based fluorescence microscopic analysis";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL4322541";"F";"Antiproliferative activity against human LCC6 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL2078384";"F";"TP_TRANSPORTER: cell accumulation in MCF7/MRP1-M6 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF7/MRP1-M6";"";"CHEMBL2074176";"16434618";"10.1124/mol.105.017988";"2006";"Mol Pharmacol";"69";"1499";"1505";"";"";"";"";"";""
"CHEMBL5160432";"F";"Antitumor immunity against human U2OS cells expressing HMGBI-GFP fusion protein assessed as accumulation HMGBI-GFP fusion protein at 3 uM measured upto 24 hrs by live cell microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U2OS";"";"CHEMBL5154772";"35235336";"10.1021/acs.jmedchem.1c01654";"2022";"J Med Chem";"65";"4633";"4648";"";"";"";"";"";""
"CHEMBL4717355";"F";"Antitumor activity against mouse H22 cells implanted in Kunming mouse assessed as reduction in tumor weight at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days (Rvb = 2.15 +/- 0.51 g)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4138774";"F";"Induction of apoptosis in human HCC78 cells assessed as early apoptotic cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 6.33%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4348399";"F";"Antitumor activity against mouse H22 cells allografted in immunocompetent Balb/c mouse assessed as inhibition of tumour formation at 2 uM incubated with cells for 5 hrs prior to 20 mins 2 mW/cm2 UVA irradiation post compound washout followed by vaccination and measured within 5 days";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL4138791";"B";"Inhibition of ROS1 in human HCC78 cells assessed as reduction in AKT phosphorylation incubated for 48 hrs by Western blot method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4143728";"B";"Inhibition of NAE in human Caco2 cells assessed as increase in p53 protein levels by measuring p53 degradation at 10 uM preincubated for 16 hrs followed by cycloheximide addition measured up to 60 mins by Western blot analysis relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4677486";"F";"Antiproliferative activity against human K562 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL4673288";"33191085";"10.1016/j.bmc.2020.115868";"2021";"Bioorg Med Chem";"29";"115868";"115868";"";"";"";"";"";""
"CHEMBL3562136";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) ";"";"1968";"1982";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3997696";"A";"Drug uptake in mouse 4T1.2 cell lysosomes at 5 uM encapsulated within cucurbit[8]uril after 20 mins by LysoTracker Green staining based laser scanning confocal microscopic method";"Mus musculus";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"Lysosome";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL3997700";"T";"Toxicity in Balb/c mouse assessed as body weight loss at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"Balb/c";"Scientific Literature";"10090";"";"";"";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL4138773";"F";"Induction of apoptosis in human HCC78 cells assessed as viable cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 80.8%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4677485";"F";"Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4673288";"33191085";"10.1016/j.bmc.2020.115868";"2021";"Bioorg Med Chem";"29";"115868";"115868";"";"";"";"";"";""
"CHEMBL4717381";"T";"Toxicity in Kunming mouse implanted with mouse H22 cells assessed as change in body weight at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days (Rvb = 5.2 %)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Kunming";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL4717324";"F";"Antiproliferative activity against human SMMC-7221 cells assessed as inhibition of cell proliferation at 5 uM measured after 48 hrs by MTT assay relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL4717323";"F";"Antiproliferative activity against human SMMC-7221 cells assessed as inhibition of cell proliferation at 1 uM measured after 48 hrs by MTT assay relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SMMC-7721";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL4143738";"F";"Induction of apoptosis in human Caco2 cells assessed as late apoptotic cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.072%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143739";"F";"Induction of apoptosis in human Caco2 cells assessed as necrotic cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.12%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143751";"B";"Inhibition of UAE1-mediated Ubc10-ubiquitin conjugation in human Caco2 cells up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4138780";"F";"Induction of apoptosis in human HCC78 cells assessed as necrotic cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 0.06%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4138790";"B";"Inhibition of ROS1 in human HCC78 cells assessed as reduction in STAT3 phosphorylation incubated for 48 hrs by Western blot method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3252371";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse at 2 mg/kg qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL5106144";"F";"Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL5104159";"35931243";"10.1016/j.bmcl.2022.128919";"2022";"Bioorg Med Chem Lett";"73";"128919";"128919";"";"";"";"";"";""
"CHEMBL3252382";"F";"Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse assessed as survival at 0.39 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Colon 26";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.39 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL5106141";"F";"Antiproliferative activity against human K562 cells assessed as inhibition of cell growth";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL5104159";"35931243";"10.1016/j.bmcl.2022.128919";"2022";"Bioorg Med Chem Lett";"73";"128919";"128919";"";"";"";"";"";""
"CHEMBL4717331";"A";"Cytotoxicity against human QSG7701 cells assessed as inhibition of cell proliferation at 1 uM measured after 48 hrs by MTT assay relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"QSG7701";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL4717376";"F";"Antimetastatic activity against mouse H22 cells implanted in Kunming mouse assessed as inhibition of metastasis at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Metastatic Oncology Models";"Metastatic Activity";"";""
"CHEMBL2330106";"B";"Inhibition of recombinant PIM1 (unknown origin) expressed in Escherichia coli BL21(DE3) after 1 hr by HTRF assay";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL4143748";"F";"Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4138768";"F";"Induction of apoptosis in human HCC78 cells incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4138766";"F";"Cytotoxicity in human HCC78 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3253046";"F";"Antitumor activity against mouse LLC cells subcutaneously implanted in mouse";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Lewis lung carcinoma cell line";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"";"";"";"";""
"CHEMBL3252743";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 2 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL2075600";"F";"TP_TRANSPORTER: inhibition of MTX update by Mitoxantrone at a concentration of 50uM in membrane vesicles from BCRP-expressing MCF7 cells";"";"1";"1";"BAO_0000249";"cell membrane format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF7";"Membrane vesicle";"CHEMBL2073962";"14500392";"None";"2003";"Cancer Res";"63";"5538";"5543";"";"";"";"";"";""
"CHEMBL3072282";"A";"Cytotoxicity against Mus musculus (mouse) NIH/3T3 cells after 24 hr by MTT assay";"Mus musculus";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL3046656";"None";"10.1007/s00044-012-0325-2";"2013";"Med Chem Res";"22";"3751";"3759";"";"";"";"";"";""
"CHEMBL2354221";"F";"PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) ";"";"172535";"175189";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4143734";"B";"Inhibition of NAE in human Caco2 cells assessed as decrease in Bcl2 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143742";"F";"Induction of apoptosis in human Caco2 cells assessed as late apoptotic cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.072%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL2354211";"F";"PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) ";"";"35070";"35135";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4322540";"F";"Antiproliferative activity against human 2008 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"2008";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL3599769";"F";"Cytotoxicity against human MCF-7 FLV1000 cells expressing ABCB2";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF-7 FLV1000";"";"CHEMBL3596161";"25811651";"10.1021/jm501180v";"2015";"J Med Chem";"58";"5699";"5727";"";"";"";"";"";""
"CHEMBL3411290";"A";"Inhibition of human OATP1B1-mediated [3H]estrone 3-sulfate at 100 uM after 5 mins relative to control";"Homo sapiens";"7";"7";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3407465";"25618019";"10.1016/j.ejmech.2015.01.011";"2015";"Eur J Med Chem";"92";"723";"731";"";"";"";"";"";""
"CHEMBL4143749";"A";"Cytotoxicity against NAE-knockdown human Caco2 cells after 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4348406";"F";"Antitumor activity against mouse H22 cells allografted in immunocompetent Balb/c mouse assessed as decrease in lump formation in vaccination site at 2 uM incubated with cells for 5 hrs prior to 20 mins 2 mW/cm2 UVA irradiation post compound washout followed by vaccination and measured over 30 days";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL4322544";"U";"Resistance factor, ratio of IC50 for human LCC6MDR cells overexpressing P-gp to IC50 for human LCC6 cells";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL5160428";"F";"Antitumor immunity against human U2OS cells assessed as decrease in ATP by measuring reduction in quinacrine green fluorescence intensity at 3 uM pretreated for 24 hrs by live fluorescence microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U2OS";"";"CHEMBL5154772";"35235336";"10.1021/acs.jmedchem.1c01654";"2022";"J Med Chem";"65";"4633";"4648";"";"";"";"";"";""
"CHEMBL2091084";"F";"Antiproliferative activity against human LoVo/DX cells after 72 hrs by SRB assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"LoVo/DX";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL2091133";"F";"Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2086290";"22944121";"10.1016/j.bmcl.2012.08.032";"2012";"Bioorg Med Chem Lett";"22";"6103";"6107";"";"";"";"";"";""
"CHEMBL2433631";"F";"Growth inhibition of human K562 cells at 10 uM after 48 hrs by MTT assay relative to control";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2429715";"None";"10.1007/s00044-013-0805-z";"2013";"Med Chem Res";"None";"1";"7";"";"";"";"";"";""
"CHEMBL3562024";"F";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50.   (Class of assay: confirmatory) ";"";"369";"370";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3072284";"F";"Cytotoxicity against Homo sapiens (human) A549 cells after 24 hr by MTT assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3046656";"None";"10.1007/s00044-012-0325-2";"2013";"Med Chem Res";"22";"3751";"3759";"";"";"";"";"";""
"CHEMBL5138899";"T";"Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as kidney lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Balb/c";"Scientific Literature";"10090";"CHEMBL3638241";"Kidney";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"";"";"";"";""
"CHEMBL3755742";"A";"Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay";"Mus musculus";"12";"12";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"NIH3T3";"";"CHEMBL3751820";"26599534";"10.1016/j.ejmech.2015.11.002";"2016";"Eur J Med Chem";"107";"288";"294";"";"";"";"";"";""
"CHEMBL5138895";"T";"Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as heart lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Balb/c";"Scientific Literature";"10090";"CHEMBL3638187";"Heart";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"";"";"";"";""
"CHEMBL5138897";"T";"Toxicity in Balb/c mouse implanted with mouse 4T1 cells assessed as spleen lesions at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by H&E staining based histopathological analysis";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Balb/c";"Scientific Literature";"10090";"CHEMBL3559722";"Spleen";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"";"";"";"";""
"CHEMBL3294562";"F";"Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay";"Homo sapiens";"19";"19";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL3286236";"24794747";"10.1016/j.bmc.2014.03.045";"2014";"Bioorg Med Chem";"22";"3213";"3219";"";"";"";"";"";""
"CHEMBL4303805";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging";"Homo sapiens";"5616";"5632";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"Caco-2";"";"CHEMBL4303101";"None";"10.21203/rs.3.rs-23951/v1";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252374";"F";"Antineoplastic activity against mouse B16 cells allografted in BDF1 mouse assessed as survival at 0.5 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL4029720";"F";"Cytotoxicity against human HL60 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"4";"4";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4028815";"28342398";"10.1016/j.ejmech.2017.03.028";"2017";"Eur J Med Chem";"132";"63";"80";"";"";"";"";"";""
"CHEMBL4196663";"F";"Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay";"Homo sapiens";"10";"10";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HeLa";"";"CHEMBL4196011";"29407981";"10.1016/j.ejmech.2018.01.074";"2018";"Eur J Med Chem";"146";"564";"576";"";"";"";"";"";""
"CHEMBL4348390";"F";"Induction of immunogenic cell death in mouse H22 cells assessed as extracellular ATP level at 2 uM measured after 24 hrs by chemiluminescence-based assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL3252744";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.5 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3257129";"F";"Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as increase in survival time at 1 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"B16";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Methods for Testing Immunological Factors | Neoplasm Oncology Models";"Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3997698";"F";"Growth inhibition of mouse 4T1.2 cells up to 20000 nM encapsulated within cucurbit[8]uril after 48 hrs by MTT assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1.2";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL3997697";"F";"Growth inhibition of mouse 4T1.2 cells up to 20000 nM after 48 hrs by MTT assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1.2";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL4138781";"F";"Induction of apoptosis in human HCC78 cells assessed as viable cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 80.8%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4138020";"A";"Growth inhibition of human umbilical cord cells";"Homo sapiens";"5";"5";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4130641";"29995404";"10.1021/acs.jmedchem.8b00813";"2018";"J Med Chem";"61";"6892";"6903";"";"";"";"";"";""
"CHEMBL4322543";"U";"Resistance factor, ratio of IC50 for human 2008/MRP1 cells overexpressing MRP1 to IC50 for human 2008 cells";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL3252388";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 4 mg/kg qd for 9 days";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:4.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3256967";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.06 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.06 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3252302";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.12 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.12 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL5138901";"F";"Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as TUNEL positive cells at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate by TUNEL staining analysis";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3252300";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in survival time at 0.5 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL4138778";"F";"Induction of apoptosis in human HCC78 cells assessed as early apoptotic cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 6.33%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4348409";"F";"Induction of immunogenic cell death in mouse H22 cells assessed as increase in intracellular calreticulin level at 2 uM measured after 5 hrs by flow cytometric analysis";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL4322539";"A";"Cytotoxicity against human HEK293 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL4233267";"F";"Resistance index, ratio of IC50 for antiproliferative activity against human HL60/MX2 cells to IC50 for antiproliferative activity against human HL60 cells";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4229419";"29945793";"10.1016/j.bmcl.2018.06.042";"2018";"Bioorg Med Chem Lett";"28";"2611";"2615";"";"";"";"";"";""
"CHEMBL2330108";"B";"Inhibition of AKT1 (unknown origin) using [gamma33P]ATP assessed as residual activity at 1 uM after 120 mins by radiometric assay";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL1055756";"F";"Ratio of GI50 for human HL60/MX2 cells to GI50 for human HL60 cells";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL1153537";"19743858";"10.1021/jm9005059";"2009";"J Med Chem";"52";"5937";"5949";"";"";"";"";"";""
"CHEMBL4233275";"F";"Antiproliferative activity against human HL60 cells after 72 hrs by SRB assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL4229419";"29945793";"10.1016/j.bmcl.2018.06.042";"2018";"Bioorg Med Chem Lett";"28";"2611";"2615";"";"";"";"";"";""
"CHEMBL4138775";"F";"Induction of apoptosis in human HCC78 cells assessed as late apoptotic cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 13.8%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3252381";"F";"Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse at 0.69 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Colon 26";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.69 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4717365";"T";"Toxicity in Kunming mouse implanted with mouse H22 cells assessed as change in mouse body weight at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days (Rvb = 21 %)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Kunming";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL3256965";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.12 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.12 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4360120";"F";"Antimycobacterial activity against Mycobacterium smegmatis atR17 assessed as decrease in drug resistance at 10 nmol/disc after 2 to 3 days by paper disc method";"Mycobacterium smegmatis";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"atR17";"Scientific Literature";"1772";"";"";"";"";"CHEMBL4359813";"31176094";"10.1016/j.ejmech.2019.05.081";"2019";"Eur J Med Chem";"178";"39";"47";"";"";"";"";"";""
"CHEMBL4303819";"F";"Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs";"Chlorocebus sabaeus";"1518";"1520";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4303097";"None";"10.1101/2020.04.03.023846";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4316387";"B";"Inhibition of Nedd8-cullin1 adduct formation in human A549 cells assessed as decrease in cullin1 neddylation at 75 uM measured after 6 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4312031";"31732254";"10.1016/j.ejmech.2019.111848";"2020";"Eur J Med Chem";"185";"111848";"111848";"";"";"";"";"";""
"CHEMBL4322542";"U";"Resistance factor, ratio of IC50 for human HEK293/R2 cells overexpressing BCRP to IC50 for human HEK293 cells";"Homo sapiens";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL4138783";"F";"Induction of apoptosis in human HCC78 cells assessed as late apoptotic cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 13.8%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3436184";"F";"Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits";"Cricetulus griseus";"1";"1";"BAO_0000219";"cell-based format";"4";"4 - Multiple homologous protein targets may be assigned";"";"Scientific Literature";"10029";"";"";"CHO";"";"CHEMBL3436045";"23812503";"10.1038/srep02100";"2013";"Sci Rep";"3";"1";"7";"standard_type:CA_SOL_CONC standard_relation:= standard_value:1.8 standard_units:mM comments:None | standard_type:DETECTION_METHOD standard_relation:None standard_value:None standard_units:None comments:None | standard_type:HOLDING_POTENTIAL standard_relation:None standard_value:None standard_units:None comments:None | standard_type:MEAS_VOLT standard_relation:= standard_value:0.0 standard_units:mV comments:None | standard_type:T1_PULSE standard_relation:= standard_value:150.0 standard_units:ms comments:None | standard_type:TEMP standard_relation:None standard_value:None standard_units:None comments:None";"";"";"";"";""
"CHEMBL2320300";"B";"Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL3256961";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.5 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.5 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3252762";"T";"Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 2 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"BDF1";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:2.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL4651403";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"4309";"8710";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"IMI-CARE SARS-CoV-2 Data";"60711";"";"";"Vero C1008";"";"CHEMBL4651402";"None";"10.6019/CHEMBL4651402";"2021";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3256966";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.12 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.12 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3256964";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.25 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4138777";"F";"Induction of apoptosis in human HCC78 cells assessed as viable cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 80.8%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL5160430";"F";"Antitumor immunity against human U2OS cells expressing CALR-GFP fusion protein assessed as accumulation CALR-GFP fusion protein at 3 uM measured upto 24 hrs by live cell microscopic analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"U2OS";"";"CHEMBL5154772";"35235336";"10.1021/acs.jmedchem.1c01654";"2022";"J Med Chem";"65";"4633";"4648";"";"";"";"";"";""
"CHEMBL4050953";"F";"Resistance factor, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"3";"3";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4049418";"28333459";"10.1021/acs.jmedchem.6b01502";"2017";"J Med Chem";"60";"2764";"2779";"";"";"";"";"";""
"CHEMBL4050952";"F";"Antiproliferative activity against human HL60/MX2 cells after 72 hrs by MTT assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL4049418";"28333459";"10.1021/acs.jmedchem.6b01502";"2017";"J Med Chem";"60";"2764";"2779";"";"";"";"";"";""
"CHEMBL4717371";"F";"Antimetastatic activity against mouse H22 cells implanted in Kunming mouse assessed as number of metastatic focus at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 11 post inoculation and measured after 18 days (Rvb = 5.73 +/- 14.6 No_unit)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Metastatic Oncology Models";"Metastatic Activity";"";""
"CHEMBL4717397";"T";"Toxicity in Kunming mouse implanted with mouse H22 cells assessed as mouse mortality at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL4348381";"T";"Dark toxicity against mouse H22 cells assessed as reduction in cell viability preincubated for 5 hrs followed by compound washout and measured after 48 hrs by CCK8 assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL4717366";"T";"Toxicity in iv dosed Kunming mouse assessed as maximum tolerated dose";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"Kunming";"Scientific Literature";"10090";"";"";"";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL3537298";"A";"Drug uptake in Sprague-Dawley rat brain slices at 100 nM after 5 hrs in presence of 10 uM of fumitremorgin-C and 20 uM of MK-571";"Rattus norvegicus";"2";"2";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638188";"Brain";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL4138779";"F";"Induction of apoptosis in human HCC78 cells assessed as late apoptotic cells level at 10 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 13.8%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4029723";"F";"Resistance index, ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"4";"4";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4028815";"28342398";"10.1016/j.ejmech.2017.03.028";"2017";"Eur J Med Chem";"132";"63";"80";"";"";"";"";"";""
"CHEMBL4143726";"F";"Upregulation of p53 protein levels in NAE knockdown human Caco2 cells at 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4138765";"B";"Inhibition of ROS1 (unknown origin) using poly (Glu,Tyr)4:1 substrate and ATP incubated for 60 mins by ELISA";"Homo sapiens";"2";"2";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4360119";"F";"Antimycobacterial activity against Mycobacterium smegmatis atR10 assessed as decrease in drug resistance development at 10 nmol/disc after 2 to 3 days by paper disc method";"Mycobacterium smegmatis";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"atR10";"Scientific Literature";"1772";"";"";"";"";"CHEMBL4359813";"31176094";"10.1016/j.ejmech.2019.05.081";"2019";"Eur J Med Chem";"178";"39";"47";"";"";"";"";"";""
"CHEMBL704051";"F";"Percentage increase in lifespan of mice in L1210 leukemia cells (in vivo) at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL2330099";"B";"Inhibition of PIM1-mediated BAD phosphorylation in human K562 cells at 0.1 to 30 uM after 12 hrs by Western blotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL816182";"F";"Tested against WiDr colon (sensitive) in the sulforhodamine B assay.";"Homo sapiens";"11";"11";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"WiDr";"";"CHEMBL1129062";"8648600";"10.1021/jm950742g";"1996";"J Med Chem";"39";"1609";"1618";"";"";"";"";"";""
"CHEMBL656352";"F";"Survivors of CDF1 mice on day 4 after 1st injection of compound at 1.5 mg/kg in six mice; 6/6";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1124546";"2754697";"10.1021/jm00128a009";"1989";"J Med Chem";"32";"1724";"1728";"standard_type:DOSE standard_relation:= standard_value:1.5 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL2114836";"F";"PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ";"Human immunodeficiency virus 1";"14580";"14595";"BAO_0000019";"assay format";"9";"9 - Direct single protein target assigned";"";"PubChem BioAssays";"11676";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561991";"F";"PubChem BioAssay. Increased HeLa cells with 2N DNA content-IC50.   (Class of assay: confirmatory) ";"";"181";"182";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL691903";"F";"Inhibitory activity against human tumor cell line HT-29.";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1128703";"7853345";"10.1021/jm00003a015";"1995";"J Med Chem";"38";"526";"536";"";"";"";"";"";""
"CHEMBL3253039";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as minimum effective dose administered as once each 4 days for 3 total injection";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3253045";"A";"Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as once each 4 days for 3 total injection";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"";"";"";"";""
"CHEMBL4138784";"F";"Induction of apoptosis in human HCC78 cells assessed as necrotic cells level at 20 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 0.06%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3562115";"F";"PubChem BioAssay. Increased HeLa cells in S-phase-IC50.   (Class of assay: confirmatory) ";"";"138";"139";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562135";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 blue channel.   (Class of assay: confirmatory) ";"";"556";"556";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252387";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse at 10.8 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:10.8 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL2330175";"B";"Inhibition of Mycobacterium tuberculosis protein kinase B";"Mycobacterium tuberculosis";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"1773";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL739487";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.8 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.8 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL2346394";"F";"Antiproliferative activity against human RKOp27IND cells after 48 hrs";"Homo sapiens";"22";"22";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2331492";"23395656";"10.1016/j.bmcl.2013.01.022";"2013";"Bioorg Med Chem Lett";"23";"1846";"1852";"";"";"";"";"";""
"CHEMBL3562144";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, green channel.   (Class of assay: confirmatory) ";"";"170";"170";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL703364";"F";"In vivo effect of dosing on L1210 leukemia measured as range at 0.4 mg/kg (cumulative dose 6.8 mg/Kg) with ip day 1,5&9 (once daily); value range 15 to 20";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL1124090";"3351863";"10.1021/jm00399a028";"1988";"J Med Chem";"31";"847";"857";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | L1210 Experimental Leukemia";"";""
"CHEMBL4143719";"B";"Inhibition of NAE-mediated Ubcl2-NEDD8 conjugation in human Caco2 cells after 16 hrs by Western blot analysis";"Homo sapiens";"2";"4";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL880798";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.2 mg/kg, expressed as body weight change";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.2 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL663967";"B";"Concentration required to give 50% fluorescence quenching of bound ethidium for [ethidium]: [(poly dG-dC)]2 DNA in ratio of 0.1:1 at pH 5";"";"19";"19";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL3214953";"F";"PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ";"";"20285";"20311";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL1925794";"F";"Cytotoxicity against doxorubicin-resistant human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"MCF7";"";"CHEMBL1921783";"22011244";"10.1021/jm200984x";"2011";"J Med Chem";"54";"8224";"8227";"";"";"";"";"";""
"CHEMBL4617047";"B";"Stabilization of [32P]-labelled dsDNA (unknown origin) assessed as drug-DNA adduct formation by measuring adduct half life incubated for 12 hrs in presence of formaldehyde by phosphorimaging analysis";"Not specified";"8";"8";"BAO_0000225";"nucleic acid format";"3";"3 - Target assigned is molecular non-protein target";"";"Scientific Literature";"";"";"";"";"";"CHEMBL4616593";"31870833";"10.1016/j.bmc.2019.115260";"2020";"Bioorg Med Chem";"28";"115260";"115260";"";"";"";"";"";""
"CHEMBL2076278";"F";"TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing MDCKII cells";"";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MDCK-II";"";"CHEMBL2073990";"14706813";"10.1016/s0928-0987(03)00204-5";"2004";"Eur J Pharm Sci";"21";"69";"75";"";"";"";"";"";""
"CHEMBL717385";"F";"In vivo antitumor activity at a single dose of 12.5 mg/kg & 37.5 mg/kg total against mammary adenocarcinoma 16C";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1122737";"6699870";"10.1021/jm00369a002";"1984";"J Med Chem";"27";"253";"255";"";"";"";"";"";""
"CHEMBL739484";"F";"Antileukemic activity towards P388 Murine Leukemia at a dose of 0.1 mg/kg";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.1 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL4627527";"B";"Inhibition of TDP-43 (unknown origin) binding to RNA";"Homo sapiens";"5";"5";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4627248";"31926785";"10.1016/j.bmcl.2019.126942";"2020";"Bioorg Med Chem Lett";"30";"126942";"126942";"";"";"";"";"";""
"CHEMBL4384570";"F";"Antiproliferative activity against human A549 cells after 72 hrs by sulforhodamine B assay";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4382251";"30485090";"10.1021/acs.jnatprod.8b00482";"2018";"J Nat Prod";"81";"2667";"2672";"";"";"";"";"";""
"CHEMBL2078386";"F";"TP_TRANSPORTER: cell accumulation in MCF7/MRP1-10 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MCF7/MRP1-10";"";"CHEMBL2074176";"16434618";"10.1124/mol.105.017988";"2006";"Mol Pharmacol";"69";"1499";"1505";"";"";"";"";"";""
"CHEMBL2078484";"F";"TP_TRANSPORTER: Cytotoxicity in MT-4 and MT-4/DOX500 cells";"";"7";"7";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"MT-4/; MT-4/DOX500";"";"CHEMBL2074221";"12488537";"10.1124/mol.63.1.65";"2003";"Mol Pharmacol";"63";"65";"72";"";"";"";"";"";""
"CHEMBL2330105";"B";"Inhibition of BTK (unknown origin)";"Homo sapiens";"1";"1";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL2320295";"U";"Ratio of Cmax unbound to IC50 for human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells";"";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL2150107";"F";"Ratio of IC50 for doxorubicin-resistant human K562 cells to IC50 for human K562 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL695191";"F";"Percent inhibition at S phase of cell cycle at a dose of 1000 ng/mL after 72 hours of induction in HT-29/Mx cell line";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HT-29";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"";"";"";"";"";""
"CHEMBL3252763";"T";"Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 1 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"BDF1";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL2346402";"F";"Antiproliferative activity against human SKOV3 cells after 48 hrs";"Homo sapiens";"21";"21";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"SK-OV-3";"";"CHEMBL2331492";"23395656";"10.1016/j.bmcl.2013.01.022";"2013";"Bioorg Med Chem Lett";"23";"1846";"1852";"";"";"";"";"";""
"CHEMBL4138021";"A";"Growth inhibition of human bone marrow cells";"Homo sapiens";"5";"5";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Bone marrow cell";"";"CHEMBL4130641";"29995404";"10.1021/acs.jmedchem.8b00813";"2018";"J Med Chem";"61";"6892";"6903";"";"";"";"";"";""
"CHEMBL4143735";"B";"Inhibition of NAE in human Caco2 cells assessed as increase in phosphorylated NF-kappaB protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4303810";"F";"Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits)";"Homo sapiens";"1629";"1637";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"9606";"";"";"HRCE";"";"CHEMBL4303122";"None";"10.1101/2020.04.21.054387";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215069";"B";"PubChem BioAssay. Counterscreen for inhibitors of the HGIII-SPLA2: QFRET-based biochemical high throughput dose response assay to identify inhibitors that optically interfere with 535nm fluorescence.   (Class of assay: confirmatory) ";"";"240";"240";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2077540";"F";"TP_TRANSPORTER: drug resistance in BCRP-expressing PA317 cells";"";"4";"4";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"PA317";"";"CHEMBL2074406";"14566825";"10.1002/ijc.11484";"2003";"Int J Cancer";"107";"757";"763";"";"";"";"";"";""
"CHEMBL3215017";"F";"PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS.   (Class of assay: confirmatory) ";"";"26950";"27095";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2114832";"F";"PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity. (Class of assay: confirmatory) ";"";"356";"356";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4143746";"F";"Induction of apoptosis in human Caco2 cells assessed as late apoptotic cells at 10 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.072%)";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL2150103";"F";"Ratio of IC50 for human HL60/MX2 cells to IC50 for human HL60 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL-60";"";"CHEMBL2146381";"22582991";"10.1021/jm300515q";"2012";"J Med Chem";"55";"5566";"5581";"";"";"";"";"";""
"CHEMBL4513082";"F";"Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging";"Chlorocebus sabaeus";"7218";"17404";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"SARS-CoV-2 Screening Data 2020-21";"60711";"";"";"Vero C1008";"";"CHEMBL4495565";"None";"10.6019/CHEMBL4495565";"2020";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4143723";"B";"Competitive inhibition of NAE (unknown origin) assessed as decrease in NAE-mediated Ubc12-NEDD8 conjugation levels at 10 uM preincubated for 10 mins followed by Mg2+ and various concentrations of ATP addition measured after 60 mins by Lineweaver-Burk plot analysis";"Homo sapiens";"2";"2";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4316388";"B";"Inhibition of Nedd8-cullin1 adduct formation in human A549 cells assessed as decrease in cullin1 neddylation at 50 uM measured after 6 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL4312031";"31732254";"10.1016/j.ejmech.2019.111848";"2020";"Eur J Med Chem";"185";"111848";"111848";"";"";"";"";"";""
"CHEMBL2339115";"F";"Antiproliferative activity against human KB/HeLa cells after 48 hrs";"Homo sapiens";"23";"23";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"KB ";"";"CHEMBL2331492";"23395656";"10.1016/j.bmcl.2013.01.022";"2013";"Bioorg Med Chem Lett";"23";"1846";"1852";"";"";"";"";"";""
"CHEMBL3252766";"T";"Toxicity in mouse P388 cells allografted BDF1 mouse assessed as body weight difference at 0.12 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"BDF1";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.12 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals";"";""
"CHEMBL3137732";"T";"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137726";"T";"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2330103";"B";"Inhibition of PIM1-mediated BAD phosphorylation in human K562 cells after 12 hrs by Western blotting analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"K562";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL3398686";"B";"Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates by gel-based excision activity assay";"Homo sapiens";"4";"4";"BAO_0000357";"single protein format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3397015";"25650313";"10.1016/j.bmc.2014.12.067";"2015";"Bioorg Med Chem";"23";"1102";"1111";"";"";"";"";"";""
"CHEMBL4354739";"A";"Cytotoxicity against human NCI-H460/MX20 cells assessed as inhibition of cell viability incubated for 2 hrs by MTT assay";"Homo sapiens";"25";"25";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4351028";"31302589";"10.1016/j.ejmech.2019.06.066";"2019";"Eur J Med Chem";"179";"849";"862";"";"";"";"";"";""
"CHEMBL3881650";"F";"Ratio of EC50 for human mitoxantrone-sensitive HL60 cells to EC50 for human mitoxantrone-resistant HL60/MX2 cells";"Homo sapiens";"9";"9";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Patent Bioactivity Data";"9606";"";"";"HL-60";"";"CHEMBL3881525";"None";"None";"2007";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3253031";"F";"Antitumor activity against mouse P388 cells allografted in mouse assessed as increase of median life span at 1.6 mg/kg, ip on day 1, 5 and 9 measured up to 60 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"standard_type:DOSE standard_relation:= standard_value:1.6 standard_units:mg.kg-1 comments:None | standard_type:ROUTE standard_relation:None standard_value:None standard_units:None comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3529273";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis";"Homo sapiens";"65";"65";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3537618";"P";"Dissociation constant, pKa of the basic compound by capillary electrophoresis-mass spectrometry analysis";"";"16";"16";"BAO_0000100";"small-molecule physicochemical format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL3537289";"A";"Unbound volume of distribution in Sprague-Dawley rat brain slices at 100 nM after 5 hrs";"Rattus norvegicus";"56";"56";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"Sprague-Dawley";"Scientific Literature";"10116";"CHEMBL3638188";"Brain";"";"";"CHEMBL3525927";"21149540";"10.1124/dmd.110.035998";"2011";"Drug Metab Dispos";"39";"353";"362";"";"";"";"";"";""
"CHEMBL3562043";"F";"PubChem BioAssay. VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50.   (Class of assay: confirmatory) ";"";"368";"369";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3398687";"B";"Binding affinity to ethenoadenine containing 5'-TCGAGGATCCTGAGCTCGAGTCGACGXTCGCGAATTCTGCGGATCCAAGC-3' duplex oligonucleotide DNA (unknown origin) at 15 uM by SPR assay";"Not specified";"3";"3";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"";"";"CHEMBL3397015";"25650313";"10.1016/j.bmc.2014.12.067";"2015";"Bioorg Med Chem";"23";"1102";"1111";"";"";"";"";"";""
"CHEMBL3215072";"B";"PubChem BioAssay. QFRET-based biochemical high throughput dose response assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2).   (Class of assay: confirmatory) ";"";"240";"240";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215035";"F";"PubChem BioAssay. qHTS for Inhibitors of Polymerase Kappa: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ";"";"917";"919";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3215169";"B";"PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus.   (Class of assay: confirmatory) ";"";"3383";"3728";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL2354282";"F";"PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ";"";"9957";"10019";"BAO_0000019";"assay format";"8";"8 - Homologous single protein target assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3252383";"F";"Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse at 0.39 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Colon 26";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.39 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3137735";"T";"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137740";"T";"Proposed mechanism(s) of liver damage. [column 'MEC' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137730";"T";"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL2330104";"B";"Inhibition of human recombinant casein kinase 2 using [gamma-32P] ATP";"Homo sapiens";"1";"1";"BAO_0000224";"protein format";"5";"5 - Multiple direct protein targets may be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL2321759";"23442188";"10.1021/jm400045y";"2013";"J Med Chem";"56";"2619";"2629";"";"";"";"";"";""
"CHEMBL3137737";"T";"Presence of at least one case with successful reintroduction. [column 'REINT' in source]";"Homo sapiens";"1214";"1216";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3137725";"T";"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]";"Homo sapiens";"1214";"1216";"BAO_0000221";"tissue-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"CHEMBL3559723";"Liver";"";"";"CHEMBL3137667";"15646539";"10.1016/s0399-8320(04)95062-2";"2004";"Gastroenterol Clin Biol";"28";"720";"759";"";"";"";"";"";""
"CHEMBL3256960";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 1 mg/kg qd for 9 days relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.0 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4143725";"B";"Inhibition of NAE in human Caco2 cells assessed as increase in p53 protein levels at 0.1 to 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3088732";"B";"Agonist activity at human recombinant dopamine D2 long receptor expressed in CHOK1 cells coexpressing mitochondrial apoaequorin at 100 uM by luminometric analysis relative to quinpirol";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"CHO-K1";"";"CHEMBL3085742";"24088053";"10.1021/jm400813y";"2013";"J Med Chem";"56";"8377";"8388";"";"";"";"";"";""
"CHEMBL2320297";"U";"Ratio of Cmax unbound to IC50 for human MATE1-mediated ASP+ uptake expressed in HEK293 cells";"";"9";"9";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"";"";"";"HEK293";"";"CHEMBL2311273";"23241029";"10.1021/jm301302s";"2013";"J Med Chem";"56";"781";"795";"";"";"";"";"";""
"CHEMBL3240731";"A";"Cytotoxicity against HEK293 cells after 72 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HEK293";"";"CHEMBL3232774";"24611893";"10.1021/jm401879z";"2014";"J Med Chem";"57";"2930";"2941";"";"";"";"";"";""
"CHEMBL3529280";"A";"Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL3788872";"A";"Cytotoxicity against human HaCaT cells by Cell titre-blue assay";"Homo sapiens";"7";"7";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HaCaT";"";"CHEMBL3785064";"26684177";"10.1021/acs.jnatprod.5b00768";"2016";"J Nat Prod";"79";"106";"115";"";"";"";"";"";""
"CHEMBL3252745";"F";"Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mouse survival at 0.25 mg/kg administered 24 hrs post challenge relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244338";"628005";"10.1021/jm00201a012";"1978";"J Med Chem";"21";"291";"294";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Methods for Testing Immunological Factors | Neoplasm Oncology Models";"P388 Experimental Leukemia | Spontaneous Autoimmune Diseases In Animals | Neoplasms";"";""
"CHEMBL3562120";"F";"PubChem BioAssay. Increased HeLa cells with 4N DNA content-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL4348393";"F";"Induction of immunogenic cell death in mouse H22 cells assessed as increase in extracellular HMGB1 level at 2 uM incubated for 5 hrs by ELISA";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL3529277";"A";"Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979";"Homo sapiens";"60";"60";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL4322537";"B";"Inhibition of MRP1 in human 2008/MRP1 cells assessed as reduction in cell viability after 5 days by MTS/PMS assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4321806";"31465686";"10.1021/acs.jmedchem.9b00963";"2019";"J Med Chem";"62";"8578";"8608";"";"";"";"";"";""
"CHEMBL3253043";"F";"Antitumor activity against mouse P388 cells allografted in ip dosed mouse assessed as dose providing 40% increase in life span administered as once each 4 days for 3 total injection";"Mus musculus";"5";"5";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL3997695";"A";"Drug uptake in mouse 4T1.2 cell nucleus at 5 uM encapsulated within cucurbit[8]uril after 4 hrs by laser scanning confocal microscopic method";"Mus musculus";"1";"1";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"Nucleus";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"";"";"";"";""
"CHEMBL4143721";"B";"Inhibition of SAE (unknown origin) assessed as decrease in SAE-mediated Ubc9-SUMO conjugation levels up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000223";"protein complex format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143737";"F";"Induction of apoptosis in human Caco2 cells assessed as early apoptotic cells at 1 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 1.40%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4143727";"B";"Inhibition of NAE in human Caco2 cells assessed as increase in p53 protein levels at 1 to 10 uM after 16 hrs by Western blot analysis";"Homo sapiens";"2";"2";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4717328";"F";"Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation at 5 uM measured after 48 hrs by MTT assay relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL4138789";"B";"Inhibition of ROS1 phosphorylation in human HCC78 cells incubated for 48 hrs by Western blot method";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL4348389";"F";"Induction of immunogenic cell death in mouse H22 cells assessed as increase in extracellular ATP level at 2 uM measured after 5 hrs by chemiluminescence-based assay";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL4233274";"F";"Antiproliferative activity against human HL60/MX2 cells after 72 hrs by SRB assay";"Homo sapiens";"3";"3";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HL60/MX2";"";"CHEMBL4229419";"29945793";"10.1016/j.bmcl.2018.06.042";"2018";"Bioorg Med Chem Lett";"28";"2611";"2615";"";"";"";"";"";""
"CHEMBL4717360";"F";"Antitumor activity against mouse H22 cells implanted in Kunming mouse assessed as tumor growth inhibition at 0.4 mg/kg, iv administered for 7 consecutive days starting from day 8 post inoculation and measured after 16 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL4138776";"F";"Induction of apoptosis in human HCC78 cells assessed as necrotic cells level at 5 nM incubated fro 48 hrs by Annexin-V FITC and propidium iodide staining based flow cytometry (Rvb = 0.06%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCC78";"";"CHEMBL4138072";"30108778";"10.1039/C6MD00643D";"2017";"Medchemcomm";"8";"621";"624";"";"";"";"";"";""
"CHEMBL3256968";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse at 0.06 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.06 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4143730";"B";"Inhibition of NAE in human Caco2 cells assessed as increase in beta-catenin protein levels after 16 hrs by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL3252379";"F";"Antineoplastic activity against mouse Colon 26 cells allografted in CDF1 mouse at 1.08 mg/kg qd for 9 days relative to control";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"Colon 26";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:1.08 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3256963";"F";"Antineoplastic activity against mouse P388 cells allografted in CDF1 mouse assessed as survival at 0.25 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:0.25 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Neoplasm Oncology Models";"P388 Experimental Leukemia | Neoplasms";"";""
"CHEMBL4143750";"B";"Inhibition of SAE-mediated Ubc9-SUMO conjugation in human Caco2 cells up to 10 uM preincubated for 10 mins followed by ATP and Mg2+ addition measured after 60 mins by Western blot analysis";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"7";"7 - Direct protein complex subunits assigned";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL4717327";"F";"Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation at 1 uM measured after 48 hrs by MTT assay relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HepG2";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL4348400";"F";"Antitumor activity against mouse H22 cells allografted in immunocompetent Balb/c mouse assessed as decrease in lump formation at challenge site at 2 uM incubated with cells for 5 hrs followed by compound washout prior to vaccination and subsequent H22 cells addition 10 days post vaccination and measured over 30 days";"Mus musculus";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"H22";"";"CHEMBL4346685";"30925340";"10.1016/j.ejmech.2019.03.051";"2019";"Eur J Med Chem";"171";"255";"264";"";"";"";"";"";""
"CHEMBL3252386";"F";"Antineoplastic activity against mouse L1210 cells allografted in CDF1 mouse assessed as survival at 10.8 mg/kg qd for 9 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"L1210";"";"CHEMBL3244053";"458801";"10.1021/jm00191a008";"1979";"J Med Chem";"22";"501";"505";"standard_type:DOSE standard_relation:= standard_value:10.8 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3997704";"F";"Antitumor activity against mouse 4T1.2 cells implanted in Balb/c mouse assessed as mouse survival time at 3 mg/kg, iv encapsulated within cucurbit[8]uril administered twice weekly for 2 weeks measured up to 33 days";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1.2";"";"CHEMBL3994676";"28523107";"10.1021/acsmedchemlett.7b00090";"2017";"ACS Med Chem Lett";"8";"538";"542";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL5138894";"F";"Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as tumor growth inhibition at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate relative to control";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL740566";"F";"In vivo antileukemic activity towards P388 Murine Leukemia at a dose of 0.8 mg/kg, expressed as long time survivors tested in 6 animals";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1132370";"10479282";"10.1021/jm980682p";"1999";"J Med Chem";"42";"3494";"3501";"standard_type:DOSE standard_relation:= standard_value:0.8 standard_units:mg.kg-1 comments:None";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Leukemia Oncology Models | Leukemia Oncology Models";"General Leukemia | P388 Experimental Leukemia";"";""
"CHEMBL3562054";"F";"PubChem BioAssay. A cell based assay for assessing THP-1 cell cytotoxicity of Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G.   (Class of assay: confirmatory) ";"";"457";"457";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"THP-1";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3527758";"A";"Fraction absorbed in human";"Homo sapiens";"62";"62";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"";"";"CHEMBL3526001";"21051535";"10.1124/dmd.110.034629";"2011";"Drug Metab Dispos";"39";"265";"274";"";"";"";"";"";""
"CHEMBL4143743";"F";"Induction of apoptosis in human Caco2 cells assessed as necrotic cells at 5 uM after 16 hrs by Annexin V-FITC/propidium iodide staining-based flow cytometric analysis (Rvb = 0.12%)";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"Caco-2";"";"CHEMBL4138244";"29232579";"10.1016/j.ejmech.2017.11.101";"2018";"Eur J Med Chem";"143";"1021";"1027";"";"";"";"";"";""
"CHEMBL1964014";"F";"PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ";"";"11487";"11548";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"PubChem BioAssays";"";"";"";"HOP-18";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562139";"F";"PubChem BioAssay. Increased chromatin condensation in HeLa cells-IC50.   (Class of assay: confirmatory) ";"";"183";"184";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"HeLa";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3562021";"F";"PubChem BioAssay. RKO viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"234";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL730538";"A";"Therapeutic effect against P388 leukemia in mice on days 1, 5 and 9 after administration of 1.6 mg/kg dose expressed as median survival time of treated and control mice (in vivo)";"Mus musculus";"1";"1";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"";"";"CHEMBL1126952";"8340911";"10.1021/jm00067a005";"1993";"J Med Chem";"36";"2084";"2090";"standard_type:DOSE standard_relation:= standard_value:1.6 standard_units:mg.kg-1 comments:None";"";"";"";"";""
"CHEMBL3072279";"F";"Inhibition of nuclear DNA synthesis in Homo sapiens (human) A549 cells assessed as decrease in bromodeoxyuridine incorporation measured during S phase after 24 hr by ELISA";"Homo sapiens";"12";"12";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL3046656";"None";"10.1007/s00044-012-0325-2";"2013";"Med Chem Res";"22";"3751";"3759";"";"";"";"";"";""
"CHEMBL3561990";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) ";"";"2189";"2208";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL3561973";"F";"PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) ";"";"558";"558";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL657466";"F";"Cytotoxic potency required to inhibit CH1 cell growth by 50%";"Homo sapiens";"13";"13";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"CH1";"";"CHEMBL1130313";"9371240";"10.1021/jm970114u";"1997";"J Med Chem";"40";"3749";"3755";"";"";"";"";"";""
"CHEMBL2439157";"F";"Trypanocidal activity against Trypanosoma brucei brucei by Alamar Blue assay";"Trypanosoma brucei brucei";"3";"3";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"5702";"";"";"";"";"CHEMBL2434842";"23927763";"10.1021/jm4004279";"2013";"J Med Chem";"56";"7727";"7740";"";"";"";"";"";""
"CHEMBL4717332";"A";"Cytotoxicity against human QSG7701 cells assessed as inhibition of cell proliferation at 5 uM measured after 48 hrs by MTT assay relative to control";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"9606";"";"";"QSG7701";"";"CHEMBL4715719";"27236067";"10.1016/j.ejmech.2016.04.031";"2016";"Eur J Med Chem";"121";"110";"119";"";"";"";"";"";""
"CHEMBL5106143";"F";"Antiproliferative activity against human A549 cells assessed as inhibition of cell growth";"Homo sapiens";"18";"18";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"A549";"";"CHEMBL5104159";"35931243";"10.1016/j.bmcl.2022.128919";"2022";"Bioorg Med Chem Lett";"73";"128919";"128919";"";"";"";"";"";""
"CHEMBL979644";"F";"Cytotoxicity against human HCT cells after 48 hrs by MTT assay";"Homo sapiens";"1";"1";"BAO_0000219";"cell-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"9606";"";"";"HCT";"";"CHEMBL1154573";"10843567";"10.1021/np9903705";"2000";"J Nat Prod";"63";"599";"601";"";"";"";"";"";""
"CHEMBL2078263";"F";"TP_TRANSPORTER: cell accumulation in KOT52 and D320 cells";"";"1";"1";"BAO_0000219";"cell-based format";"8";"8 - Homologous single protein target assigned";"";"TP-search Transporter Database";"";"";"";"KOT52;D320";"";"CHEMBL2074571";"10485464";"None";"1999";"Cancer Res";"59";"4237";"4241";"";"";"";"";"";""
"CHEMBL3088734";"F";"Antagonist activity at human recombinant dopamine D1 receptor expressed in CHOK1 cells assessed as inhibition of agonist-induced cAMP accumulation at 100 uM preincubated for 10 mins prior to agonist addition measured after 30 mins by HTRF assay relative to SCH23390";"Homo sapiens";"14";"14";"BAO_0000219";"cell-based format";"9";"9 - Direct single protein target assigned";"";"Scientific Literature";"9606";"";"";"CHO-K1";"";"CHEMBL3085742";"24088053";"10.1021/jm400813y";"2013";"J Med Chem";"56";"8377";"8388";"";"";"";"";"";""
"CHEMBL3561996";"F";"PubChem BioAssay. SW480 viability from Cell TiterGlo-IC50.   (Class of assay: confirmatory) ";"";"233";"233";"BAO_0000019";"assay format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"PubChem BioAssays";"";"";"";"";"";"CHEMBL1201862";"None";"None";"None";"None";"None";"None";"None";"";"";"";"";"";""
"CHEMBL5138900";"F";"Antitumor activity against mouse 4T1 cells implanted in Balb/c mouse assessed as nuclei disappearance at 50 mg/kg administered intratumorally every four days for 14 days in the presence of liquid cyanoacrylate";"Mus musculus";"2";"2";"BAO_0000218";"organism-based format";"1";"1 - Target assigned is non-molecular";"";"Scientific Literature";"10090";"";"";"4T1";"";"CHEMBL5137015";"35477142";"10.1016/j.ejmech.2022.114375";"2022";"Eur J Med Chem";"237";"114375";"114375";"";"ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS";"Neoplasm Oncology Models";"Neoplasms";"";""
"CHEMBL3253044";"A";"Therapeutic index, ratio of MTD for mouse P388 cells allografted ip dosed mouse to MED for mouse P388 cells allografted in ip dosed mouse administered as single dose";"Mus musculus";"6";"6";"BAO_0000218";"organism-based format";"0";"0 - Default value - Target unknown or has yet to be assigned";"";"Scientific Literature";"10090";"";"";"P388";"";"CHEMBL3244336";"490545";"10.1021/jm00195a002";"1979";"J Med Chem";"22";"1024";"1030";"";"";"";"";"";""
